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ABSTRACT 
Nathan James Gesmundo: The Development of Complexity Generating Organic Photoredox 
Transformations and the Application of These Transformations in Complex Molecule Synthesis 
(Under the direction of David A. Nicewicz) 
 
Described herein are three methods for the direct functionalization of alkenes, enabled by 
organic photoredox catalysis. Additionally, a model system studying the application of a 
photoredox cyclization method in natural product synthesis is described. 
I. Introduction to Visible Light Photoredox Catalysis 
An overview of visible light photoredox catalysis is presented. The principles of 
photoredox catalysis and single electron transfer are discussed and excited state photooxidants 
are introduced.  
II. Cyclization-Endoperoxidation Cascade of Unconjugated Dienes Mediated by a 
Pyrylium Photoredox Catalyst 
A method for the direct synthesis of bicyclic endoperoxides from unconjugated dienes 
using a pyrylium photoredox catalyst is presented. The reaction proceeds through the 
intermediacy of a distonic cation radical, with molecular oxygen serving as the peroxide source. 
Emphasis of this chapter is on the complimentary nature of our endoperoxidation strategy. 
III. Development of a Method to Directly Access γ-Lactam and Pyrrolidine Heterocycles 
via Polar Radical Crossover Cyclizations 
A method for the direct synthesis of γ-lactam and pyrrolidine heterocycles from alkenes 
and unsaturated N-nucleophiles is described. The reaction proceeds via a cation radical 
intermediate and utilizes a dual catalytic system comprised of an acridinium photooxidant and a 
 iv 
redox active hydrogen atom donor to produce the heterocyclic products. The boundaries of this 
mode of reactivity are explored and the complimentary nature of this method is emphasized. 
IV. Application of a Cation Radical Mediated Polar Radical Crossover Cycylization in a 
Rubriflordilactone B Model System 
A model system to explore the possibility of rubriflordilactone B synthesis utilizing a 
polar radical crossover cyclization as the key step is designed. Work on a key Mukaiyama 
vinylogous aldol reaction is presented as well as exploratory work on the central tetrahydrofuran-
forming cyclization. Discussions of related syntheses, retrosynthetic analysis, and future work 
are also presented. 
V. Hydrotrifluoromethylation of Aliphatic Alkenes and Styrenes 
A method for the catalytic hydrotrifluoromethylation of alkenes using an organic 
photoredox system is disclosed. The strategy operates by single electron oxidation of sodium 
trifluoromethane sulfinate and is tolerant of aliphatic and styrenyl alkene substrates. A dual 
catalytic system of an acridinium photoredox catalyst and a redox-active hydrogen atom donor is 
used to generate the observed products. 
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PREFACE 
Portions of the work, results, and supporting information disclosed for the synthesis of 
bicyclic endoperoxides from unconjugated dienes (Chapter 2) were published in Beilstein 
Journal of Organic Chemistry in 2014 as part of a thematic series on photoredox catalysis. The 
results and supporting information presented for the synthesis of γ-lactams and pyrrolidines from 
alkenes and unsaturated N-nucleophiles (Chapter 3) were published in as a communication in 
Organic Letters in 2015. The design and results pertaining to the rubriflordilactone B model 
system (Chapter 4) are unpublished and will hopefully aide current and future graduate students 
in their synthetic endeavours. Materials relating to the regioselective hydrotrifluoromethylation 
of aliphatic alkenes and styrenes (Chapter 5) were published as an article in Chemical Science 
in 2013.  
While the projects presented in this dissertation are covered in the most logical order for 
the overarching story and for ease of understanding, the chronological order in which the 
projects were completed is as follows:  
1) Endoperoxidation of unconjugated dienes (2012, Chapter 2),  
2) Hydrotrifluoromethylation of alkenes (2013, Chapter 5),  
3) γ-Lactam synthesis via polar radical crossover cyclization (2013-2014, Chapter 3)  
4) The rubriflordilactone B model system (2014-2015, Chapter 4) 
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CHAPTER 1: INTRODUCTION TO VISIBLE LIGHT PHOTOREDOX CATALYSIS 
 Introduction to photoinduced single electron transfer 1.1
Synthetic method development through visible light photoredox catalysis is a growing 
and continually maturing field in organic synthesis. Photoredox catalysis allows one to rapidly 
construct complex products from simple precursors, utilizing novel disconnections, under mild 
reaction conditions. While this statement applies to many fields in organic synthesis, the 
controlled generation of uniquely reactive intermediates under photoredox conditions (using 
visible light) allows one to devise completely new reaction pathways to construct previously 
inaccessible products.1–11 This is especially relevant in target-oriented synthesis, where the 
development of novel disconnections or new synthons can allow for the synthesis of key 
intermediates in fewer steps or, more importantly, allow for the synthesis of previously 
unapproachable frameworks. 
 Photoredox catalysis depends on single electron transfer (SET) between an electron 
donor (D) and an electron acceptor (A) to produce the donor cation radical and acceptor anion 
radical, as shown in Figure 1.1. In photoredox systems, one of these key species (either the donor 
or the acceptor) is created upon photoexcitation.4,6 The reverse of this process, back electron 
transfer (BET) is depicted in Figure 1.1 as the regeneration of the ground state donor (D) and 
acceptor (A).6 
Figure 1.1 Single Electron Transfer 
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With respect to the reaction substrate, two modes of single electron transfer exist: single 
electron reduction and single electron oxidation. In photoinduced single electron reduction 
chemistry (oxidative quenching of the catalyst), the acceptor is the substrate and the donor a 
strong reductant generated upon excitation. After SET, during which the reduced substrate 
(acceptor) is generated, reactivity can proceed via two paths: the anion radical or fragmentation 
(Figure 1.2). Reactivity through the intermediate anion radical was shown by Yoon and 
coworkers in a crossed intermolecular [2+2] cyclization of enones (Figure 1.2A).12 Reduction of 
the enone substrate forms the key anion radical intermediate (vide infra), from which enone 
trapping, cyclization, and single electron oxidation generates the shown cyclobutane product. 
Reactivity upon fragmentation was shown by MacMillan and coworkers (Figure 1.2B).12 In their 
system, single electron reduction of a bromomalonate results in expulsion of bromide and 
formation of the malonate radical. The shown aldehyde product is formed after radical C−C bond 
formation, single electron oxidation, and iminium ion hydrolysis. 
Figure 1.2 Reactivity arising from single electron reduction of a substrate 
 
In photoinduced single electron oxidation chemistry (reductive quenching of the 
catalyst), the electron donor is the substrate and the acceptor a strong oxidant generated upon 
photoexcitation. After SET and oxidation of the substrate, reactivity can proceed from either the 
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cation radical intermediate or fragmentation (Figure 1.3). Reactivity through the intermediate 
cation radical was again shown by Yoon and coworkers in their crossed intermolecular [2+2] 
cycloaddition using styrenes (Figure 1.3A).13 The desired reactivity proceeds from the cation 
radical (vide infra), from which the cyclobutane product is formed after styrene 
trapping/cyclization and single electron reduction. Reactivity upon fragmentation was shown 
recently by MacMillan (Figure 1.3B).14 In their novel system for the generation of α-aryl amines, 
the key radical intermediate is formed upon single electron oxidation of the carboxylate and 
rapid CO2 extrusion. From the α-amino radical intermediate, radical-radical coupling with a 
cyanoarene anion radical and loss of the cyanide nucleofuge generates the α-aryl amine product. 
Figure 1.3 Reactivity arising from single electron oxidation of a substrate 
 
 While both single electron oxidation and reduction have proven to be powerful strategies 
for synthetic method development in other groups, the Nicewicz group is interested in 
methodology and natural product synthesis through photoinduced single electron oxidation. 
Specifically, we seek to access the unique reactivity of olefin cation radicals through 
photoinduced electron transfer (PET) using organic photooxidants (Figure 1.4). This chapter will 
shed light on PET and the advantages of organic photooxidants, providing necessary background 
for the following chapters. 
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Figure 1.4 Olefin cation radical reactivity 
 
 Principles of photoinduced single electron oxidation 1.2
Single electron oxidation of a donor via photoinduced electron transfer relies on electron 
transfer between a ground state donor (the substrate) and an excited state acceptor (the oxidant) 
to generate cation radical intermediates. Visually, a molecular orbital depiction of this is shown 
in Figure 1.5, between a neutral donor and a neutral acceptor.2,15 In the ground state, the 
photooxidant (A) is a poor electron acceptor, rendering electron transfer with a donor (D) 
endergonic and unfavorable (Figure 1.5A). Excitation of the acceptor however generates a 
powerful oxidant. Excitation of an electron from the HOMO to the LUMO generates a vacancy 
(“electron hole”) in the lower lying SOMO of the acceptor. Electron transfer from the donor 
molecule fills this vacancy, affording the donor cation radical and the 1e− reduced acceptor. In 
practice, this is realized when using acceptors such as the N-methyl mesityl acridinium cationic 
photooxidant (Figure 1.5B). In the ground state, the acridinium is a poor oxidant (possessing a 
low reduction potential), however it is a powerful oxidant upon excitation (possessing a high 
reduction potential), capable of oxidizing a diverse range of substrates.16,17 This gives one 
significant control over the system as well, as light is required for excitation, the reaction will not 
proceed in the absence of light. Energy is selectively put into the photoredox catalyst rather than 
the whole system, as most simple organic molecules do not absorb in the visible region. 
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Figure 1.5 FMO diagram of photoinduced electron transfer 
 
In solution, with a neutral donor and a neutral acceptor, electron transfer proceeds as 
depicted in Figure 1.6A.15 After excitation, the solvated excited state acceptor forms an 
encounter complex with a donor molecule. In this complex the donor and excited state acceptor 
are separated by ~7 Å and are together surrounded by several shells of solvent molecules. During 
the lifetime of the encounter complex, the donor and acceptor undergo critical structural 
(nuclear) and electronic (orbital) changes to allow for quenching by electron transfer. Electron 
transfer then proceeds through the collision complex (where the donor and acceptor are in 
contact) to produce a contact ion pair (CIP, oxidized donor and reduced acceptor). Dissociation 
of the paired ions via solvation produces a solvent separated ion pair (SSIP) and eventually free 
ions able to engage another reactant. Solvent separation of the ion pair is key to minimizing back 
electron transfer and for reaction progression, but is solvent dependent. Polar solvents better 
solubilize the ions and encourage formation of the SSIP, whereas nonpolar solvents encourage 
formation of the CIP.15 Another strategy to encourage dissociation is through the use of a 
cationic photosensitizer (Figure 1.6B).  Proceeding through the same encounter complex → 
collision complex → CIP pathway, electron transfer in this case produces the donor cation 
radical and a ground state acceptor radical (A•). Lacking Coulombic attraction, these species 
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more freely dissociate.1 In this sense, cationic acceptors are superior to neutral acceptors as back 
electron transfer is minimized and reaction efficiency improved. 
Figure 1.6 Electron transfer in solution 
 
 Redox potentials as a predictive tool for electron transfer 1.3
The oxidation potential (half wave, E1/2ox) of a donor measures the tendency of a species 
to give up an electron in a redox event, and is measured in volts (V). Species that are more easily 
oxidized possess lower (more negative) oxidation potentials. Likewise, the reduction potential 
(half wave, E1/2red, measured in volts) of an acceptor measures its ability to acquire an electron 
and be reduced. Stronger oxidants, species that more readily accept an electron, possess higher 
(more positive) reduction potentials. The oxidation potential of the donor and reduction potential 
of the acceptor can be used to understand the viability of a redox process between a given 
donor/acceptor pair. The Nernst Equation, (1), relates these two values to free energy, where ΔG 
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As ΔG is negative for an exergonic process, a favorable redox event should utilize an acceptor 
whose reduction potential exceeds (is more positive than) the oxidation potential of the donor. 
Steckhan and coworkers reinforced the relationship between ΔG and redox potentials, using the 
simplified Weller Equation (2) as a predictive tool to rationalize electron transfer.1 Here, solvent 
effects are expressed through the Coulombic interaction term, ΔEcoul, but are minimized when 
using a cationic acceptor with a neutral donor as the number of charged species does not change 
during the redox event. Examining the relationship between E1/2ox(D) and E1/2red(A), the Weller 
equation further demonstrates the importance of acceptor reduction potential exceeding donor 
oxidation potential to ensure ΔG is negative and the redox event exergonic.  ∆𝐺!" =   𝐸!/!!" (𝐷)− 𝐸!/!!"#(𝐴)− ∆𝐸!"#$% + ∆𝐸!"#$ (2) 
 Donor redox potential scale 1.4
Figure 1.7 depicts relative ease of oxidation for selected donors in a redox event through 
a scale of oxidation potential (measured in V vs. SCE [saturated calomel electrode]).19 Donors 
such as transient carbon-centered radicals possess very low oxidation potentials,20 as do amine 
donors (+0.89 and +1.19 V for triethylamine and tetrahydroisoquinoline, respectively19), and 
thus readily give up an electron. Sodium trifluoromethanesulfinate, Langlois reagent, also 
possesses a low oxidation potential of +1.05 V vs. SCE.21 Lastly, electron rich arenes such as 
1,2-dimethyoxybenzene (+1.49 V) possess relatively low oxidation potentials and are thus more 
easily undergo single electron oxidation compared to their less electron rich counterparts (1,2-
dimethylbenzene: +2.28 V).19 
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Figure 1.7 Donor oxidation potentials 
 
 Olefin donors exist over a much wider range of oxidation potentials and display more 
obvious trends (Figure 1.7).22 Examining the styrene donors shown in Figure 1.7, increasing 
substitution has a stabilizing effect as observed when comparing styrene with β-methylstyrene 
(lowering Ep/2ox by 0.35 V). Inductive or resonance donating groups also have stabilizing effects, 
further lowering donor oxidation potential (cf. β-methylstyrene, +1.68 V, and β-methyl-4-
methoxystyrene, +1.28 V). While the o-methoxy group is still donating by resonance, the 
stabilizing effect observed in the oxidation potential of β-methyl-2-methoxystyrene is not as 
significant as observed in anethole (+1.54 V vs. +1.28 V respectively).19 This observation is 
rationalized by a steric clash between the propenyl substituent and the o-methoxy group, forcing 
the arene out of plane and conjugation with the alkene, thus providing less of a stabilizing effect 
on the cation radical generated after SET. Withdrawing groups have the opposite effect of 
donating groups, raising oxidation potential, as seen when comparing β-methylstyrene and β-
methyl-4-chlorostyrene. The effect of increasing substitution and installing inductively donating 
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groups is also observed when surveying oxidation potentials of aliphatic alkenes. Examining 1-
hexene, 2-methyl-1-butene, and 2-methyl-2-butene (Figure 1.7), the additional substitution 
lowers the oxidation potential significantly (from +2.85 V to +2.56 V to +2.04 V), providing a 
stabilizing effect on the alkene cation radical generated after SET.22 
 Suitable acceptors for alkene donors 1.5
Alkene cation radicals display umpulong (electrophilic) reactivity relative to their alkene 
precursors (typically nucleophilic) and possess both radical and polar (cationic) reaction 
vectors.1,2 Because of the unique reactivity of alkene cation radicals as well as the diversity and 
abundance of alkene substrates, alkenes are attractive substrates for a redox system. Alkenes 
however exist over a wide range of oxidation potentials (Figure 1.7) and require powerful 
oxidants capable of oxidizing a wide range of substrates. Many ground state chemical oxidants 
and excited state photochemical oxidants have been employed with success in SET systems and 
the reduction potentials of select representatives from both classes of oxidants are shown in 
Figure 1.8.1,6,15,17,23,24 While ground state oxidants such as ceric ammonium nitrate (CAN, +1.07 
V vs. SCE) or Ru(bpy)33+ (+1.29 V vs. SCE) excel in the oxidation of easily oxidized donors 
such as triethylamine (+0.89 V vs. SCE), sodium trifluoromethanesulfinate (+1.05 V vs. SCE), 
or anethole (+1.28 V vs. SCE) we are unaware of any ground state oxidants that possess 
reduction potentials in excess of +1.5 V. Even the excited state photooxidant *Ru(bpz)32+ (+1.45 
V vs. SCE) is only capable of oxidizing the most electron rich substrates, despite being a 
significantly stronger oxidant than either *Ru(bpy)32+ (+0.77 V vs. SCE) or Ru(bpy)33+ (+1.29 V 
vs. SCE). 
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Figure 1.8 Acceptor reduction potential scale 
 
Oxidation of a larger range of alkene donors becomes possible when organic excited state 
photooxidants such as cyanoarenes, mesityl acridinium, or the pyrylium family are employed 
(Figure 1.8). N-methyl mesityl acridinium (Mes-Acr+), triphenylpyrylium (TPT), and 9,10-
dicyanoanthracene (9,10-DCA) all possess excited state reduction potentials in excess of 2.0 V, 
allowing for successful electron transfer with electronically and functionally diverse styrenyl 
alkenes as well as select aliphatic alkenes.1,17,24 For this reason primarily, excited state organic 
photooxidants are used to access alkene cation radicals in the Nicewicz laboratory. It should be 
noted however that even with elevated excited state reduction potentials, substrate limitations 
still exist. For example, SET between these photooxidants and less substituted aliphatic alkenes, 
such as 2-methyl-1-butene (+2.56 V) is endergonic and therefore not favorable. 
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Several other factors separate the acridinium and pyrylium scaffolds from cyanoarenes as 
excited state photooxidants: their cationic nature, redox tenability, modular synthesis, and cost. 
As discussed in 1.2 and displayed in Figure 1.6, cationic photosensitizers such as pyrylium or 
acridinium catalysts minimize Coulombic attraction after electron transfer (there is no net change 
in number of charged species after SET; the reduced acceptor exists as a ground state persistent 
radical), thereby making solvent separation and dissociation to the free cation radical more 
likely.1 Neutral photosensitizers such as 9,10-DCA form an acceptor anion radical along with the 
donor cation radical as a contact ion pair after SET.15 Separation of the CIP to the SSIP (then to 
free ions) can be difficult, increasing the probability of unproductive back electron transfer. As 
shown in Figure 1.9, the redox properties and electronic/steric environments of the pyrylium and 
acridinium catalysts are also easily tunable due to their modular syntheses. 
Figure 1.9 Redox tenability through modular syntheses 
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acridinium catalyst can be controlled by introducing substitution at the highlighted positions 
during its four-step synthesis (Figure 1.9B).25 Electron donating or releasing groups can have 
subtle effects on excited state reduction potential and substitution can reduce susceptibility to 
nucleophilic decomposition.26 An advantage the acridinium catalyst does have over the pyrylium 
catalyst is that it is relatively inert to nucleophilic deactivation (Figure 1.10). The mesityl group 
at the 9-position of the acridinium core, oriented perpendicularly, introduces a steric effect that 
diminishes the chances of catalyst decomposition. Still, increased substitution can render the 
catalyst even more robust. A current focus of the Nicewicz laboratory is designing more 
powerful acridinium photooxidants and catalysts more capable of withstanding nucleophilic 
conditions through strategic substitution (Figure 1.9B, Figure 1.10).  
Figure 1.10 Nucleophilic deactivation pathway of organic photooxidants 
 
Lastly, 2,4,6-triphenylpyrylium tetrafluoroborate (λmax = 416 nm), its derivatives (e.g. 
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irradiation e.g. p-dicyanobenzene, λmax = 290 nm15), it is still expensive and thus less attractive as 
an excited state photooxidant. 
N
Me
Me
Me
Me
O
BF4BF4
Nu:
Nu:
2,4,6-triphenylpyrylium
tetrafluoroborate
9-mesityl-10-methylacridinium
tetrafluoroborate
 13 
 Successful application of organic photooxidants 1.6
Having provided background on photoredox catalysis and excited state organic 
photooxidants, to conclude this introductory chapter, examples showcasing successful 
applications of organic photooxidants in complex molecule synthesis will be presented. The first 
example comes from Steckhan in 1993: a pyrylium salt (1) catalyzed [4+2] cycloaddition 
between dienes and styrene dienophiles (Figure 1.11).1 Steckhan proposed oxidation of the 
styrene to the corresponding cation radical followed by trapping of the diene (as shown) to 
produce a distonic cation radical. Single electron reduction produces the [4+2] adduct with exo 
selectivity. They showed use of electronically diverse styrene derivatives in this transformation 
and later demonstrated other cycloaddition reactions as well. 
Figure 1.11 Cation radical mediated [4+2] cycloaddition catalyzed by a pyrylium salt 
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alkene generates a distonic cation radical (vide infra), from which the cyclobutane product is 
produced upon single electron reduction. The authors showed a diverse styrene scope, with the 
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electron relay system being key for product formation due to competitive cycloreversion (via 
oxidation of the cyclobutane product). Additionally the method was applied to the direct 
synthesis of cyclobutane lignin natural products. 
Figure 1.12 [2+2] Dimerization of styrenes using a pyrypium photoredox catalyst  
 
Fukuzumi reported the synthesis and photophysical characterization of the mesityl 
acridinium organic photooxidant (Mes-Acr+, 3 below) in early 2004 and shortly thereafter 
showed its utility in photochemical oxidation chemistry.16,29 One example of its use, the 
oxidative cleavage of electron rich olefins to carbonyl products, is shown below in Figure 1.13. 
The transformation is believed to occur via an olefin cation radical/superoxide pathway: 3* 
fluorescence is quenched by tetraphenylethylene to generate the requisite cation radical. Oxygen 
is then reduced to superoxide, regenerating 3, and radical coupling forms the shown 1,2-
dioxetane. Prolonged irradiation then cleaves the dioxetane to ketone products (benzophenone). 
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Figure 1.13 Oxidative cleavage of olefin donors to carbonyl products 
 
Fukuzumi later used the acridinium photosensitizer in aryl bromination, as shown below 
in Figure 1.14.27 A noticeable difference in this system is the use of oxygen as the terminal 
oxidant (producing hydrogen peroxide) rather than a coupling partner. The reaction begins with 
generation of the arene cation radical, produced from PET with 3*. PET is followed by addition 
of bromide to the cation radical and O2 reduction (regenerating 3). H-atom abstraction by HO2•, 
generated upon superoxide protonation, restores aromaticity and produces the observed products, 
the brominated arene and hydrogen peroxide. The mesityl acridinium catalyst 3 excelled at 
oxidizing a diverse array of arenes and this method showcased the umpulong electrophilicity of 
cation radical intermediates. 
Figure 1.14 Aryl bromination under oxygen using the mesityl acridinium catalyst 
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The above examples show unequivocally the utility of acridinium and pyrylium organic 
photoredox catalysts in the generation of cation radicals from substrates possessing elevated 
oxidation potentials and their utility in the development of novel cation radical mediated 
methods. Because of this precedent, prior referenced examples, and the reasons emphasized 
earlier in this chapter, pyrylium and acridinium organic photoredox catalysts are used in the 
photoredox olefin functionalization methods described herein. 
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CHAPTER 2: CYCLIZATION-ENDOPEROXIDATION CASCADE OF UNCONJUGATED DIENES 
MEDIATED BY A PYRYLIUM PHOTOREDOX CATALYST* 
 Introduction  2.1
In the previous chapter, the field of photoredox catalysis was introduced and principles of 
photoredox catalysis were discussed. This chapter presents our first application of organic 
photoredox catalysis towards the generation of complex molecules. Specifically, a strategy for 
the direct synthesis of bicyclic endoperoxides from unconjugated dienes is displayed (Figure 
2.1). This reaction proceeds via the intermediacy of a distonic cation radical with molecular 
oxygen serving as the peroxide source and is unique in its use of visible light photoredox 
catalysis coupled with an organic triarylpyrylium photooxidant. The state of the field will be 
addressed followed by discussion of our contributions. 
Figure 2.1 Photoredox endoperoxidation of unconjugated dienes 
 
 Endoperoxidation background 2.2
 Endoperoxide natural products, biological activity, functional handle 2.2.1
Endoperoxides, cyclic compounds possessing an internal peroxide bridge, embody a 
unique class of natural products, often eliciting strong physiological effects and possessing 
                                                
* Portions of this chapter previously appeared as an article in Beilstein Journal of Organic Chemistry. The original 
citation is as follows: Gesmundo, N. J.; Nicewicz, D. A. “Cyclization-Endoperoxidation Cascade Reactions of 
Dienes Mediated by a Pyrylium Photoredox Catalyst” Beilstein J. Org. Chem. 2014, 10, 1272-1281. 
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functionally dense, polycyclic frameworks.1 Relevant members of this family of compounds are 
shown in Figure 2.2. Artemisinin, a champion of the class, displays potent antimalarial activity 
and is regularly used to treat the disease.2,3 Other biologically active endoperoxide natural 
products include yingzhaosu A, which also displays antimalarial activity, and the structurally 
related polycyclic species merulin A,4 merulin C,4 and talaperoxide D,5 which display ranging 
cytotoxic activity against cancer cell lines.  Sesquiterpene muurolan-4,7-peroxide was recently 
isolated and possesses a unique polycyclic structure with little functionality beyond the O−O 
endoperoxide bridge.6 Lastly, prostaglandin H2 is a necessary precursor, from which 
physiologically active prostaglandins are produced. 
Figure 2.2 Biologically active, physiologically relevant, and functionally rich endoperoxides 
 
Endoperoxide natural products are united by the presence of a peroxide bridge between 
two carbons within a ring (highlighted in Figure 2.2). Biological activity is thought to arise from 
the weak nature of the O−O bond (BDE 35-40 kcal/mol), where O−O cleavage produces reactive 
oxygen-centered radicals, which then cause cell damage.2,3,7 In the case of artemisinin, data 
supports the endoperoxide as the active pharmacophore.2,7,8 
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Beyond its presence in natural products and the biological activity it can impart, the 
endoperoxide moiety is useful to a synthetic chemist as a functional handle to produce new 
oxygenated motifs. Two such transformations are shown in Figure 2.3: reduction of the 
endoperoxide using Zn/AcOH yields a diol product and subjecting the endoperoxide to basic 
conditions (Et3N in DCM) elicits the Kornblum-DeLaMare rearrangement to produce a 
hydroxyketone.9 
Figure 2.3 The endoperoxide as a functional handle 
 
 The utility of the endoperoxide as a functional handle to access oxygenated products and 
the biological activity of endoperoxide containing natural products makes them rewarding targets 
for a synthetic chemist.  In target-oriented synthesis, installation of the peroxide bridge however 
can be challenging due its relative sensitivity.  As a result, endoperoxidation is often 
accomplished late-stage in a synthesis, requiring good functional group tolerance and 
regioselectivity for the chosen endoperoxidation strategy.  Thus, synthetic methods that allow for 
the generation of endoperoxide cores under milder conditions, in fewer synthetic operations, and 
in a controlled manner are viewed favorably by the synthetic community. 
 Classic examples of endoperoxide construction in total synthesis 2.2.2
Endoperoxide formation in natural product synthesis has traditionally been achieved 
through a multistep approach: hydroperoxide synthesis followed by cyclization of the 
hydroperoxide utilizing an appropriate electrophile. First, in the 1980 total synthesis of 
artemisinin, Hofheinz achieved endoperoxidation via a two-step, one-pot singlet oxygen 
mediated hydroperoxide formation/acid-catalyzed cyclization cascade (Figure 2.4).10 Methylene 
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blue was used to generate requisite singlet oxygen (1O2) from atmospheric triplet oxygen.  
Interception of the enol ether substrate by singlet oxygen produced the shown hydroperoxide-
acetal via the intermediacy of 1) a transient perepoxide and 2) the shown 1,2-dioxetane (vide 
infra).11 The dioxetane opened to reveal the hydroperoxide and was trapped as the dimethylacetal 
intermediate.10 Treatment of the in situ generated hydroperoxide with acid (HCOOH) revealed 
the requisite aldehyde and initiated a cyclization cascade: 1) cyclization of the hydroperoxide 
onto the tethered ketone (7-exo-trig), 2) cyclization of the intermediate peroxy hemiketal onto the 
aldehyde (7-exo-trig), and 3) condensation/lactonization (6-exo-trig).12 From this 
oxygenation/cyclization cascade, artemisinin was produced in a 30% yield.10 
Figure 2.4 Endoperoxidation in the 1980 total synthesis of artemisinin 
 
 The second example comes from Xu’s 1991 total synthesis of (+)-yingzhaosu A and 
employs a singlet oxygen ene reaction/hydroperoxide conjugate addition cascade to install the 
endoperoxide (Figure 2.5).13 Methylene blue was again used to generate singlet oxygen, however 
in an example of the divergent reactivity of singlet oxygen, an ene reaction involving the 
exocyclic olefin produced an allylic hydroperoxide (vide infra).  The hydroperoxide then 
underwent 6-exo-trig cyclization via enone conjugate addition to form the key bicyclic 
endoperoxide intermediate as a mixture of C8 epimers. This intermediate was carried on to 
yingzhaosu A over seven additional transformations. 
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Figure 2.5 Endoperoxidation in the 1991 total synthesis of yingzaosu A 
 
 While elegant, these cyclization cascade approaches are limited due to the intermediacy 
of singlet oxygen and their multistep nature. In both cases endoperoxidation was accomplished 
by 1) hydroperoxide synthesis and 2) hydroperoxide cyclization. Hydroperoxides are sensitive 
functional groups and subsequent manipulations to an endoperoxide framework are therefore 
limited.  While singlet oxygen is known for its ability to produce hydroperoxides (vide supra), 
singlet oxygen is highly reactive and participates in [4+2] and formal [2+2] processes in addition 
to ene pathways.14,15 Multiple oxygenated products are thus possible from one substrate. Because 
product distribution in singlet oxygen pathways can be difficult to control and functional group 
tolerance can be limited, a general endoperoxidation method carried out under mild conditions 
would be a welcome synthetic capability. 
 Direct approaches or alternative cyclization strategies for endoperoxidation 2.2.3
 Singlet oxygen [4+2] cycloaddition 2.2.3.1
The intermediacy of a hydroperoxide can be bypassed and the two C−O bonds of the 
endoperoxide formed directly in one step in a singlet oxygen [4+2] cycloaddition. In this system, 
singlet oxygen participates as the dienophile when paired with a diene (Figure 2.6, singlet 
oxygen produced using tetraphenylporphyrin as a photosensitizer).15 While direct, the 
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requirement of reactive singlet oxygen is a drawback due to previously mentioned competing 
reaction pathways, and the cycloadduct can possibly react further with 1O2 (vide infra). 
Figure 2.6 Singlet oxygen [4+2] cycloaddition 
 
 Peroxyquinol desymmetrization to produce 1,2,4-trioxanes 2.2.3.2
The Rovis lab developed a powerful method for the asymmetric synthesis of 1,2,4-
trioxanes via the desymmetrization of peroxyquinols through a Brønsted acid cascade (Figure 
2.7).16 The reaction proceeds via reversible formation of a racemic peroxy hemiacetal. Dynamic 
kinetic resolution of the peroxy hemiacetal followed by Brønsted acid-catalyzed symmetry-
breaking oxa-Michael cyclization produces the endoperoxide products with exceptional levels of 
enantioenrichment. These products and their derivatives were screened for cytotoxicity and 
showed activity against a number of cancer cell lines. This report further emphasized the pivotal 
role of synthetic method development in granting quick access to novel biologically active 
scaffolds and in contrast to the previous case, the peroxy group was installed in a separate step.  
Figure 2.7 Thiourea/Brønsted acid-catalyzed synthesis of 1,2,4-trioxanes 
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discussed: a 2009 report from Woerpel and the 2012 communication from Johnson and 
coworkers. Woerpel utilized palladium catalysis to cyclize a tertiary hydroperoxide into a 
pendant alkene in an oxidative process to produce 1,2-dioxane products (Figure 2.8).17 
Benzoquinone was necessary to regenerate the active palladium catalyst. However, yields were 
unfortunately low as reduction of the hydroperoxide to the alcohol followed by cyclization to the 
related tetrahydrofuran was identified as a competing process. 
Figure 2.8 Palladium-catalyzed hydroperoxide/alkene cyclization 
 
 The Johnson lab achieved endoperoxidation utilizing gold catalysis and α-hydroperoxy 
Meldrum’s Acid derivatives (Figure 2.9).18 The hydroperoxide substrates were produced under 
mild, aerobic, Cu(II)-catalyzed conditions and then cyclized using Au(I) catalysis. Yields were 
high for both steps of the sequence, but more importantly, the conditions were very mild. 
Figure 2.9 Gold-catalyzed hydroperoxide/alkyne cyclization of Meldrum’s Acid derivatives 
 
 Peroxidation of unconjugated dienes in a Co(II)/O2 system 2.2.3.4
Masuyama was able to achieve endoperoxidation of unconjugated dienes to produce 1,2-
dioxanes in good yields using a system comprised of catalytic Co(II), Et3SiH as a reductant, and 
atmospheric oxygen (Figure 2.10).19 The transformation proceeds via substrate hydrocobaltation 
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molecular oxygen produces the oxygen-centered radical shown in Figure 2.10 (vide infra) which 
readily cyclizes to produce a tertiary carbon-centered radical.  Trapping of this radical with 
oxygen followed by cobalt(II)-mediated silylation/acid-catalyzed desilylation produces the 
endoperoxide depicted in Figure 2.10.  This method is elegant for its use of atmospheric oxygen 
and mild reaction conditions for rapid molecular complexity generation, however pathways to 
produce uncyclized hydroperoxides or 1,2-dioxolane products were sometimes competitive. 
Figure 2.10 Direct endoperoxide synthesis by a Co(II)/O2 cyclization cascade 
 
 Construction of polycyclic endoperoxides via single electron transfer 2.2.4
A powerful technique for endoperoxide synthesis is through single electron transfer 
(SET) strategies. The generation of reactive carbon-centered radical intermediates though SET 
allows one to form multiple bonds of a polycyclic core in one step using atmospheric (triplet) 
oxygen as the peroxide source. Seminal work in this area began in the 1980’s and was the 
inspiration for our work in the area of radical cation mediated endoperoxidation. 
 Nelsen’s cation radical mediated [4+2] cycloaddition with oxygen 2.2.4.1
Nelsen reported endoperoxide synthesis from α-terpanine and atmospheric oxygen via a 
cation radical-mediated [4+2] cycloaddition (Figure 2.11).20 The reaction proceeds by single 
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V vs. SCE)21 and the triarylaminium oxidant to generate the cation radical intermediate pictured. 
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Radical trapping of oxygen followed by single electron reduction (via oxidation of another 
equivalent of substrate in a chain process) furnishes the bridged bicyclic endoperoxide shown. 
This and earlier reports were key in establishing cation radical-mediated strategies using ground 
state triplet oxygen as a viable option for endoperoxide synthesis.22 
Figure 2.11 Nelson’s endoperoxidation via cation radical mediated [4+2] cycloaddition  
 
 Miyashi’s cation radical mediated cyclization of unconjugated dienes with oxygen 2.2.4.2
Cation radical-mediated oxygenation methodology was extended by Miyashi during his 
studies into the mechanism of the cation radical-mediated Cope rearrangement (Figure 2.13).23 
Of interest to Miyashi was the possible intermediacy of a 1,4-distonic cation radical in the Cope 
rearrangement.24,25 He sought to trap the 1,4-distonic cation radical with oxygen to provide 
evidence for its intermediacy in the Cope rearrangement. 
Figure 2.12 Generic cation radical Cope rearrangement mechanism 
 
Miyashi showed endoperoxidation of unconjugated bis(styrenyl) substrates in a formal [2+2+2] 
cyclization proceeding via a distonic cation radical intermediate utilizing oxygen as the peroxide 
source (Figure 2.13). 9,10-Dicyanoanthracene (9,10-DCA, E1/2red* = +2.17 V vs. SCE) 
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2.13) to generate a localized cation radical intermediate (ion paired with reduced 9,10-DCA•−).  
The localized intermediate readily cyclized to form the key distonic cation radical intermediate, 
which was transformed into the bicyclic endoperoxide upon oxygen trapping and single electron 
reduction.24 The key aspect of this transformation is that that three bonds of the bicyclic 
endoperoxide are formed in one operation: one C−C and two C−O. This allows one to forge the 
polycyclic carbon framework and the peroxide together in one step. As Miyashi’s endoperoxide 
product lacks saturation (a common theme among endoperoxide natural products) in the 
dioxabicyclo[2.2.2]octane core, this technology could be applicable to complex molecule 
synthesis. The scope of this endoperoxidation strategy over time was extended to include less 
electron-rich bis(styrenyl) substrates and extended tethers.26,27 
Figure 2.13 Miyashi’s studies into cation radical mediated processes 
 
 Yoon’s strategy for the synthesis of fused bicyclic endoperoxides via SET 2.2.4.3
Yoon and coworkers published a related strategy to construct fused bicyclic 
endoperoxides from bis(styrene) substrates and oxygen in 2012 (Figure 2.14).9 Yoon’s method is 
mechanistically similar to Miyashi’s: Ru(bpz)32+ (E1/2red* = +1.45 V vs. SCE) fluorescence is 
quenched by the shown bis(styrene) substrate (E1/2ox = +1.1 V vs. SCE) to generate the localized 
cation radical intermediate which readily cyclizes to the stable distonic cation radical. Oxygen 
trapping and single electron reduction then furnishes the fused bicyclic endoperoxide. The 
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visible light as the energy source) in place of 9,10-DCA, the ability to cyclize unsymmetrical 
bis(styrene) substrates, and the structure/substitution patterns of the novel endoperoxides 
produced. This method was however unsuccessful in the cyclization of substrates bearing 
aliphatic as opposed to styrenyl alkenes and catalyst limitations precluded the cyclization of 
electron deficient substrates. This work was published during our investigation into the 
cyclization and endoperoxidation of unconjugated dienes. 
Figure 2.14 Yoon’s endoperoxidation of bis(styrene) substrates 
 
 Designing a method to access endoperoxides through organic photoredox catalysis 2.3
Examining previous work in the field of cation radical-mediated oxygenation, we were 
inspired by Miyashi’s report of unconjugated diene endoperoxidation.24 The one step formation 
of one C−C and two C−O bonds (forming both the endoperoxide and the polycyclic core) made 
this transformation very powerful. If this method could be extended to unsymmetrical 
unconjugated dienes with aliphatic substitution, variable tether lengths, and new cyclization 
modes, this method could be of broad use in endoperoxide natural product synthesis (Figure 
2.15). It was our goal to take this chemistry in the direction just described. We hoped to achieve 
this goal using atmospheric oxygen (at low pressures) as the peroxide source, and also by using 
triarylpyrylium organic photoredox catalysts to achieve single electron oxidation. The 
triarylpyrylium catalysts were attractive because of their tunable redox properties (Figure 2.15), 
their absorption bands extending into the visible region, and most importantly because they do 
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not produce either singlet oxygen or superoxide in aerobic systems.23,28 That these deleterious 
pathways would not be accessible would give us better control of the system. 
Figure 2.15 Endoperoxide project genesis 
 
 Early work in the pyrylium-catalyzed cyclization/endoperoxidation cascade 2.4
 Replicating Miyashi’s endoperoxidation 2.4.1
We first tested the feasibility of the endoperoxidation using a pyrylium catalyst, visible 
light, and atmospheric oxygen (1 atm) with Miyashi’s symmetric unconjugated bis(styrene) 
substrate 2a, as the corresponding endoperoxide was known. We were pleased to see that when 
employing 0.5 mol % 1c in acetonitrile, 470 nm LED strips, under an atmosphere of oxygen at 
ambient temperature, known endoperoxide 3a was produced from diene 2a in a 50% yield 
(Figure 2.16). While the yield was lower than what Miyashi reported in his system and we 
isolated 5% of the 1,4-dione oxidative cleavage product 4a, this promising result proved that 
general endoperoxidation using a pyrylium based organic photoredox system was possible. 
Figure 2.16 Successful cyclization of Miyashi’s model substrate 
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 Moving away from Miyashi’s substrate 2.4.2
We next decided to examine less electron rich, unsymmetrical substrates in the 
cyclization/endoperoxidation cascade (Figure 2.17). First, substrates that were expected to 
cyclize through a 6-endo-trig cyclization (analogous to Miyashi’s substrate) were examined (2b 
and 2c). Despite examining all relevant reaction parameters (catalyst, solvent, temperature, 
oxygen source, see Figure 2.17), the dominant reaction pathway was always olefin oxidative 
cleavage to dione products; endoperoxidation was never observed. Despite the dominance of the 
oxidative cleavage pathway, unsaturated ketone 2c did yield trace quantities of the novel bicyclic 
ketal product 5c. We proposed that this product was formed according to the cyclization shown 
in Figure 2.17 involving formaldehyde and 2c. The formaldehyde would have been generated in 
situ from oxidative cleavage of an equivalent of 2c (to give formaldehyde along with dione 4c). 
Figure 2.17 Attempted endoperoxidation of unsymmetric unconjugated dienes 
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As less electron rich, unsymmetrical 6-endo-trig substrates were unsuccessful in this 
transformation, we decided to examine a 5-exo-trig cyclization mode (Figure 2.17, substrates 2d, 
2e, 2f). Believing that formation of the 5-exo distonic cation radical (see Figure 2.15) would be 
kinetically more facile (while still producing the thermodynamically most stable distonic 
species), we thought endoperoxidation would be more favorable. Unfortunately, again after 
examining all relevant reaction parameters (vide supra), endoperoxidation through a 5-exo-trig 
cyclization was never realized. In the case of substrates 2d and 2f, potential oxygenation 
products were difficult to isolate or identify. Oxygenation was observed with enol ether substrate 
2e, however this was only realized in the form of olefin oxidative cleavage through the isolation 
of para-methoxybenzaldehyde 4e. Interestingly however, Claisen rearrangement product 5e was 
isolated in reactions involving enol ether substrate 2e. If this product was produced via a SET 
pathway (analogous to the cation radical Cope rearrangement, Figure 2.12), it suggests the 
intermediacy of a 1,4-distonic cation radical. If this intermediate was produced over the course of 
the reaction, it must be fleeting, as products of oxygen trapping were never identified. It is also 
possible however that the Claisen rearrangement product was produced via a pathway 
independent of single electron transfer such as Lewis acid catalysis, as pyrylium salts also 
possess strong Lewis acidity.28 In all cases where products were identified, either with 6-endo-
trig or 5-exo-trig substrates, oxidative cleavage was the dominant oxygenation pathway. 
Following literature precedent, we believe oxidative cleavage occurred according to the pathway 
shown in Figure 2.18. Oxidation of the olefin to the cation radical, followed by oxygen trapping 
and single electron reduction furnishes a 1,2-dioxetane product. A formal retro [2+2] then 
cleaves the 1,2-dioxetane to the observed carbonyl products.20,28,29  
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Figure 2.18 Olefin oxidative cleavage mechanism to carbonyl products 
 
 Success through careful substrate engineering 2.5
The frequent observation of olefin oxidative cleavage in the reactions of 2a, 2b, 2c, and 
2e indicated to us that the necessary distonic cation radical intermediates were not forming or 
were too fleeting. This was either due to an unfavorable cyclization or due to lack of stability in 
the distonic species. We then decided to design a substrate where distonic cation radical 
formation (and thus endoperoxidation) would be more favorable (Figure 2.19). 
Figure 2.19 Substrate design to favor distonic cation radical formation and endoperoxidation 
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2.1 entries 2 and 3). Ultimately the yield of the endoperoxide was increased measurably by 
lowering catalyst loading while increasing substrate concentration in DCM (entries 4 and 5). The 
oxygen source (1 atm air vs. 1 atm O2) had no effect on 3g yields while both lowering 
temperature (-78 °C) and raising temperature (to ambient temperature) had deleterious effects on 
3g yields. The relevant control experiments showed the importance of each component of this 
reaction: excluding O2 (entry 6), light (entry 7), or catalyst 1c (entry 8) resulted in low 
conversion and no product formation. Additionally, the unique reactivity imparted by the 2,4,6-
triarylpyrylium catalyst was emphasized in an oxygenation reaction using an acridinium 
photoxidant in place of 1c (entry 9). In this reaction, complete consumption of 2g was observed, 
but endoperoxide 3g was not produced. We attributed this result to the acridinium catalysts 
known ability to produce reactive superoxide from oxygen, a pathway not accessible to 1c or 
related 2,4,6-triarylpyrylium catalysts.29,30 
Table 2.1 Endoperoxidation using 2g: reaction optimization and control experiments 
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To exclude the intervention of singlet oxygen in this process, an experiment using triplet 
photosensitizer Rose Bengal was conducted (Figure 2.20). In this system only hydroperoxide 
product 4g, produced by the 1O2 ene reaction, was isolated. This result further underscores the 
unique reactivity of the pyrylium photoredox system. 
Figure 2.20 Singlet oxygen control: hydroperoxide isolation 
 
Finally, for complete characterization, x-ray quality crystals of product 3g definitively confirmed 
the structure of the bridged bicyclic endoperoxide (Figure 2.21). 
Figure 2.21 ORTEP of bicyclic endoperoxide 3g 
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Figure 2.22 Divergence in reactivity between Masuyama and Nicewicz  
 
 Mechanism and DFT analysis 2.6
We propose the construction of endoperoxide 3g by a mechanism similar to those 
proposed by Miyashi (Figure 2.13)24 and Yoon (Figure 2.14).9 Excitation of the pyrylium 
photoredox catalyst followed by single electron transfer with 2g, produces localized cation 
radical A and ground state pyranyl radical 1• (Scheme 2.1). Localized cation radical A then 
cyclizes to distonic cation radical B through a 5-exo-trig cyclization, subsequent oxygen capture 
forms peroxy cation radical C, and single electron reduction furnishes endoperoxide 3g. The 
necessary single electron reduction can occur either in a redox event involving pyranyl radical 1• 
to regenerate the pyrylium catalyst 1 or through oxidation of another equivalent of substrate 2g 
in a radical chain propagation step. 
Scheme 2.1 Mechanism for triarylpyrylium-catalyzed endoperoxidation of unconjugated dienes 
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During our investigation of the endoperoxidation of 2g the question of spin and charge 
density in the distonic cation radical arose (Figure 2.23). Since oxygen is captured through the 
radical, the spin density locale in intermediate B (vide infra) could impact product distribution. 
Specifically, if spin density is located in the iso-propyl substituent (as shown in B1 below), 
oxygen trapping will always produce an intermediate (C1) that can close to form 3g. However, if 
spin density is concentrated at the benzylic position and charge density on the iso-propyl 
substituent (distonic species B2 below), stereoselective oxygen addition would be required for 
endoperoxidation or one could imagine production two diastereomeric oxygen trap 
intermediates, C2 and C3 (below). Intermediate C3 could cyclize to 3g after reduction as the 
peroxy radical and the iso-propyl groups are on the same face of the cyclopentane. Intermediate 
C2 however could not produce the desired endoperoxide due to the relevant groups being 
positioned on opposite faces of the cyclopentane. Unless the 5-exo-trig cyclization to produce 
distonic cation radicals B2 or C2 was reversible, one would expect uncyclized/hydroperoxy 
products to also be produced. 
Figure 2.23 Distonic cation radical intermediates: spin and charge density possibilities 
 
With the help of fellow graduate student Nathan Romero, we turned to Density 
Functional Theory to answer the question of the location of the spin and charge densities. DFT 
analysis showed that generation of distonic cation radical B (Scheme 2.1) from localized cation 
radical A (Scheme 2.1) is exothermic by 3 kcal/mol. This is rationalized by increased 
Ar
Me
Me
Me
Me B1
Ar
Me
Me
Me
Me B2
O O
H
Ar
Me
Me
Me
Me
O OAr
Me
Me
Me
Me
H
O OAr
Me
Me
Me
Me
H
C1
C2 C3
and/or
O OAr
Me
Me
Me
Me 3g
 38 
substitution in the distonic intermediate relative to the localized intermediate. More importantly 
however, DFT calculations showed build up of spin density on the iso-propyl substituent (Figure 
2.24), as depicted in intermediate B1 in Figure 2.23, rendering the stereoselectivity of the oxygen 
addition irrelevant.31 
Figure 2.24 Spin and charge density DFT analysis of the distonic intermediate, optimized at the 
UB3LYP/6-311G(d) level of theory 
 
0.20$eV$0$eV$
A. Spin density in the key distonic intermediate!
B. Electrostatic potential map of the key distonic intermediate !
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 Probing the impact of the electron rich arene and the Thorpe-Ingold Effect 2.7
When moving from unsuccessful substrate 2f to successful substrate 2g two variables 
changed: the electronic nature of the arene and the Thorpe-Ingold tether. To probe the impact of 
both variables separately, two intermediate substrates were constructed: 2h possessing the 
Thorpe-Ingold tether and 2i lacking the Thorpe-Ingold tether but possessing the electron rich 
arene (Figure 2.25). Despite employing photooxidants with a range of oxidizing power (1a, 1b, 
or 1c, Figure 2.15), substrate 2h failed to produce an endoperoxide. Substrate 2i on the other 
hand formed the desired endoperoxide in a 10% yield at conditions optimized for substrate 2g. 
This indicated to us that distonic cation radical stability was paramount for this transformation to 
proceed; the necessary distonic species formed from substrates 2f and 2h were either not stable 
enough to form or were too fleeting upon formation for oxygen trapping to occur. While the 
Thorpe-Ingold Effect greatly improved reaction efficiency (as expected), it was not necessary for 
endoperoxide formation (compare 2g and 2i).  
Figure 2.25 Probing both variables through intermediate substrates 
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less concentrated conditions and higher catalyst loadings (entry 2). Unfortunately, neither lower 
temperatures (entry 3) nor using air in place of O2 (entry 4) had positive effects on 3i yield. 
While yield was negatively impacted by using more concentrated conditions in DCM at -41 °C 
(entry 5), the yield increased by moving from -41 °C to -10 °C and from DCM [0.02 M] to DCE 
[0.02 M] (entries 6-8). Unfortunately, the yield of 3i was never higher than 30% (relative to 
(Me3Si)2O NMR internal standard) despite thorough examination of all reaction parameters, nor 
could the reaction be made more concentrated than 0.02 M without adverse effects. Despite low 
yields of 3i but high conversions of 2i, compounds comprising the mass balance could not be 
isolated. It was presumed that oxidative decomposition of the substrate might be occurring. 
Table 2.2 Optimization of substrate 2i 
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 Endoperoxidation scope with respect to the arene 2.8
Adopting the conditions optimized for the synthesis of 3i from 2i as standard, we elected 
to examine the scope of this transformation with respect to the arene more thoroughly. Table 2.3 
summarizes this work. Electron rich dienes 2j, 2i, and 2l (entries 1, 3, and 4 respectively) were 
competent substrates in this transformation, producing the desired endoperoxides 3j, 3i, and 3l in 
9%, 32%, and 16% yields, respectively. While the desired endoperoxides were isolated in these 
three examples, the dominant pathway appeared to be oxidative decomposition as complete 
substrate consumption was always observed. Additionally, ortho substitution on the arene had a 
noticeable negative effect on yield (entries 1 and 4), likely due to the o-methoxy substituent 
forcing the arene out of plane and limiting its ability to stabilize the distonic cation radical. 
Interestingly 3,4-dimethoxystyrene substrate 2k failed to give any of the desired adduct; we 
ultimately attributed this to the lack of charge density on the alkene.32,33 Substrates with either 
weakly donating (2m, entry 5) or withdrawing (2n, entry 6) substituents were also unsuccessful, 
producing only oxidative decomposition products. These results support our hypothesis that 
electron rich substrates provide greater stability to the distonic intermediate, thus allowing it to 
remain and be intercepted by oxygen. Lastly, heterocyclic substrate 2o was also unsuccessful; 
only decomposition was observed (entry 7). 
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Table 2.3 Arene scope 
 
 Endoperoxidation scope with respect to the tethered alkene 2.9
Possessing knowledge of the limitations imposed on this transformation by the arene 
substituent, we next sought to examine the scope of this transformation with respect to the 
tethered alkene more thoroughly. Table 2.4 summarizes this work. Model substrate 2g with a 
tethered trisubstituted alkene produced model endoperoxide 3g in a 66% isolated yield (entry 1). 
Substrate 2p possessing a styrenyl tether produced the corresponding endoperoxide (3p, entry 2) 
in a 68% yield as a 1:1 mixture of separable diastereomers and substrate 2q with a tethered 
cyclic tetrasubstituted olefin produced tricyclic endoperoxide 3q (entry 3) in a 64% yield as a 
6.4:1 mixture of inseparable diastereomers. Unfortunately, the use of 1,2-dialkyl (2r, entry 4), 
1,1-dialkyl (2s, entry 5), or monoalkyl-substituted (2t, entry 6) tethered alkenes appeared to 
completely disfavor the endoperoxidation pathway. Instead, in all three cases, novel α-allylated 
ketones 3r, 3s, and 3t were isolated in moderate yields.  
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Table 2.4 Tethered alkene scope 
 
Production of allylated ketones 3r, 3s, and 3t from unconjugated dienes 2r, 2s, and 2t 
respectively can be rationalized invoking the Miyashi precedent (Scheme 2.2).24 With these 
substrates, due to the substitution pattern about the tethered alkene, the distonic cation radical 
produced from 5-exo-trig cyclization is destabilized relative to the distonic cation radical 
produced from 6-endo-trig cyclization. Thus, after single electron oxidation, localized cation 
radical D cyclizes to more stabilized 6-endo distonic cation radical F rather than 5-exo distonic 
cation radical E. From here, the cation radical Cope rearrangement occurs to produce 
intermediate G23 and single electron reduction/oxidative cleavage furnishes the α-allylated 
ketone and acetone. It should be noted that while the intermediacy of a 1,4-distonic cation radical 
(F) is invoked in this scheme, products of oxygen trapping from this intermediate were never 
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isolated. It is possible that the driving force to produce localized tetrasubstituted styrenyl cation 
radical G is too great and thus distonic intermediate F is too fleeting for oxygen trapping to 
occur. In an attempt to remove the Cope rearrangement driving force, substrates 2u (Table 2.4 
entry 7) and 2v (Table 2.4 entry 8) bearing 1,2-dialkyl and monoalkyl-substituted alkenes 
respectively but lacking the dimethyl tether were constructed. While the Cope pathway was 
suppressed with these substrates, decomposition was the dominant pathway and endoperoxide 
formation was not observed.  
Scheme 2.2 Synthesis of allylated ketones from unconjugated dienes 
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endoperoxide 3w from 2w in a 16% yield (entry 1). Bis(styrene) 2x, Professor Yoon’s model 
substrate in his endoperoxidation system (Figure 2.14),9 was very successful, producing 
endoperoxide 3x in a 79% yield as a 5.7:1 mixture of diastereomers (entry 2). This result is 
noteworthy because 2,4,6-triphenylpyrylium catalyst 1a was not successful when employed by 
Yoon under his conditions.9 We however were able to achieve endoperoxidation with Yoon’s 
model substrate in our system, using pyrylium organic photoredox catalyst 1c and 1 atm O2 in 
high yield and good diastereomeric ratio. Despite the success of substrate 2x in our system, 
substrates that were unsuccessful in Yoon’s system (2y and 2z, entries 3 and 4 respectively) also 
failed in our system, producing neither of the expected 1,2-dioxane products in 
appreciable/isolable amounts. Degradation pathways were dominant for 2y and unreacted 
starting material was observed with 2z. To rule out substrate 2z existing outside the operable 
range of catalyst 1c, stronger photooxidants such as 1a or 1b were tested as well. The stronger 
oxidants still returned starting material - no endoperoxide was observed. 
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Table 2.5 Manipulating the cyclization mode 
 
 Concluding remarks and future directions 2.11
In conclusion, we have developed a method to access novel bicyclic endoperoxides using 
atmospheric oxygen by a cation radical mediated process. Through the use of photoredox 
catalysis, mild reaction conditions could be employed to synthesize a new family of 
endoperoxides. In this system, one C−C and two C−O bonds were formed in a single synthetic 
operation, forging the bicyclic carbon framework and the sensitive peroxide bridge together in 
one step. Nine examples were shown for the endoperoxidation and three examples were shown 
proceeding via an alternative pathway to produce α-allylated ketones. The work presented in this 
chapter further defines the boundaries of photoredox/cation radical mediated endoperoxidation 
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strategies. Prior work in the field, presented earlier in this chapter for comparison, highlights the 
complimentary nature of our system. 
While the method described in this chapter was powerful with regard to rapid complexity 
generation, the scope of the transformation was unfortunately limited in every aspect examined. 
Development of a general endoperoxidation method operating via photoinduced electron transfer 
would likely require an entirely new approach. Gleaning insight from the photoredox methods 
developed in our lab for intramolecular anti-Markovnikov alkene hydrofunctionalization, 
endoperoxidation may be possible in the form of a hydroperoxide cyclization (anti-Markovnikov 
alkene hydroperoxidation) as shown in Figure 2.26.34,35 The system would require a 
hydroperoxide nucleophile, a single electron oxidant (likely the shown acridinium dye), and a 
suitable hydrogen-atom donor (to intercept the intermediate carbon-centered radicals and 
regenerate the catalyst).34 Formation of 1,2-dioxolane of 1,2-dioxane products would be possible, 
depending on tether length. While hydroperoxide synthesis would still be necessary (making this 
formally a two-step endoperoxidation), this simplified approach could render the method more 
general. 
Figure 2.26 Hydroperoxide cyclization proceeding via a cation radical intermediate 
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 Experimental Details 2.12
General Methods. Proton and carbon nuclear magnetic resonance spectra (1H NMR and 13C 
NMR) were recorded on a Bruker model DRX 400 or AVANCE III 600 CryoProbe (1H NMR at 
400 MHz or 600 MHz and 13C NMR at 100 MHz or 150 MHz) spectrometer. Chemical shifts for 
protons are reported in parts per million downfield from tetramethylsilane and are referenced to 
residual protium in solvent (1H NMR: CHCl3 at 7.24 ppm, DMSO at 2.49 ppm). Chemical shifts 
for carbons are reported in parts per million downfield from tetramethylsilane and are referenced 
to the carbon resonances of the residual solvent peak (13C NMR: CDCl3 at 77.0 ppm, DMSO at 
39.5 ppm). NMR data are represented as follows: chemical shift, multiplicity (s = singlet, br s = 
broad singlet, d = doublet, dd = doublet of doublet, t = triplet, ddd = doublet of doublet of 
doublet, q = quartet, m = multiplet), coupling constants (Hz), and integration. Mass spectra were 
obtained using a Micromass Quattro II (triple quad) instrument with nanoelectrospray ionization. 
Analytical thin layer chromatography (TLC) was performed on SiliaPlate 250 µm thick silica gel 
plates provided by Silicycle. Visualization was accomplished using fluorescence quenching, 
KMnO4 stain, or ceric ammonium molybdate (CAM) stain followed by heating. Organic 
solutions were concentrated under reduced pressure using a Büchi rotary evaporator. Purification 
of the reaction products was carried out by chromatography using Siliaflash-P60 (40-63 µm) or 
Siliaflash-T60 (5-20 µm) silica gel purchased from Silicycle. All reactions were carried out 
under an inert atmosphere of nitrogen in flame-dried glassware with magnetic stirring or under 
an atmosphere of oxygen in flame-dried glassware with magnetic stirring unless otherwise noted. 
Irradiation of photochemical reactions was carried out using a SE-WFLS-B60 blue (470 nm) 
LED flexible light strip purchased from Super Bright LEDs Inc. (St. Louis, MO, USA), with 
standard borosilicate glass vials purchased from Fisher Scientific.  Yield refers to isolated yield 
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of analytically pure material unless otherwise noted.  NMR yields were determined using 
hexamethyldisiloxane, (Me3Si)2O, as an internal standard. 
Procedure for yield determination using (Me3Si)2O NMR internal standard: upon 
consumption of starting material (as determined by TLC), crude reaction mixture was passed 
through a short silica gel plug with DCM.  The crude mixture was concentrated and then taken 
up in deuterated NMR solvent (CDCl3).  A carefully measured amount of (Me3Si)2O was then 
added to the solution via micro syringe and a 1H NMR spectrum acquired. 
 
Materials. Commercially available reagents were purchased from Sigma Aldrich, Acros, Alfa 
Aesar, or TCI, and used as received unless otherwise noted. Diethyl ether (Et2O), 
dichloromethane (DCM), tetrahydrofuran (THF), toluene (PhMe), and dimethylformamide 
(DMF) were dried by passing through activated alumina columns under nitrogen prior to use. 
Other common solvents and chemical reagents were purified by standard published methods 
where noted.  
Thermogravimetric Analysis on Product 3g 
 
O O
Me
Me
Me Me
MeO
 50 
Preparation of 2,4,6-Triarylpyrylium Tetrafluoroborate Photooxidanats 
 
All variants prepared according to a published procedure; spectral data were in agreement with 
the literature values.23 
Preparation of Unconjugated Diene Substrates 
4,4'-(hexa-1,5-diene-2,5-diyl)bis(methoxybenzene) (2a) 
 
 Prepared according to a published procedure; spectral data were in agreement with the 
literature values.36 
(5-methylhexa-1,5-dien-2-yl)benzene (2b) and 5-phenylhex-5-en-2-one (2c) 
 
 
1.05 equiv. of sodium hydride were dispensed into a flame dried round bottom flask, 
which was subsequently purged with N2.  The sodium hydride was suspended in dry THF (0.4 
mmol/mL) and the stirred suspension was cooled to 0 °C in an ice bath.  At 0 °C, ethyl 
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acetoacetate was added dropwise with stirring.  The solution was stirred at 0 °C for 30 minutes 
after effervescence ceased.  At 0 °C, (3-bromoprop-1-en-2-yl)benzene (1.05 equiv.) was added to 
the mixture dropwise.  The reaction was allowed to warm to room temperature and stirred for 16 
hours overnight.  The reaction was then quenched with concentrated NH4Cl solution and diluted 
with DI water and diethyl ether.  The organic layer was separated and aqueous layer extracted 
three times with diethyl ether in a separatory funnel.  The combined organics were washed with 
brine, dried with anhydrous MgSO4, filtered, and concentrated to afford a crude oil.  
Decarboxylation of the crude alkylation product was carried out as follows: sodium 
hydroxide (5.2 equiv.) was weighed into a round bottom flask containing a 2:1 water/ethanol 
mixture (approx. concentration 0.3 mmol/mL) and stirred to dissolution.  At room temperature 
the crude alkylation product was introduced dropwise, then the reaction was heated to 70 °C 
overnight.  The reaction was cooled to room temperature and quenched with concentrated 
NH4Cl.  The organic phase was separated and the aqueous phase extracted three times with 
diethyl ether.  The combined organics were washed with brine, dried with anhydrous MgSO4, 
filtered, and concentrated to afford a crude oil, which was taken on to the next step without 
further purification. A portion of this crude product was purified by silica gel column 
chromatography (20% EtOAc/hexanes) to afford substrate 2c (spectral data were in agreement 
with literature values). The remaining crude decarboxylation product was taken on to the next 
step without further purification, for the synthesis of 2b. 
The crude aryl ketone was converted to the diene product by Wittig olefination.  
Olefination procedure for this substrate was identical to the Wittig olefination procedure in 
General Procedure A below (step 2).  The final product was purified using silica gel column 
chromatography (20% EtOAc/hexanes) to furnish 0.78 g of pure product (47% overall) as a 
 52 
colorless oil.  Spectral data were in agreement with the reported literature values.19 Analytical 
data for 2b:  1H NMR (600 MHz, CDCl3): δ 7.40 (m, 2H), 7.32 (m, 2H), 7.26 (m, 1H), 5.28 (d, J 
= 1.2 Hz, 1H), 5.08 (d, J = 1.2 Hz, 1H), 4.73 (d, J = 1.2 Hz, 1H), 4.68 (d, J = 1.2 Hz, 1H), 2.64 
(dt, J = 7.8 Hz, J = 1.2 Hz, 2H), 2.16 (t, J = 7.8 Hz, 2H), 1.74 (s, 3H); 13C NMR (150 MHz, 
CDCl3); δ 148.2, 145.4, 141.2, 128.3, 127.3, 126.1, 112.3, 110.0, 36.5, 33.6, 22.5 
(E)-1-methoxy-4-(3-(prop-1-en-2-yloxy)prop-1-en-1-yl)benzene (2e) 
 
 To a flame dried and nitrogen-purged round bottom flask equipped with a stir bar was 
added 2-methoxypropene (0.2 M). 1.0 g p-MeO-cinnamyl alcohol (6.1 mmol, 1 equiv.) was then 
added followed quickly 1.31 g Hg(OAc)2 (4.1 mmol, 0.67 equiv.). The headspace was then 
flushed with N2 once more. The stirring solution was then heated to reflux overnight. The 
reaction was then quenched using saturated aqueous Na2CO3 and partitioned with Et2O. The 
organic phase was separated and the aqueous phase was extracted three times with Et2O. The 
combined organics were washed with brine, dried with anhydrous MgSO4, and concentrated to 
yield the crude product. 2e was isolated via column chromatography (85/12/3 
hexanes/Et2O/Et3N) on treated silica gel as a white solid (0.67 g, 54%). Analytical data for 2e:  
1H NMR (400 MHz, CDCl3): δ  7.32 (d, J = 8.7 Hz, 2H), 6.83 (d, J = 8.7 Hz, 2H), 6.58 (d, J = 
15.9 Hz, 1H), 6.21 (dt, J = 15.9 Hz, J = 6.2 Hz, 1H), 4.33 (dd, J = 6.1 Hz, J = 1.4 Hz, 2H), 3.88 
(s, 2H), 3.79 (s, 3H), 1.85 (s, 3H). 
 
 
O
Me
MeO
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(6-methylhepta-1,5-dien-2-yl)benzene (2f) 
 
 
Carried out using procedure above for synthesis of 2b.  In the initial alkylation, ethyl 
benzoyl acetate was used in place of ethyl acetoacetate and 3,3-dimethylallyl bromide in place of 
(3-bromoprop-1-en-2-yl)benzene.  The remaining steps were carried out without alteration.  The 
final product was purified using silica gel column chromatography (20% Et2O/hexanes) to 
furnish 0.67 g of pure product (50% overall) as a colorless oil.  Spectral data were in agreement 
with the reported literature values.19 Analytical data for 2f:  1H NMR (600 MHz, CDCl3): δ 7.41 
(m, 2H), 7.32 (m, 2H), 7.26 (m, 1H), 5.27 (s, 1H), 5.14 (m, 1H), 5.06 (s, 1H), 2.51 (t, J = 7.2 Hz, 
2H), 2.13 (q, J = 7.2 Hz, 2H), 1.67 (s, 3H), 1.54 (s, 3H); 13C NMR (150 MHz, CDCl3); δ 148.3, 
141.3, 131.9, 128.2, 127.2, 126.1, 123.8, 112.2, 35.4, 26.9, 25.7, 17.7 
General Procedure A: Preparation of Substrates with the Geminal Dimethyl Tether 
 
A flame-dried round bottom flask equipped with magnetic stirbar containing potassium 
tert-butoxide (1.2 equiv.) was purged with nitrogen.  Dry THF was added via syringe 
(approximate concentration 0.4 mmol/mL) and the solution was cooled to 0 °C in an ice bath 
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with stirring.  At 0 °C, 1-(4-methoxyphenyl)-2-methylpropan-1-one (prepared according to 
literature procedure)37 was added to the stirring solution via syringe dropwise and stirred for 1 
hour. At 0 °C, the appropriate allylic bromide was added dropwise via syringe and stirred to 
room temperature for 16 hours.  The reaction was then quenched with concentrated NH4Cl 
solution and diluted with DI water and diethyl ether.  The organic layer was separated and 
aqueous layer extracted three times with diethyl ether in a separatory funnel.  The combined 
organics were washed with brine, dried with anhydrous MgSO4, filtered, and concentrated to 
afford a crude oil, which was taken on to the next step without further purification (acceptable 
purity confirmed by TLC and 1H NMR). 
 The crude allylation product was converted to the desired diene by Wittig olefination.  
Potassium tert-butoxide (1.3 equiv.) and methyltriphenylphosphonium bromide (1.4 equiv.) were 
dispensed into a flame-dried round bottom flask equipped with a magnetic stirbar.  The flask was 
purged with nitrogen and cooled to 0 °C with stirring.  At 0 °C, dry THF was added via syringe 
(approximate concentration 0.4 mmol/mL) and the solution was stirred at 0 °C for 1 hour.  At 0 
°C, the crude allylation product was added via syringe (in THF) dropwise.  The reaction was 
warmed to room temperature and stirred overnight.  Upon completion, the reaction was 
quenched with concentrated NH4Cl solution and then diluted with DI water and diethyl ether.  
The organic layer was separated and aqueous layer extracted three times with diethyl ether in a 
separatory funnel.  The combined organics were washed with brine, dried with anhydrous 
MgSO4, filtered, and concentrated to afford the crude product.  The product was purified by 
silica gel column chromatography. 
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1-methoxy-4-(3,3,6-trimethylhepta-1,5-dien-2-yl)benzene (2g) 
 
Diene prepared according to general procedure A using 3,3-dimethylallyl bromide as 
the electrophile in the first step.  The final product was purified by silica gel column 
chromatography (20% diethyl ether/hexanes) to furnish 2.16 g of pure product (88%) as a 
colorless oil.  Analytical data for 2g:  1H NMR (600 MHz, CDCl3): δ 7.05 (d, J = 9.0 Hz, 2H), 
6.80 (d, J = 9.0 Hz, 2H), 5.18 (m, 1H), 5.11 (s, 1H), 4.83 (s, 1H), 3.79 (s, 3H), 2.03 (d, J = 7.2 
Hz, 2H), 1.73 (s, 3H), 1.56 (s, 3H), 1.06 (s, 6H); 13C NMR (150 MHz, CDCl3); δ 158.0, 157.6, 
135.8, 132.6, 129.9, 121.5, 113.3, 112.7, 55.1, 39.7, 39.0, 27.4, 26.0, 18.1 
(3,3,6-trimethylhepta-1,5-dien-2-yl)benzene (2h) 
 
Diene prepared according to general procedure A using 3,3-dimethylallyl bromide as 
the electrophile and isobutyrophenone in place of 1-(4-methoxyphenyl)-2-methylpropan-1-one in 
the alkylation step.  The final product was purified by silica gel column chromatography (20% 
diethyl ether/hexanes) to furnish 1.77 g of pure product (82%) as a colorless oil.  Analytical data 
for 2h:  1H NMR (600 MHz, CDCl3): δ 7.24 (m, 3H), 7.11 (m, 2H), 5.18 (m, 1H), 5.13 (s, 1H), 
4.84 (s, 1H), 2.03 (d, J = 6.9 Hz, 2H), 1.72 (s, 3H), 1.55 (s, 3H), 1.06 (s, 6H); 13C NMR (150 
MHz, CDCl3); δ 158.1, 143.4, 132.6, 129.0, 127.3, 126.2, 121.4, 113.2, 39.6, 39.0, 27.3, 26.0, 
18.1 
MeO
Me Me
Me
Me
Me Me
Me
Me
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(E)-1-(3,3-dimethyl-6-phenylhexa-1,5-dien-2-yl)-4-methoxybenzene (2p) 
 
Diene prepared according to general procedure A using cinnamyl bromide as the 
electrophile in the first step.  The final product was purified by silica gel column chromatography 
(20% diethyl ether/hexanes) to furnish 2.73 g of pure product (93%) as a yellow oil.  Analytical 
data for 2p:  1H NMR (600 MHz, CDCl3): δ 7.36 (d, J = 7.8 Hz, 2H), 7.31 (t, J = 7.2 Hz, 2H), 
7.21 (t, J = 7.8 Hz, 1H), 7.12 (d, J = 8.4 Hz, 2H), 6.85 (d, J = 8.4 Hz, 2H), 6.37 (d, J = 15.6 Hz, 
1H), 6.23 (m, 1H), 5.18 (s, 1H), 4.90 (s, 1H), 3.82 (s, 3H), 2.29 (d, J = 6.6 Hz), 1.15 (s, 6H); 13C 
NMR (150 MHz, CDCl3); δ 158.2, 157.3, 137.8, 135.6, 132.0, 130.0, 128.5, 127.8, 126.9, 126.0, 
113.7, 112.8, 55.2, 44.4, 39.7, 27.5 
1-(3,3-dimethyl-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-1-en-2-yl)-4-methoxybenzene (2q) 
 
Diene prepared according to general procedure A using 2-(bromomethyl)-1,3,3-
trimethylcyclohex-1-ene (prepared according to literature procedure)38 as the electrophile in the 
first step.  The final product was purified by silica gel column chromatography (20% 
Et2O/hexanes) to furnish 1.10 g of pure product (50%) as a colorless oil.  Analytical data for 2q:  
1H NMR (600 MHz, CDCl3): δ 7.18 (d, J = 9.0 Hz, 2H), 6.82 (d, J = 9.0 Hz, 2H), 5.14 (d, J = 
1.2 Hz, 1H), 4.81 (d, J = 1.2 Hz, 1H), 3.80 (s, 3H), 2.32 (s, 2H), 1.95 (t, J = 6.6 Hz, 2H), 1.56 
(m, 2H), 1.55 (s, 3H), 1.40 (m, 2H), 1.14 (s, 3H), 0.94 (s, 6H); 13C NMR (150 MHz, CDCl3); δ 
158.4, 158.1, 143.6, 135.8, 130.0, 114.0, 113.2, 112.7, 55.2, 48.4, 39.3, 28.0, 25.3 
MeO
Me Me
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Me Me
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(E)-1-(3,3-dimethylhepta-1,5-dien-2-yl)-4-methoxybenzene (2r) 
 
Diene prepared according to general procedure A using crotyl bromide as the 
electrophile in the first step.  The final product was purified by silica gel column chromatography 
(20% diethyl ether/hexanes) to furnish 1.86 g of pure product (81%) as a colorless oil (5.5:1 
mixture of isomers).  Analytical data for 2r:  1H NMR for E isomer (600 MHz, CDCl3): δ 7.05 
(d, J = 8.4 Hz, 2H), 6.80 (d, J = 8.4 Hz, 2H), 5.41 (m, 1H), 5.10 (d, J = 1.2 Hz, 1H), 4.82 (d, J = 
1.2 Hz, 1H), 3.79 (s, 3H), 2.03 (m, 2H), 1.66 (m, 3H), 1.04 (s, 6H); 13C NMR for E isomer (150 
MHz, CDCl3); δ 158.1, 157.6, 135.8, 130.0, 128.0, 127.2, 113.3, 112.7, 55.2, 43.9, 39.3, 27.3, 
18.1 
1-methoxy-4-(3,3,5-trimethylhexa-1,5-dien-2-yl)benzene (2s) 
 
Diene prepared according to general procedure A using methallyl bromide as the 
electrophile in the first step.  The final product was purified by silica gel column chromatography 
(20% EtOAc/hexanes) to furnish 1.55 g of pure product (67%) as a colorless oil.  Analytical data 
for 2s:  1H NMR (600 MHz, CDCl3): δ 7.10 (d, J = 8.4 Hz, 2H), 6.81 (d, J = 8.4 Hz, 2H), 5.17 
(s, 1H), 4.85 (s, 1H), 4.83 (s, 1H), 4.71 (s, 1H), 3.79 (s, 3H), 2.14 (s, 2H), 1.75 (s, 3H), 1.11 (s, 
6H); 13C NMR (150 MHz, CDCl3); δ 158.4, 158.1, 143.6, 135.8, 130.0, 114.0, 113.2, 112.7, 
55.2, 48.4, 39.2, 28.0, 25.3 
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1-(3,3-dimethylhexa-1,5-dien-2-yl)-4-methoxybenzene (2t) 
 
Diene prepared according to general procedure A using allyl bromide as the electrophile 
in the first step.  The final product was purified by silica gel column chromatography (20% 
EtOAc/hexanes) to furnish 1.94 g of pure product (90%) as a colorless oil.  Analytical data for 
2t:  1H NMR (600 MHz, CDCl3): δ 7.06 (d, J = 7.8 Hz, 2H), 6.81 (d, J = 7.8 Hz, 2H), 5.81 (m, 
1H), 5.12 (s, 1H), 5.02 (m, 2H), 4.84 (s, 1H), 3.79 (s, 3H), 2.11 (d, J = 7.2 Hz, 2H), 1.07 (s, 6H); 
13C NMR (150 MHz, CDCl3); δ 158.1, 157.3, 135.8, 135.6, 130.0, 116.7, 113.5, 112.7, 55.2, 
45.2, 39.1, 27.3 
General Procedure B: Preparation of Substrates with Methylene Tether 
 
 
Freshly activated and dried magnesium turnings (1.38 equiv. relative to aldehyde) were 
weighed into a flame dried round bottom flask equipped with a stir bar.  The flask was purged 
with nitrogen, cooled to 0 °C, and diethyl ether dispensed (to approximate concentration 0.6 
mmol/mL).  Seventy microliters 1,2-dibromoethane were added to activate the magnesium and 
stirred for 15 minutes.  At 0 °C, 5-bromo-2-methyl-2-pentene (1.25 equiv. relative to aldehyde) 
was added dropwise to the stirring magnesium turnings and stirred for 2 hours (consumption of 
magnesium observed).  After formation of the Grignard reagent, the necessary aldehyde (freshly 
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distilled to ensure purity), in diethyl ether, was added to the reaction mixture dropwise at 0 °C 
and stirred for 18 hours.  The reaction was quenched with concentrated NH4Cl solution dropwise 
and diluted with DI water and diethyl ether.  The organic layer was separated and aqueous layer 
extracted three times with diethyl ether in a separatory funnel.  The combined organics were 
washed with brine, dried with anhydrous MgSO4, filtered, and concentrated to afford a crude oil, 
which was taken on to the next step without further purification (acceptable purity confirmed by 
TLC and 1H NMR). 
 The crude alkenol product was then converted to the aryl ketone via Swern oxidation.  A 
flame dried round bottom flask containing a stir bar was charged with dry DCM (to approximate 
concentration of 0.25 mmol/mL) and cooled to -78 °C.  At -78 °C, the flask was charged with 
oxalyl chloride (1.2 equiv.) and stirred.  After 10 minutes, DMSO (2.4 equiv.) was added to the 
flask dropwise then stirred for 25 minutes at -78 °C.  The alkenol substrate was next added to the 
reaction mixture dropwise and stirred for an additional 25 minutes at -78 °C.  Finally, 
triethylamine (5 equiv.) was added to the reaction dropwise.  The reaction was warmed to room 
temperature and stirred overnight.  The reaction was quenched with concentrated NH4Cl, the 
organic layer was separated, and the aqueous layer extracted three times with DCM.  The 
combined organics were washed with brine, dried with anhydrous MgSO4, filtered, and 
concentrated to afford the crude aryl ketone, which was further purified by silica gel column 
chromatography. 
 The purified aryl ketone was converted to the desired unconjugated diene by Wittig 
olefination.  Wittig olefination procedure for General Procedure B identical to Wittig olefination 
procedure in General Procedure A above (step 2). 
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(7-methyl-3-methyleneoct-6-en-1-yl)benzene (2d) 
 
Diene prepared according to general procedure B using hydrocinnamaldehyde in the 
Grignard addition step.  The alkyl ketone product from oxidation was purified by silica gel 
column chromatography (20% EtOAc/hexanes).  The final product was purified using silica gel 
column chromatography (20% EtOAc/hexanes) to furnish 2.06 g of the desired diene (68%) as a 
colorless oil.  Analytical data for 2d:  1H NMR (600 MHz, CDCl3): δ 7.27 (m, 2H), 7.18 (m, 
3H), 5.12 (m, 1H), 4.76 (s, 2H), 2.74 (t, J = 7.8 Hz, 2H), 2.32 (t, J = 8.4 Hz, 2H), 2.12 (m, 2H), 
2.07 (m, 2H), 1.69 (s, 3H), 1.61 (s, 3H); 13C NMR (150 MHz, CDCl3); δ 149.1, 142.3, 131.7, 
128.3, 128.3, 125.7, 124.1, 109.2, 38.0, 36.3, 34.7, 26.5, 25.7, 17.7 
1-methoxy-4-(6-methylhepta-1,5-dien-2-yl)benzene (2i) 
 
Diene prepared according to general procedure B using 4-anisaldehyde in the Grignard 
addition step.  The aryl ketone product from oxidation was purified by silica gel column 
chromatography (20% EtOAc/hexanes).  The final product was purified using silica gel column 
chromatography (20% Et2O/hexanes) to furnish 2.46 g of the desired diene (59%) as a colorless 
oil.  Spectral data were in agreement with the reported literature values.39 Analytical data for 2i:  
1H NMR (600 MHz, CDCl3): δ 7.35 (d, J = 9.0 Hz, 2H), 6.85 (d, J = 9.0 Hz, 2H), 5.20 (s, 1H), 
5.14 (m, 1H), 4.97 (s, 1H), 3.80 (s, 3H), 2.48 (t, J = 7.2 Hz, 2H), 2.13 (q, J = 7.2 Hz, J = 7.8 Hz, 
Me
Me
Ph
Me
Me
MeO
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2H), 1.68 (s, 3H), 1.55 (s, 3H); 13C NMR (150 MHz, CDCl3); δ 158.9, 147.6, 133.7, 131.8, 
127.1, 123.9, 113.5, 110.6, 55.2, 35.5, 27.0, 25.7, 17.7 
1,2-dimethoxy-4-(6-methylhepta-1,5-dien-2-yl)benzene (2k) 
 
Diene prepared according to general procedure B using 3,4-dimethoxybenzaldehyde in 
the Grignard addition step.  The aryl ketone product from oxidation was purified by silica gel 
column chromatography (20% EtOAc/hexanes).  The final product was purified using silica gel 
column chromatography (20% Et2O/hexanes) to furnish 1.29 g of the desired diene (42%) as a 
colorless oil.  Analytical data for 2k:  1H NMR (600 MHz, CDCl3): δ 6.95 (m, 2H), 6.81 (d, J = 
8.4 Hz, 1H), 5.20 (d, J = 1.8 Hz, 1H), 5.14 (m, 1H), 4.98 (d, J = 1.8 Hz, 1H), 3.88 (s, 3H), 3.87 
(s, 3H), 2.47 (t, J = 7.2 Hz, 2H), 2.13 (q, J = 7.2 Hz, 2H), 1.67 (s, 3H), 1.54 (s, 3H); 13C NMR 
(150 MHz, CDCl3); δ 148.6, 148.5, 147.9, 134.2, 131.8, 123.9, 118.4, 110.9, 110.8, 109.4, 55.9, 
55.8, 35.5, 27.0, 25.7, 17.7 
1-methoxy-2-(6-methylhepta-1,5-dien-2-yl)benzene (2l) 
 
Diene prepared according to general procedure B using o-anisaldehyde in the Grignard 
addition step.  The aryl ketone product from oxidation was purified by silica gel column 
chromatography (10% EtOAc/hexanes).  The final product was purified using silica gel column 
chromatography (hexanes) to furnish 1.58 g of the desired diene (47%) as a colorless oil.  
MeO
Me
Me
OMe
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Spectral data were in agreement with the reported literature values.40 Analytical data for 2l:  1H 
NMR (600 MHz, CDCl3): δ 7.24 (m, 1H), 7.13 (m, 1H), 6.91 (m, 1H), 6.86 (m, 1H), 5.14 (s, 
1H), 5.12 (m, 1H), 5.02 (s, 1H), 3.82 (s, 3H), 2.51 (t, J = 7.8 Hz, 2H), 2.04 (q, J = 7.8 Hz, 2H), 
1.67 (s, 3H), 1.53 (s, 3H); 13C NMR (150 MHz, CDCl3); δ 156.5, 149.0, 132.1, 131.4, 130.2, 
128.2, 124.2, 120.4, 114.0, 110.5, 55.4, 36.3, 26.8, 25.7, 17.6 
1-methyl-4-(6-methylhepta-1,5-dien-2-yl)benzene (2m) 
 
Diene prepared according to general procedure B using 4-tolualdehyde in the Grignard 
addition step.  The aryl ketone product from oxidation was purified by silica gel column 
chromatography (10% Et2O/hexanes).  The final product was purified using silica gel column 
chromatography (hexanes) to furnish 1.27 g of the desired diene (52%) as a colorless oil.  
Spectral data were in agreement with the reported literature values.40 Analytical data for 2m:  1H 
NMR (600 MHz, CDCl3): δ 7.31 (d, J = 7.8 Hz, 2H), 7.13 (d, J = 7.8 Hz, 2H), 5.25 (d, J = 1.2 
Hz, 1H), 5.15 (m, 1H), 5.01 (d, J = 1.2 Hz, 1H), 2.49 (dt, J = 7.8 Hz, J = 1.2 Hz, 2H), 2.34 (s, 
3H), 2.13 (q, J = 7.8 Hz, 2H), 1.68 (s, 3H), 1.55 (s, 3H); 13C NMR (150 MHz, CDCl3); δ 148.1, 
138.3, 137.0, 131.8, 128.9, 125.9, 123.9, 111.4, 35.4, 27.0, 25.7, 21.1, 17.7 
1-chloro-4-(6-methylhepta-1,5-dien-2-yl)benzene (2n) 
 
Diene prepared according to general procedure B using 4-chlorobenzaldehyde in the 
Grignard addition step.  The aryl ketone product from oxidation was purified by silica gel 
Me
Me
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column chromatography (5% Et2O/hexanes).  The final product was purified using silica gel 
column chromatography (hexanes) to furnish 1.44 g of the desired diene (40%) as a colorless oil.  
Analytical data for 2n:  1H NMR (600 MHz, CDCl3): δ 7.32 (d, J = 9.0 Hz, 2H), 7.27 (d, J = 9.0 
Hz, 2H), 5.25 (d, J = 1.2 Hz, 1H), 5.11 (m, 1H), 5.06 (d, J = 1.2 Hz, 1H), 2.47 (t, J = 7.8 Hz, 
2H), 2.10 (q, J = 7.8 Hz, 2H), 1.66 (s, 3H), 1.53 (s, 3H); 13C NMR (150 MHz, CDCl3); δ 147.0, 
139.5, 132.8, 131.8, 128.1, 127.2, 123,4, 112.5, 35.1, 26.6, 25.5, 17.5 
2-(6-methylhepta-1,5-dien-2-yl)furan (2o) 
 
Diene prepared according to general procedure B using furfural in the Grignard addition 
step.  The aryl ketone product from oxidation was purified by silica gel column chromatography 
(10% Et2O/hexanes).  The final product was purified using silica gel column chromatography 
(hexanes) to furnish 0.61 g of the desired diene (14%) as a yellow oil.  Analytical data for 2o:  
1H NMR (600 MHz, CDCl3): δ 7.34 (d, J = 1.8 Hz, 1H), 6.36 (m, 1H), 6.29 (d, J = 3.6 Hz, 1H), 
5.51 (s, 1H), 5.16 (m, 1H), 4.96 (s, 1H), 2.36 (t, J = 7.8 Hz, 2H), 2.23 (q, J = 7.8 Hz, 2H), 1.68 
(s, 3H), 1.59 (s, 3H); 13C NMR (150 MHz, CDCl3); δ 154.8, 141.7, 137.3, 132.1, 123.7, 111.0, 
109.2, 105.8, 33.3, 27.3, 25.7, 17.7 
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2,4-dimethoxy-1-(6-methylhepta-1,5-dien-2-yl)benzene (2j) 
 
 
 A flame dried round bottom flask, containing 2,4-dimethoxybenzoic acid (1.0 equiv.) and 
N,O-dimethylhydroxylamine hydrochloride (1.2 equiv.) dissolved in anhydrous dichloromethane 
(0.2 M), was cooled to 0 °C with stirring.  At 0 °C, triethylamine (1.2 equiv.) was added to the 
solution dropwise via syringe and stirred for 15 minutes.  Next, at 0 °C, 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDCI•HCl, 1.2 equiv) was added to the 
stirring solution in one portion.  The reaction was allowed warm to room temperature and stir 
overnight.  The reaction was then quenched with 2N HCl and diluted with DCM.  The organic 
layer was separated and washed twice with DI water.  The combined organics were then washed 
with brine, dried with anhydrous MgSO4, filtered, and concentrated to afford a crude oil, which 
was taken on to the Grignard addition without further purification. 
Grignard addition into the Weinreb amide and Wittig olefination were carried out 
according the equivalent procedures in General Procedure B.  The aryl ketone produced from 
Grignard addition into the Weinreb amide was purified by column chromatography (20% 
EtOAc/hexanes) to yield a colorless oil (1.76 g, 47%).  The Wittig olefination product was 
purified by column chromatography (20% Et2O/hexanes) to give 1.42 g (81%) of the desired 
unconjugated diene as a colorless oil.  Analytical data for 2j:  1H NMR (600 MHz, CDCl3): 
δ 7.03 (m, 1H), 6.42 (m, 2H), 5.08 (m, 2H), 4.96 (d, J = 2.4 Hz, 1H), 3.79 (s, 3H), 3.78 (s, 3H), 
MeO OMe
OH
O N
H
MeMeO
•HCl
1.2 equiv. EDCI•HCl
1.2 equiv. Et3N
1.2 equiv.
0.2 DCM, 0 °C to rt, 14h MeO OMe
N
O
OMe
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Me
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BrMg
0.4 M Et2O, 0 °C to rt, 18h MeO OMe
O
Me
Me
1.25 equiv.
MeO
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1.4 equiv. Ph3PCH3Br
1.3 equiv. t-BuOK
0.4 M THF, 0 °C to rt, 16h
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2.45 (t, J = 7.8 Hz, 2H), 2.00 (q, J = 7.8 Hz, 2H), 1.64 (s, 3H), 1.51 (s, 3H); 13C NMR (150 
MHz, CDCl3); δ 160.0, 157.5, 148.5, 131.3, 130.5, 124.8, 124.3, 113.9, 103.9, 98.5, 55.4, 55.3, 
36.5, 26.9, 25.7, 17.6 
(Z)-1-(hepta-1,5-dien-2-yl)-4-methoxybenzene (2u) 
 
 4-(4-methoxyphenyl)pent-4-enal was prepared according to a procedure published by 
Hartwig and coworkers.41 Wittig olefination of the terminal aldehyde carried out using 
ethyltriphenylphosphonium bromide following the procedure in general procedure A above.  
The desired diene product was purified by column chromatography (20% Et2O/hexanes) to 
furnish 1.13 g (67%) of pure product as a colorless oil (8.5:1 mixture of E/Z isomers).  Analytical 
data for 2u:  1H NMR (400 MHz, CDCl3): δ 7.34 (d, J = 8.8 Hz, 2H), 6.85 (d, J = 8.8 Hz, 2H), 
5.41 (m, 2H), 5.21 (d, J = 1.6 Hz, 1H), 4.98 (d, J = 1.6 Hz, 1H), 3.80 (s, 3H), 2.51 (m, 2H), 2.20 
(m, 2H), 1.53 (d, J = 5.6 Hz, 3H); 13C NMR (100 MHz, CDCl3); δ 158.9, 147.3, 133.5, 129.8, 
127.1, 124.1, 113.5, 110.7, 55.1, 35.1, 25.7, 12.7 
1-(hexa-1,5-dien-2-yl)-4-methoxybenzene (2v) 
 
4-(4-methoxyphenyl)pent-4-enal was prepared according to a procedure published by 
Hartwig and coworkers.41 Wittig olefination of the terminal aldehyde carried out using 
methyltriphenylphosphonium bromide following the procedure in general procedure A above.  
The diene product was purified by column chromatography (20% Et2O/hexanes) to furnish 1.13 
MeO
O
H
1.4 equiv. Ph3PCH2CH3Br
1.3 equiv. t-BuOK
0.4 M THF, 0 °C to rt, 16h
MeO
8.5 : 1 as measured by 1H NMR integrations
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0.4 M THF, 0 °C to rt, 16h
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g of pure product (75%) as a colorless oil.  Spectral data were in agreement with the reported 
literature values.42 Analytical data for 2v:  1H NMR (600 MHz, CDCl3): δ 7.24 (d, J = 7.2 Hz, 
2H), 6.85 (d, J = 7.2 Hz, 2H), 5.83 (m, 1H), 5.21 (s, 1H), 4.98 (m, 3H), 3.80 (s, 3H), 2.56 (t, J = 
7.8 Hz, 2H), 2.20 (q, J = 7.8 Hz, 2H); 13C NMR (150 MHz, CDCl3); δ 159.0, 147.1, 138.2, 
133.6, 127.2, 114.6, 113.6, 110.9, 55.2, 34.8, 32.5 
1-methoxy-4-(3-((3-methylbut-2-en-1-yl)oxy)prop-1-en-2-yl)benzene (2w) 
 
1.6 equiv. sodium hydride was dispensed into a flame dried round bottom flask, which 
was subsequently purged with N2.  The sodium hydride was suspended in dry THF (0.4 
mmol/mL relative to substrate) and the stirred suspension was cooled to 0 °C in an ice bath.  At 0 
°C, a solution of 2-(4-methoxyphenyl)prop-2-en-1-ol (prepared according to literature 
procedure)43 in THF was added dropwise with stirring.  The solution was stirred at 0 °C for 30 
minutes after effervescence ceased.  At 0 °C, prenyl bromide (1.4 equiv.) was added to the 
mixture dropwise.  The reaction was allowed to warm to room temperature and stirred for 15 
hours overnight.  The reaction was then quenched with concentrated NH4Cl solution, and diluted 
with DI water and diethyl ether.  The organic layer was separated and aqueous layer extracted 
three times with diethyl ether in a separatory funnel.  The combined organics were washed with 
brine, dried with anhydrous MgSO4, filtered, and concentrated to afford a crude oil.  The crude 
allylic ether was purified by silica gel column chromatography (20% Et2O/hexanes) to yield 2.16 
g (70%) of the desired product as an off-white oil.  Analytical data for 2w:  1H NMR (600 MHz, 
CDCl3): δ 7.41 (d, J = 8.4 Hz, 2H), 6.85 (d, J = 8.4 Hz, 2H), 5.43 (d, J = 1.2 Hz, 1H), 5.35 (m, 
MeO
OH
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0.4 M THF, 0 °C to rt, 15h
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1H), 5.22 (d, J = 1.2 Hz, 1H), 4.32 (s, 2H), 3.98 (d, J = 7.2 Hz, 2H), 3.79 (s, 3H), 1.72 (s, 3H), 
1.62 (s, 3H); 13C NMR (150 MHz, CDCl3); δ 159.2, 143.7, 137.1, 131.4, 127.2, 121.0, 113.6, 
112.7, 72.0, 65.3, 55.3, 25.8, 18.0 
1-((E)-3-(cinnamyloxy)prop-1-en-1-yl)-4-methoxybenzene (2x) 
 
 Prepared according to a published procedure; spectral data were in agreement with the 
literature values.9 
(E)-1-methoxy-4-(3-((3-methylbut-2-en-1-yl)oxy)prop-1-en-1-yl)benzene (2y) 
 
Prepared according to published procedure for (2x) above, however using 3,3-
dimethylallyl bromide in place of cinnamyl bromide.  The desired product was purified by 
column chromatography (10% Et2O/hexanes) to furnish 1.81 g of pure product (78%) as a 
yellow oil.  Analytical data for 2y:  1H NMR (600 MHz, CDCl3): δ 7.30 (d, J = 8.4 Hz, 2H), 
6.83 (d, J = 8.4 Hz, 2H), 6.53 (d, J = 16.2 Hz, 1H), 6.16 (m, 1H), 5.38 (m, 1H), 4.09 (dd, J = 6.6 
Hz, J = 1.8 Hz, 2H), 3.99 (d, J = 6.6 Hz, 2H), 3.78 (s, 3H), 1.74 (s, 3H), 1.67 (s, 3H); 13C NMR 
(150 MHz, CDCl3); δ 159.2, 137.0, 132.0, 129.5, 127.6, 124.0, 121.1, 113.9, 70.8, 66.4, 55.2, 
25.8, 18.0 
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((1E,1'E)-oxybis(prop-1-ene-3,1-diyl))dibenzene (2z) 
 
 Prepared according to a published procedure; spectral data were in agreement with the 
literature values.9  
Isolated Products of Cyclization – Endoperoxidation Cascade Reactions 
Procedure for Synthesis of Bicyclic Endoperoxide 3a from Diene 2a 
 
 A flame dried 1-dram vial equipped with a magnetic stir bar and 0.25 mg and 2,4,6-tris(4-
methoxyphenyl)pyrylium tetrafluoroborate catalyst, then sealed with a septum cap.  0.5 mL dry 
acetonitrile was then added via syringe under an atmosphere of nitrogen.  Finally, 30 mg diene 
3a was added to the stirring reaction mixture in 0.5 mL acetonitrile.  A balloon of oxygen was 
fitted to the vial and bubbled through the stirring solution for 2 minutes.  After bubbling was 
suspended, an atmosphere of oxygen was maintained over the solution and the reaction was 
irradiated for two hours at ambient temperature using 470 LEDs.  Upon completion, the desired 
product was isolated using silica gel column chromatography (33% Et2O/hexanes).  Spectral data 
were in agreement with the literature values.24 
1-phenylpentane-1,4-dione (4b and 4c) 
 
Produced from substrates 2b and 2c. Spectral data were in agreement with the literature values.44 
 
O
Ar
Ar O
O
Ar
Ar
Ar = 4-MeO-C6H4Ar = 4-MeO-C6H4
0.5 mol% 1c
0.1 M MeCN, rt
1 atm O2
470 nm LEDs
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1-methyl-5-phenyl-2,8-dioxabicyclo[3.2.1]octane (5c) 
 
Produced from substrate 2c in low yields. The title compound was purified by column 
chromatography on silica gel (50% DCM/hexanes). Analytical data for 3c: 1H NMR (600 MHz, 
DMSO-d6): δ 7.33 (m, 4H), 7.24 (m, 1H), 3.99 (td, J = 12.0 Hz, J = 3.8 Hz, 1H), 3.84 (ddd, J = 
11.9 Hz, J = 6.3 Hz, J = 0.8 Hz, 1H), 2.36 (ddd, J = 12.2 Hz, J = 9.5 Hz, J = 4.3 Hz, 1H), 2.16 
(ddd, J = 13.2 Hz, J = 9.5 Hz, J = 4.9 Hz, 1H), 1.95 (td, J = 13.1 Hz, J = 4.3 Hz, 1H), 1.82 (m, 
2H), 1.67 (m, 1H), 1.42 (s, 3H); 13C NMR (150 MHz, DMSO-d6) δ 145.7, 128.1, 126.7, 124.2, 
105.2, 83.6, 59.4, 36.9, 35.1, 34.9, 24.5; MS (+ESI): m/z calculated for C13H16O2 [M+H]+ 
205.13, found 205.06. 
4-methoxybenzaldehyde (4e) 
 
Produced from substrate 2e in generally high yields. Spectral data were in agreement with the 
literature values.45 
4-(4-methoxyphenyl)hex-5-en-2-one (5e) 
 
Produced from substrate 2e in condition-dependent yields. The title compound was 
purified by column chromatography on silica gel (67% DCM/hexanes). Spectral data were in 
O O
Ph
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agreement with the literature values.46 Analytical data for 3e: 1H NMR (400 MHz, CDCl3): δ 
7.10 (d, J = 8.7 Hz, 2H), 6.82 (d, J = 8.7 Hz, 2H), 5.92 (ddd, J = 17.1 Hz, J = 10.3 Hz, J = 6.7 
Hz, 1H), 4.99 (m, 2H), 3.78 (app. s, 1H), 3.76 (s, 3H), 2.79 (m, 2H), 2.06 (s, 3H)  
General Procedure for Endoperoxidation of Unconjugated Dienes Under Oxygen 
Atmosphere. 
 
 A flame dried flask (2-dram vial, scintillation vial, or round-bottom flask) was equipped 
with a magnetic stir bar and 2,4,6-tris(4-methoxyphenyl)pyrylium tetrafluoroborate catalyst (1c, 
4-MeO-TPT, see conditions above for catalyst loading), then sealed with a septum.  The solvent 
(DCM for conditions A and C, DCE for condition B, see conditions above for concentration) was 
then added to the flask via syringe under an atmosphere of nitrogen.  Substrate was then added to 
the flask via microsyringe and stirred to ensure a homogeneous reaction mixture.  A balloon of 
oxygen was fitted to the reaction flask and oxygen was bubbled through the stirring solution for 
3 minutes to ensure oxygen saturation in the solvent.  After bubbling was suspended the reaction 
was fitted with a balloon of oxygen to ensure an oxygen atmosphere and submerged in a 
temperature-controlled bath (-41 °C for conditions A and C, -10 °C for condition B).  The 
reaction was irradiated with 470 nm LEDs until completion (as monitored by TLC).  Upon 
completion, the reaction mixture was concentrated under reduced pressure and the products 
isolated by silica gel column chromatography.  
 
 
R2
Ar X
R3 O O
X
Ar R
3
R2
catalyst 1c
Solvent, T °C 
1 atm O2
470 nm LEDs
Condition A
0.7 mol% 1c
0.07 M DCM, -41 °C
Condition B
2 mol% 1c
0.02 M DCE, -10 °C
Condition C
2 mol% 1c
0.02 M DCM, -41 °C
R1
R1
X = CMe2, CH2, CH2O
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1-(4-methoxyphenyl)-4,4,7,7-tetramethyl-2,3-dioxabicyclo[3.2.1]octane (3g) 
 
The average yield for the title compound was 66% (2 trials) at the 0.72 mmol scale, using 
Condition A, and an irradiation time of 3.5 hours. The title compound was purified by column 
chromatography on silica gel (10% EtOAc/hexanes) to yield a white solid. Analytical data for 
3g:  
1H NMR (400 MHz, CDCl3): δ 7.28 (d, J = 8.8 Hz, 2H), 6.84 (d, J = 8.8 Hz, 2H), 3.78 (s, 3H), 
2.35 (dd, J = 12.0 Hz, J = 5.6 Hz, 1H), 2.24 (dd, J = 12.0 Hz, J = 2.8 Hz, 1H), 2.03 (t, J = 6.0 
Hz, 1H), 1.98 (dd, J = 13.2 Hz, J = 2.8 Hz, 1H), 1.66 (dd, J = 13.2 Hz, J = 6.4 Hz), 1.41 (s, 3H), 
1.32 (s, 3H), 1.13 (s, 3H), 0.58 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 159.2, 130.3, 127.5, 
113.2, 93.4, 80.3, 55.2, 42.5, 42.4, 41.6, 33.7, 31.6, 24.9, 23.4, 21.6; MS (+ESI): m/z calculated 
for C17H24O3 [M+H]+ 277.18, found 277.11. 
O O
Me
Me
Me Me
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1-(4-methoxyphenyl)-4,4-dimethyl-2,3-dioxabicyclo[3.2.1]octane (3i) 
 
The average yield for the title compound was 32% (2 trials) at the 1.0 mmol scale, using 
Condition B, and an irradiation time of 3.5 hours. The title compound was purified by column 
chromatography on silica gel (20% EtOAc/hexanes) to yield a white solid. Analytical data for 3i:  
1H NMR (400 MHz, CDCl3): δ 7.35 (d, J = 8.8 Hz, 2H), 6.85 (d, J = 8.8 Hz, 2H), 3.78 (s, 3H), 
2.49 (m, 2H), 2.16 (t, J = 5.4 Hz, 1H), 2.09 (m, 1H), 1.84 (dt, J = 12.4 Hz, J = 3.6 Hz, 1H), 1.74 
(m, 2H), 1.45 (s, 3H), 1.16 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 159.4, 132.2, 127.9. 113.6, 
90.0, 80.6, 55.2, 43.7, 35.6, 34.8, 26.3, 24.8, 23.4; MS (+ESI): m/z calculated for C15H20O3 
249.15, found 249.15. 
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1-(2,4-dimethoxyphenyl)-4,4-dimethyl-2,3-dioxabicyclo[3.2.1]octane (3j) 
 
The average yield for the title compound was 9% (2 trials) at the 0.5 mmol scale, using 
Condition B, and an irradiation time of 3 hours. The title compound was purified by column 
chromatography on silica gel (10% to 20% Et2O/pentane) to yield a colorless oil. Analytical data 
for 3j:  
1H NMR (600 MHz, CDCl3): δ 7.25 (s, 1H), 6.42 (m, 2H), 3.79 (s, 3H), 3.77 (s, 3H), 2.78 (m, 
1H), 2.58 (dt, J = 11.4 Hz, J = 3.0 Hz, 1H), 2.09 (t, J = 5.4 Hz, 1H), 2.05 (m, 1H), 1.88 (m, 1H), 
1.80 (dd, J = 11.4 Hz, J = 5.4 Hz, 1H), 1.66 m, 1H), 1.43 (s, 3H), 1.15 (s, 3H); 13C NMR (150 
MHz, CDCl3) δ 161.0, 160.0, 129.1, 120.4, 103.6, 99.4, 89.6, 80.6, 55.5, 55.3, 43.4, 36.2, 33.4, 
26.3, 24.9, 23.5; MS (+ESI): m/z calculated for C16H22O4 [M+H]+ 279.15, found 279.15. 
1-(2-methoxyphenyl)-4,4-dimethyl-2,3-dioxabicyclo[3.2.1]octane (3l) 
 
The average yield for the title compound was 16% (2 trials) at the 0.5 mmol scale, using 
Condition B, and an irradiation time of 5 hours. The title compound was purified by column 
chromatography on silica gel (20% EtOAc/hexanes) to yield a white solid. Analytical data for 3l:  
1H NMR (600 MHz, CDCl3): δ 7.34 (dd, J = 7.8 Hz, J = 1.8 Hz, 1H), 7.26 (m, 1H), 6.89 (m, 
2H), 3.81 (s, 3H), 2.77 (m, 1H), 2.57 (dt, J = 12.0 Hz, J = 2.4 Hz, 1H), 2.10 (t, J = 5.4 Hz, 1H), 
2.06 (m, 1H), 1.94 (m, 1H), 1.89 (dd, J = 11.4 Hz, J = 5.4 Hz, 1H), 1.69 (m, 1H), 1.44 (s, 3H), 
1.16 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 158.7, 129.6, 128.2, 127.7, 120.2, 111.8, 89.9, 80.8, 
O O
Me
Me
OMe
MeO
O O
Me
Me
OMe
 75 
55.6, 42.4, 36.1, 33.3, 26.3, 24.8, 23.5; MS (+ESI): m/z calculated for C15H20O3 [M+H]+ 249.15, 
found 249.09. 
1-(4-methoxyphenyl)-7,7-dimethyl-4-phenyl-2,3-dioxabicyclo[3.2.1]octane (3p) 
 
The average yield for the title compound was 68% (2 trials, 1:1 mixture of diastereomers) 
at the 0.5 mmol scale, using Condition C, and an irradiation time of 3 hours. The title compound 
was purified by column chromatography on silica gel (10% Et2O/pentane) to yield a white solid. 
Analytical data for 3p:  
1H NMR for diastereomer 1 (400 MHz, CDCl3): δ 7.48 (d, J = 8.8 Hz, 2H), 7.31 (t, J = 7.2 Hz, 
2H), 7.23 (m, 3H), 6.81 (d, J = 8.8 Hz, 2H), 5.0 (d, J = 3.6 Hz, 1H), 3.76 (s, 3H), 2.80 (m, 1H), 
2.28 (dd, J = 12.0 Hz, J = 6.0 Hz, 1H), 2.07 (m, 2H), 1.83 (dd, J = 12.0 Hz, J = 2.0 Hz, 1H), 1.47 
(s, 3H), 0.62 (s, 3H); 13C NMR for diastereomer 1 (150 MHz, CDCl3) δ 159.3, 140.5, 130.4, 
128.2, 127.5, 126.7, 126.1, 113.2, 94.9, 86.2, 55.2, 45.8, 43.4, 37.3, 32.0, 31.4, 21.6; 1H NMR 
for diastereomer 2 (400 MHz, CDCl3): δ 7.35 (m, 4H), 7.27 (m, 3H), 6.87 (d, J = 8.8 Hz, 2H), 
5.26 (s, 1H), 3.80 (s, 3H), 2.82 (dd, J = 11.6 Hz, J = 5.9 Hz, 1H), 2.59 (t, J = 6.3 Hz, 1H), 2.12 
(dd, J = 11.6 Hz, J = 2.3 Hz, 1H), 1.87 (dd, J = 13.2 Hz, J = 2.3 Hz, 1H), 1.58 (dd, J = 13.2 Hz, J 
= 6.7 Hz, 1H); 13C NMR for diastereomer 2 (150 MHz, CDCl3) δ 159.4, 138.8, 129.7, 128.2, 
127.6, 127.5, 126.1, 113.3, 94.3, 85.5, 55.2, 43.6, 40.3, 39.4, 38.3, 31.6, 20.8; MS (+ESI): m/z 
calculated for C21H24O3 [M+H]+ 325.18, found 325.18 
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3-(4-methoxyphenyl)-4,4,6,6,9a-pentamethylhexahydro-3H,6H-3,5a-
methanobenzo[c][1,2]dioxepine (3q) 
 and  
The average yield for the title compound was 64% (2 trials) at the 0.5 mmol scale, using 
Condition C, and an irradiation time of 4 hours. The polycyclic product was isolated as 6.5:1 
mixture of inseparable diastereomers (shown above, left thought to be major diastereomer).  The 
title compound was purified by column chromatography on silica gel (10% Et2O/pentane) to 
yield a colorless oil. Analytical data for 3q:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.28 (d, J = 8.8 Hz, 2H), 6.83 (d, J = 8.8 
Hz, 2H), 3.77 (s, 3H), 2.46 (d, J = 12.0 Hz, 1H), 2.31 (dt, J = 13.2 Hz, 5.4 Hz, 1H), 2.17 (dd, J = 
12.0 Hz, 2.4 Hz, 1H), 1.84 (dd, J = 13.2 Hz, 2.5 Hz, 1H), 1.72-1.57 (m, 3H), 1.55 (d, J = 13.2 
Hz, 1H), 1.48 (dt, J = 13.8 Hz, 4.8 Hz, 1H), 1.41 (dt, J = 13.2 Hz, 3.4 Hz, 1H), 1.31 (s, 3H), 1.25 
(s, 3H), 1.01 (s, 3H), 0.96 (s, 3H), 0.57 (s, 3H); 13C NMR for major diastereomer (150 MHz, 
CDCl3) δ 159.1, 130.9, 127.3, 113.2, 113.1, 92.8, 85.0, 55.2, 50.4, 43.8, 42.6, 37.0, 36.6, 35.5, 
31.7, 30.7, 27.7, 25.3, 23.5, 21.7, 20.4; MS (+ESI): m/z calculated for C22H32O3 [M+H]+ 345.24, 
found 345.24 
1-(4-methoxyphenyl)-3-methylpent-4-en-1-one (3r) 
 
The yield for the title compound was 36% (1 trial) at the 0.5 mmol scale, using 
Condition C, and an irradiation time of 23 hours (-41 °C to rt). The title compound was purified 
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by column chromatography on silica gel (20% Et2O/pentane) to yield a colorless oil.  Analytical 
data for 3r:  
1H NMR (600 MHz, CDCl3): δ 7.91 (d, J = 8.9 Hz, 2H), 6.91 (d, J = 8.9 Hz, 2H), 5.82 (m, 1H), 
5.00 (d, J = 17.2 Hz, 1H), 4.92 (d, J = 10.4 Hz, 1H), 3.84 (s, 3H), 2.95 (dd, J = 14.9 Hz, J = 5.8 
Hz, 1H), 2.86 (m, 1H), 2.81 (dd, J = 14.9 Hz, J = 7.2 Hz, 1H), 1.06 (d, J = 6.5 Hz, 1H); 13C 
NMR (150 MHz, CDCl3) δ 197.9, 163.3, 143.2, 130.4, 130.3, 113.6, 112.9, 55.4, 44.8, 33.8, 
19.8; MS (+ESI): m/z calculated for C13H17O2 [M+H]+ 205.12, found 205.09 
1-(4-methoxyphenyl)-4-methylpent-4-en-1-one (3s) 
 
The yield for the title compound was 37% (1 trial) at the 0.5 mmol scale, using 
Condition C, and an irradiation time of 23 hours (-41 °C to rt). The title compound was purified 
by column chromatography on silica gel (20% Et2O/pentane) to yield a colorless oil.  Spectral 
data were in agreement with the literature values.47 Analytical data for 3s:  
1H NMR (600 MHz, CDCl3): δ 7.93 (d, J = 8.9 Hz, 2H), 6.91 (d, J = 8.9 Hz, 2H), 4.74 (s, 1H), 
4.70 (s, 1H), 3.84 (s, 3H), 3.04 (m, 2H), 2.41 (t, J = 7.8 Hz, 2H), 1.76 (s, 3H); 13C NMR (150 
MHz, CDCl3) δ 198.3, 163.3, 144.8, 130.3, 130.0, 113.7, 110.0, 55.4, 36.4, 32.1, 22.7 
1-(4-methoxyphenyl)pent-4-en-1-one (3t) 
 
The yield for the title compound was 27% (1 trial) at the 0.5 mmol scale, using 
Condition C, and an irradiation time of 23 hours (-41 °C to rt). The title compound was purified 
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by column chromatography on silica gel (20% Et2O/pentane) to yield a colorless oil.  Spectral 
data were in agreement with the literature values.47 Analytical data for 3t:  
1H NMR (600 MHz, CDCl3): δ 7.93 (d, J = 8.9 Hz, 2H), 6.91 (d, J = 8.9 Hz, 2H), 5.88 (m, 1H), 
5.06 (dq, J = 17.1, J = 1.8 Hz, 1H), 4.98 (dq, J = 10.2, J = 1.8 Hz, 1H), 3.85 (s, 3H), 3.00 (t, J = 
7.2 Hz, 2H), 2.47 (m, 2H); 13C NMR (150 MHz, CDCl3) δ 198.0, 163.4, 137.5, 130.3, 130.0, 
115.1, 113.7, 55.4, 37.4, 28.3 
1-(4-methoxyphenyl)-4,4-dimethyl-2,3,7-trioxabicyclo[3.3.1]nonane (3w) 
 
The average yield for the title compound was 16% (2 trials) at the 0.5 mmol scale, using 
modified Condition C (0.04 M DCE, other conditions unaltered), and an irradiation time of 4 
hours. The title compound was purified by column chromatography on silica gel (20% 
Et2O/pentane) to yield a white solid. Analytical data for 3w:  
1H NMR (400 MHz, CDCl3): δ 6.96 (d, J = 8.7 Hz, 2H), 6.82 (d, J = 8.6 Hz, 2H), 4.19 (m, 2H), 
4.01 (dd, J = 9.6 Hz, J = 2.4 Hz, 1H), 3.77 (s, 3H), 3.72 (d, J = 9.6 Hz, 1H), 2.53 (m, 1H), 1.97 
(dt, J = 6.7 Hz, J = 2.0 Hz, 1H), 1.87 (d, J = 9.2 Hz, 1H), 1.26 (s, 3H), 0.93 (s, 3H); 13C NMR 
(100 MHz, CDCl3) δ 158.1, 134.5, 127.2, 113.6, 74.6, 68.3, 55.2, 50.1, 40.9, 39.3, 30.4, 23.6, 
19.7; MS (GC-MS): m/z calculated for C15H20O4 264.14, found 264.1 
1-(4-methoxyphenyl)-4-phenyltetrahydro-1H,4H-furo[3,4-d][1,2]dioxine (3x) 
 
The average yield for the title compound was 79% (2 trials, 5.7:1 mixture of 
diastereomers) at the 0.5 mmol scale, using Condition C, and an irradiation time of 3 hours. The 
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title compound was purified by column chromatography on silica gel (33% to 50% 
EtOAc/hexanes) to yield a colorless oil.  Spectral data were in agreement with the literature 
values.9 Analytical data for 3x:  
1H NMR major diastereomer (600 MHz, CDCl3): δ 7.49 (d, J = 7.0 Hz, 2H), 7.36 (t, J = 7.5 Hz, 
2H), 7.30 (m, 3H), 6.90 (d, J = 8.7 Hz, 2H), 5.55 (d, J = 5.8 Hz, 1H), 5.03 (d, J = 9.9 Hz, 1H), 
4.16 (t, J = 7.3 Hz, 1H), 3.80 (s, 3H), 3.77 (m, 1H), 3.42 (dd, J = 11.4 Hz, J = 8.4 Hz, 1H), 3.24 
(dd, J = 11.4 Hz, J = 7.8 Hz, 1H), 2.83 (m, 1H), 2.60 (m, 1H); 1H NMR minor diastereomer (600 
MHz, CDCl3): δ 7.37 (s, 5H), 7.33 (d, J = 8.7 Hz, 2H), 6.90 (d, J = 8.7 Hz, 2H), 5.14 (d, J = 9.4 
Hz, 1H), 5.11 (d, J = 9.4 Hz, 1H), 3.90 (m, 2H), 3.80 (s, 3H), 3.53 (m, 2H), 2.63 (m, 2H) 
Singlet oxygen control: hydroperoxidation / ene reaction of 2g 
 
(E)-1-(6-hydroperoxy-3,3,6-trimethylhepta-1,4-dien-2-yl)-4-methoxybenzene (4g) 
 
The yield for the title compound was 65% (1 trial) at the 0.36 mmol scale, using modified 
Condition A, and an irradiation time of 3.5 hours. Rose Bengal was used in place of catalyst 1c 
and dry MeOH as solvent in place of DCM.  The reaction was carried out at ambient 
temperature.  The title compound was purified by column chromatography on silica gel (20% 
Et2O/hexanes) to yield a colorless oil.  It should be noted that the shown tertiary allylic 
hydroperoxide was the major product in a transformation possibly producing multiple oxidation 
products (complete consumption of starting material was observed by 1H NMR).  No 
endoperoxidation/cyclization products were observed.  Analytical data for shown hydroperoxide 
4g:  
1H NMR (600 MHz, CDCl3): δ 7.16 (s, 1H) 7.07 (d, J = 8.7 Hz, 2H), 6.77 (d, J = 8.7 Hz, 2H), 
5.78 (d, J = 16.2 Hz, 1H), 5.42 (d, J = 16.2 Hz, 1H), 5.17 (d, J = 1.5 Hz, 1H), 4.90 (d, J = 1.5 Hz, 
MeO
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1H), 3.77 (s, 3H), 1.32 (s, 6H), 1.19 (s, 6H); 13C NMR (150 MHz, CDCl3) δ 158.3, 156.6, 140.4, 
135.2, 130.0, 129.8, 113.1, 112.7, 82.3, 55.2, 41.6, 27.2, 24.3; MS (+ESI): m/z calculated for 
C17H24O3 [M+H]+ 277.18, found 277.11 
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CHAPTER 3: DEVELOPMENT OF A METHOD TO DIRECTLY ACCESS γ-LACTAM AND 
PYRROLIDINE HETEROCYCLES VIA POLAR RADICAL CROSSOVER CYCLIZATIONS* 
 Introduction 3.1
In this chapter the utility of visible light photoredox catalysis as a mode of regioselective 
alkene functionalization will be expanded. Here, bond formation proceeds from an unsaturated 
heteroatom nucleophile engaging the alkene cation radical, rather than intramolecular alkene 
cyclization to a distonic intermediate. Herein, a method for the direct synthesis of γ-lactam and 
pyrrolidine heterocycles from oxidizable alkenes and unsaturated N-nucleophiles is presented, 
forming a C−C, C−N, and C−H bond in a single synthetic step (Figure 3.1). Key to the success 
of this method (and related systems) is the dual catalytic system comprised of an acridinium 
organic photoredox catalyst and a redox-active H-atom donor cocatalyst. The role of both will be 
discussed in detail in following sections. 
Figure 3.1 Photoredox mediated cyclization to form N-heterocycles from oxidizable alkenes 
 
 Background 3.2
 Representative examples and inspiration 3.2.1
Heterocyclic γ-lactam and pyrrolidine motifs represent a significant portion of chemical 
space, as they are present in natural products, biologically active synthetic species, and 
                                                
* Reprinted (adapted) with permission from Gesmundo, N. J.; Grandjean, J.-M.; Nicewicz, D. A. “Amide and 
Amine Nucleophiles in Polar Radical Crossover Cycloadditions: Synthesis of γ-Lactams and Pyrrolidines” Org. 
Lett. 2015, 17, 1316-1319. Copyright 2015 American Chemical Society. 
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catalysts.1–7 Figure 3.2 shows representative examples of highly functionalized naturally 
occurring pyrrolidine species (acromelic acid B and domoilactone A), highly substituted γ-
lactam natural products (cynolujine, anantine, and lactacystin), and two examples of 
physiologically active synthetic γ-lactams. One of the synthetic species, developed by 
GlaxoSmithKline, shows HIV protease inhibition, and the other, developed at Georgetown 
University, shows protein kinase C (PKC) modulation.4,5 Due to the ubiquity and importance of 
these structures, particularly as pharmacophores, developing synthetic methods that facilitate the 
rapid synthesis of these heterocycles has been an area of study for many groups. 
Figure 3.2 Biologically active N-heterocyclic natural products and synthetic entities 
 
 Extant intermolecular methods for the construction of γ-lactams 3.2.2
Traditional strategies for γ-lactam and pyrrolidine synthesis have often relied on 
intramolecular disconnections. Strategies for γ-lactam synthesis such as ester/amine 
cyclization/lactamization, halolactamization,8–14 Rh-catalyzed C−H insertion,15 and Pd-catalyzed 
alkene functionalization have been extensively studied.16,17 For pyrrolidine synthesis, strategies 
such as γ-lactam reduction or intramolecular alkene hydroamination,18–27 halocyclization,28,29 and 
the aza-Cope/Mannich reaction have been developed.30,31 As this chapter discloses an 
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intermolecular approach to these scaffolds, discussion will center on recent intermolecular 
methods to access these structures rather than established intramolecular strategies. 
Bode and coworkers disclosed a one-step, intermolecular N-heterocyclic carbene (NHC)-
catalyzed method to access γ-lactams from enal and N-sulfonyl imine precursors in a 2005 
follow up to a related lactonization method (Figure 3.3).32 The reaction proceeds through a 
homoenolate pathway, via the Breslow intermediate A formed in situ from the enal and 
NHC/deprotonated imidazolium salt (shown below). Addition into the sulfonyl imine (to form B) 
and lactamization via NHC expulsion furnishes the γ-lactam product. This method is noteworthy 
for its ability to quickly generate highly decorated lactam products, but is limited to aromatic or 
vinyl N-sulfonyl imines and in accessible substitution patterns. 
Figure 3.3 Bode’s NHC-catalyzed method 
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(further expanded in 2011), forming highly functionalized γ-lactam products in a three-
component coupling between β-nitro esters, aldehydes, and amines via in situ iminium ion 
formation (Figure 3.4).33,34 Imine formation followed by proton exchange (vide infra) results in 
nitro-Mannich C−C bond formation (to form A). From here, lactamization produces the γ-lactam 
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decorated products to be produced in a one-step, three-component coupling. The limitation, 
however, is the necessity of the nitro group, which is required to render the β C−H bond 
sufficiently acidic, and is preserved in the final product. 
Figure 3.4 Dixon’s cascade annulation 
 
The final lactam-constructing method highlighted here is a 2011 report from Wang and 
coworkers, in which they presented a Cu(I)/BINAP-catalyzed enantioselective synthesis of α-
benzylidene γ-lactams bearing a C5 quaternary stereocenter (Figure 3.5).35 These products were 
produced in a three-step sequence consisting of Michael addition/elimination between the 
Morita-Baylis-Hillman carbonate and the aldimino ester (to form A, mediated by the 
Cu(I)/BINAP catalyst to set the quaternary stereocenter), an acidic deprotection to reveal amine 
B, and lactamization under reflux. This method is unique in its ability to produce enantioenriched 
γ-lactams bearing a quaternary stereocenter and α-benzylidene functionality, motifs common in 
γ-lactam natural products (Figure 3.2). While a broad substrate scope was displayed, the 
transformation is limited in accessible substitution patterns. The reaction is also a three-step 
process, resulting in overall lower yields and prolonged reaction times. 
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Figure 3.5 Wang’s enantioselective synthesis of γ-lactams 
 
 Recent advances in pyrrolidine synthesis – novel radical/polar disconnects 3.2.3
While pyrrolidines are readily accessible via γ-lactam reduction and many established 
intramolecular strategies, direct intermolecular pyrrolidine synthesis (via new disconnections) is 
a continuing focus of many groups. Two recent examples that take advantage of both radical and 
polar reactivity, from the MacMillan and Jahn laboratories, will be discussed.  
MacMillan and coworkers developed an asymmetric strategy to construct N-sulfonyl 
pyrrolidine heterocycles from alkenes and β-amino aldehydes.36 The reaction uses an 
imidazolidinone catalyst and operates through enamine single electron oxidation (SOMO 
catalysis), as shown in Figure 3.6A. The transformation proceeds as follows: condensation to 
form the enamine intermediate, followed by single electron oxidation (SOMO activation) to 
generate enamine cation radical I. Intermolecular radical C−C bond formation with the alkene 
(β-methylstyrene), followed by a second oxidation step produces benzylic carbocation II. 
Trapping of the cation with the tethered sulfonamide produces the N-sulfonyl pyrrolidine. The 
process is net oxidative (requiring two SET oxidation events) and the reaction proceeds with 
generally high diastereoselectivity and enantioselectivity. Lastly, the transformation is very 
general, producing the corresponding substituted pyrrolidines from functionally diverse alkene 
precursors while also displaying broad functional group tolerance (Figure 3.6B). 
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Figure 3.6 Pyrrolidine synthesis through SOMO catalysis 
 
Jahn disclosed an oxidative strategy in 2014 to construct functionalized pyrrolidines via a 
novel anion-radical cyclization between enoates and allylic amines (Figure 3.7).37 The 
transformation is a two-step process overall: 1) amine deprotonation/conjugate addition, and 2) 
oxidation/cyclization. Amine deprotonation followed by conjugate addition into the enoate 
furnishes the enolate intermediate A shown. Oxidation of the enolate by Ferrocenium (B, 
produced from SET with temponium, C) elicits radical C−C bond formation to form the 
pyrrolidine core D. Finally, TEMPO trapping of the exocyclic radical produces the final product. 
The authors show a diverse substrate scope with respect to amine nucleophile and Michael 
acceptor. Notably, this method produces complex pyrrolidines from simple starting materials 
while minimizing waste, despite being a formally two-step, one-pot procedure. The authors also 
extended this strategy to intermolecular cyclopentane and cyclohexane construction using 
carbon-nucleophiles. 
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Figure 3.7 Anion-radical cyclization between allylic amines and Michael acceptors 
 
Each method described above for γ-lactam and pyrrolidine synthesis, as well as the extant 
methods not examined in detail, fills a gap in the field and renders direct N-heterocycle synthesis 
more feasible. We sought to develop a complimentary intermolecular method for synthesis of 
functionalized γ-lactams and pyrrolidines through visible light photoredox catalysis, utilizing a 
novel polar radical crossover cyclization (PRCC) disconnection and unique precursors, 
accessible due to the intermediacy of olefin cation radicals.  
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disconnect, but to understand this PRCC system a complete understanding of the 
hydrofunctionalization manifold is required.42,43 
 Anti-Markovnikov hydroacetoxylation: scope, regioselectivity, H-atom donor 3.3.1
A relevant example of cation radical-mediated anti-Markovnikov olefin 
hydrofunctionalization is the intermolecular hydroacetoxylation strategy disclosed by Perkowski 
and Nicewicz in 2013 (Figure 3.8A).39 The transformation utilizes Mes-Acr+-BF4 photooxidant 
1b and thiophenol as the H-atom donor cocatalyst. The method is mild (450 nm LEDs and 
ambient temperature) and displays a broad substrate scope with respect to alkene substitution 
patterns and electronics as well as nucleophile steric demands and electronics (Figure 3.8B). 
Figure 3.8 Anti-Markovnikov addition of carboxylic acids to alkenes 
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 The transformation is believed to proceed as shown in Figure 3.8C. Excitation of the 
acridinium catalyst is followed by fluorescence quenching with the olefin donor to produce 
radical cation A and the acridine radical (1b•). The cation radical is then intercepted by a 
carboxylate nucleophile in solution to form carbon-centered radical B and H-atom transfer with 
thiophenol produces the anti-Markovnikov acetoxylation product. The redox event between thiyl 
radical C and acridine radical 1b• regenerates the acridinium catalyst and thiolate protonation 
regenerates the H-atom donor. 
 Importance of the H-atom donor 3.3.1.1
The linchpin of this transformation is the redox-active hydrogen atom donor (HAD) 
cocatalyst, as the reaction does not proceed in the absence of this cocatalyst. Considering the 
mechanism shown in Figure 3.8C it is clear why the H-atom donor is so important: it plays a role 
in H-atom transfer (HAT), catalyst turnover, and deprotonation. Thiophenol traps the carbon-
centered radical (B) via H-atom transfer, producing the final product and thiyl radical (C). This 
is due to the low S−H BDE of thiophenol (79.1 kcal/mol) relative to C−H bonds (85-95 
kcal/mol).44 Thiyl radical C regenerates acridinium catalyst 1b via SET with acridine radical 1b•. 
According to the simplified Weller equation, this redox event is favorable by +0.94 V (acridine 
radical: E1/2ox = −0.49 V vs. SCE, thiyl radical: E1/2red = +0.45 V vs. SCE).45–47 Lastly, the 
thiolate is basic enough (pKa = 10.3 in DMSO) to quench strong acids produced over the course 
of the reaction.44 Without an H-atom donor, quenching of carbon-centered radical B does not 
occur and there is no avenue for acridinium catalyst regeneration as acridine radical 1b• is not a 
strong enough reductant to directly reduce transient carbon-centered radicals to their 
corresponding carbanions (benzylic radical E1/2red ≈ −1.45 V vs. SCE).48  
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 Anti-Markovnikov regioselectivity observed 3.3.1.2
A defining feature of the above-described transformation is the complete regiocontrol 
observed with respect to nucleophilic addition into the cation radical. Working off the seminal 
report by Arnold in photochemical nucleophile/olefin combination, aromatic substitution (photo-
NOCAS) chemistry, the observed regioselectivity is rationalized as the result of stability 
differences between two possible distonic cation radicals produced after nucleophilic addition 
(Figure 3.9A).49,50 Observed products are produced from the more stable (substituted) 
intermediate, resulting in anti-Markovnikov selectivity. Hamilton and Nicewicz showed in an 
intramolecular system that regioselectivity trends with carbon-centered radical stability (Figure 
3.9B), regardless of cyclization mode, producing products arising from the most stabilized 
distonic intermediate exclusively.38 This trend was further confirmed in Perkowski’s 
intermolecular hydrofunctionalization system (Figure 3.9C).39 
Figure 3.9 Observed regiocontrol in cation radical mediated processes  
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 Cation radical mediated polar radical crossover cyclization to access O-heterocycles 3.3.2
The polar radical crossover cyclization methods (PRCC) developed in the Nicewicz 
laboratory to form tetrahydrofuran and γ-butyrolactone heterocycles from alkene cation radicals 
are formally “interrupted” hydrofunctionalization methods, where a radical C−C bond-forming 
event precedes H-atom transfer (Figure 3.10A).42,43 A PRCC can be defined as a cyclization 
exploiting the orthogonality of polar and radical reaction vectors, utilizing these two vectors 
together to form multiple bonds of a cyclic product in a controlled, predictable sequence (Figure 
3.10B). Key to the success of these photoredox-mediated PRCC methods is the generation of 
both requisite polar and radical reaction vectors after PET (Figure 3.10). The cation is a suitable 
electrophile for nucleophilic capture and the radical can be used in C−C and C−H bond forming 
steps. Thus, under photoredox conditions, oxidizable alkenes and unsaturated alcohol or 
carboxylic acid nucleophiles are coupled in the presence of an organic photooxidant and a redox 
active H-atom donor to form O-heterocycles. 
Figure 3.10 Polar radical crossover cyclization 
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comprised of mesityl acridinium photooxidant 1a, used to generate the requisite cation radical 
intermediates in situ, and 2-phenylmalononitrile (2-PMN) as the hydrogen atom donor cocatalyst 
was used to generate highly functionalized tetrahydrofurans resembling those found in natural 
products. The only notable limitation of this technology was the alkene scope (accessible by 
photooxidant 1a); overall diverse substitution patterns and a variety of functional groups were 
tolerated on both cyclization partners (Figure 3.11B). An H-atom donor screen showed that 2-
PMN was the optimum H-atom donor for this transformation. Thiol H-atom donors such as t-
butylthiol resulted in isolation of uncyclized hydroetherification products, produced from H-
atom transfer occurring before C−C bond formation could take place. While 2-PMN is uniquely 
effective in this transformation, it possesses all the properties that made thiophenol effective for 
hydroacetoxylation (Figure 3.11C): low C−H BDE (77 kcal/mol) for H-atom transfer, positive 
reduction potential (D, E1/2red = +0.19 V vs. SCE) for efficient photoredox catalyst turnover, and 
a conjugate base that is sufficiently basic (E, pKa = 4.2 in DMSO) to quench strong acids 
produced during the reaction.51 The transformation proceeds as shown in Figure 3.11C, with 
regiocontrol again derived from the initial interaction of the allylic alcohol nucleophile and the 
cation radical (to produce the most stable distonic species, B). 
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Figure 3.11 Tetrahydrofuran synthesis under photoredox conditions 
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transformation was applied to the total synthesis of γ-butyrolactone natural products 
methylenolactocin and protolichesterinic acid as shown in Figure 3.12C. 
Figure 3.12 γ-Butyrolactone synthesis under photoredox conditions 
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present a new disconnect with unique regioselectivity and accessible substitution patterns to the 
synthetic community while complimenting existing methods for γ-lactam and pyrrolidine 
synthesis (Figure 3.13). 
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Figure 3.13 Disconnects in discussed strategies for γ-lactam and pyrrolidine synthesis 
 
 Design, challenges, considerations 3.4
In designing a system to access γ-lactams from unsaturated amide nucleophiles and 
oxidizable alkenes, we knew there would be many challenges to address (Figure 3.14). The most 
significant hurdle was chemoselectivity arising from the ambident nucleophile. N-nucleophilicity 
would yield the desired lactam after cyclization, however O-nucleophilicity would result in an 
imidate product. Additionally, uncyclized products, produced from H-atom transfer before 5-
exo-trig cyclization, would also be possible. Uncyclized products were observed in the lactone 
PRCC (Figure 3.12) when radical-stabilizing β-substituents were omitted, presumably due to a 
less favorable radical cyclization.43 In summary, activating groups (PG, below) necessary to 
modulate amide nucleophilicity that also select for N-nucleophilicity, and tolerated β-substituents 
(R) for cycloadduct formation were important variables at the front of our minds.  
Figure 3.14 Challenges in system design 
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Utilizing cinnamamide as a model nucleophile, our initial strategy was to activate the 
amide for N-addition through the use of an electron withdrawing, labile activating group to 
render the amide N−H proton more acidic (Figure 3.15). When using unactivated cinnamamide 
together with β-methylstyrene (2a), catalyst 1b, and phenyldisulfide as an H-atom donor, no 
identifiable products were produced. Unfortunately, the same result was obtained when using N-
Boc or N-trifluoroacetyl cinnamamide in the cyclization. Nucleophile decomposition was 
observed (possibly due to the sensitivity and labile nature of the chosen activating groups) and 
unconsumed alkene was identified after workup. These results were not improved through the 
use of alternative H-atom donors (PhSH, 2-PMN, 9-cyanofluorene, or methyl thiosalicylate). 
Figure 3.15 Initial strategy – labile withdrawing activating groups 
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Figure 3.16 Halolactamization using N-tosyl amides 
 
Inspired by these halolactamization examples, we elected to construct an N-tosyl 
cinnamamide nucleophile and test it in the PRCC system with photoredox catalyst 1b (Figure 
3.17). When using phenyldisulfide or its thiol equivalent as the H-atom donor with β-
methylstyrene (2a), trace quantities of two cyclized products were produced, labeled as the 
desired γ-lactam and the undesired imidate, after three days irradiation. The H-atom donor was 
found to play a significant role in this transformation; moving to either more electron rich 
thiophenol derivatives (4-methoxythiophenol) or electron deficient thiophenol derivatives (4-
nitrothiophenol) raised yields of the two products significantly after 72 hours (Figure 3.17A), 
while first-generation H-atom donors such as 9-cyanofluorene (9-CNFl) and 2-PMN produced 
no detectable products. DBU-catalyzed hydrolysis/epimerization revealed the major product of 
both the 4-MeO-PhSH and 4-NO2-PhSH catalyzed reactions to be the 3,4-cis/4,5-trans imidate 
and minor product the desired 3,4-cis/4,5-trans γ-lactam. 
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Figure 3.17 N-Tosyl cinnamamide H-atom donor screen 
 
Considering the failure of thiophenol as an H-atom donor, the success of both electron 
rich and electron deficient thiophenol derivatives was surprising given their dissimilarities in 
S−H BDE, pKa, and thiolate oxidation potential (Figure 3.17B).44 Success of 4-
methoxythiophenol relative to less electron rich thiols would suggest either H-atom transfer (due 
to the lower S−H BDE) or thiolate protonation (due to an elevated pKa ) as limiting steps, 
however success of 4-nitrothiophenol relative to electron rich thiols would suggest thiyl 
radical/acridine radical SET as the limiting step due to a more positive thiolate oxidation 
potential (thus a higher thiyl radical reduction potential, making SET more exergonic) and lower 
pKa. While this study brought up mechanistic questions, the empirical results were promising. 
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product distribution was noticeably impacted. Moving to more electron deficient activating 
groups (N-Ts 3b to N-Ns 3c to N-Tf 3d) resulted in higher conversions and greater selectivity for 
γ-lactam formation over imidate formation. This was most evident when using N-Tf 
cinnamamide nucleophile 3d where desired lactam 4a was produced in a 58% yield and an N/O 
(lactam/imidate) ratio of 5.8:1. This trend tracked well with N−H acidity; as the amide proton 
was rendered more acidic, selectivity for N-alkylation over O-alkylation increased. The 
noticeable outlier was N-Ms nucleophile 3a where conversion and yields were reliably higher 
than N-Ts counterpart 3b, anomalous given the slightly higher pKa of methanesulfonamide 
compared to p-toluenesulfonamide. It was thought that this outcome could be the result of 
unequal steric demands imposed on the reaction by nucleophiles 3a (N-Ms) and 3b (N-Ts), 
however the A-values for methanesulfonyl and phenylsulfonyl substituents are identical (2.5 
kcal/mol). Regardless, despite higher conversion and yields for 3a relative to 3b, the reaction 
was still selective for the imidate product over the γ-lactam 1.6:1. 
Figure 3.18 Effect of sulfonyl group electronics on the cyclization 
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To confirm the product assignments and stereochemistry, the lactam and imidate adducts 
formed using N-Tf nucleophile 3d and β-methylstyrene (2a) were isolated and subjected to 
epimerization/deprotection experiments (Figure 3.19). We presumed that the 3,4-trans/4,5-trans 
diastereomer would be the most stable (as observed by Zeller and Riener in the analogous 
lactonization), therefore DBU-catalyzed epimerization of a 3,4-cis/4,5-trans product would result 
in diastereomer inversion while a 3,4-trans/4,5-trans product would be enriched. Subjecting 
major product 4a, the suspected lactam, to DBU-catalyzed epimerization resulted in 
diastereomeric inversion, producing 4a’ in a 10:1 d.r. (Figure 3.19A). Subjecting epimerized 
adduct 4a’ to TiCl3/Li0 deprotection in THF revealed N−H γ-lactam 6, confirming the identity of 
the major cyclization product as the desired 3,4-cis/4,5-trans lactam (Figure 3.19A). Likewise, 
subjecting the minor cyclization product, presumed 3,4-cis/4,5-trans imidate 5a, to DBU-
catalyzed epimerization resulted in incomplete inversion after 24 hours (10:1 d.r. eroded to 1.6:1 
d.r.). However, subjecting the minor cyclization adduct to DBU-catalyzed 
epimerization/hydrolysis in DMF/H2O produced 3,4-trans/4,5-trans lactone 7, confirming the 
identity of the minor cyclization adduct as the 3,4-cis/4,5-trans imidate 5a (Figure 3.19B). 
Figure 3.19 Cyclization product confirmation 
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Anisotropic shielding and key vicinal proton relationships, observed by 1H-NMR 
spectroscopy, reinforced the 3,4-cis/4,5-trans assignment of the lactam 4a major diastereomer 
(Figure 3.19C). Anisotropic shielding between the C4 phenyl group and the exocyclic methylene 
protons results in an upfield shift of 0.47 ppm relative to the equivalent signal of the minor 
diastereomer. Additionally, a conformational bias imposed by the 3,4-cis/4,5-trans relative 
stereochemistry about the ring in 4a (visualized in a model) results in no observable coupling 
between Ha and Hb (0 Hz, due to nearly 90° dihedral angle, Ha appears as a quartet) and 8.4 Hz 
coupling between Hb and Hc. As the same conformational constraint is not present in minor 
diastereomer 4a’, coupling between Ha and Hb (8.7 Hz) and Hb and Hc (11.5 Hz, dihedral angle 
approaching 180°) are both seen with Ha appearing as a doublet of quartets. 
 Continuing optimization of conditions 3.6
Competitive nucleophile (3d) decomposition during irradiation was thought to be a 
possible reason for the unaccounted mass balance when the nucleophile was limiting, as 
irradiation times were long and conversion was universally high (Figure 3.18). Utilizing the 
alkene as the limiting reagent and the nucleophile in slight excess (1.5 equiv.) resulted in better 
mass balance, more reproducible results, and slightly higher yields. 
 Photoredox catalyst 3.6.1
After optimizing the limiting reagent we next set out to examine the optimum photoredox 
catalyst for this transformation (Figure 3.20). We found that moving to the more hindered N-Ph 
acridinium catalyst 1c from N-Me acridinium catalyst 1b measurably increased yield. This trend 
did not continue with increasing substitution about the acridine core, as dimethyl acridinium 
catalyst 1d gave diminished yields of 4a even at prolonged reaction times. Lastly, 2,4,6-
triphenylpyrylium catalyst 1e produced lactam 4a in 46% yield, lower than 1b or 1c. The lower 
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yield in the case of pyrylium catalyst 1e may be rationalized due to the enhanced electrophilicity 
of the pyrylium catalyst and less demanding steric environment (specifically, lacking the 
orthogonal mesityl substituent). A catalyst loading study revealed that the 5 mol % loading used 
up to this point was the optimum catalyst loading as well. Due to the elevated yield observed 
with catalyst 1c in this study we chose to continue optimization around 1c. 
Figure 3.20 Catalyst optimization 
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reaction efficiency further and yield plateaued (59%). First generation H-atom donors such as 9-
CNFl or 2-PMN resulted in complex mixtures and significantly diminished yields even after 
prolonged irradiation. 4-Methoxyphenyl disulfide produced a similar result to its parent thiol, a 
result rationalized by 4-methoxythiophenol being generated in situ from the disulfide. Examining 
these results together, 4-methoxythiophenol was found to be the ideal H-atom donor for this 
transformation, producing the highest yields and cleanest reactions.  
Figure 3.21 H-atom donor screen with N-Tf cinnamamide 
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using nucleophile 3d (Figure 3.21) but comparable results with nucleophile 3b (Figure 3.17). 
Rendering the thiolate more basic (4-methoxythiophenol pKa = 11.2, 4-nitrothiophenol pKa = 
5.5) may facilitate N-sulfonyl amide or 2,6-lutidinium (pKa = 4.5 in DMSO) deprotonation to 
form a deprotonated nucleophile and regenerate the H-atom donor. Rendering the nucleophile 
more acidic (N-Ts 3b to N-Tf 3d) would further enable this process by making deprotonation 
more feasible by basic species in solution (2,6-lutidine or thiolate). 
A 4-methoxythiophenol H-atom donor-loading study revealed that H-atom donor 
catalytic loading could be lowered from 30 mol % to 20 mol % with no deleterious effect on the 
reaction. However, catalytic loadings below 20 mol % resulted in complete conversion but 
significantly lower yields. Thus, 20 mol % 4-methoxythiophenol was adopted as standard for the 
transformation. 
 Concentration, solvent, and control experiments 3.6.3
The final variables to optimize were concentration and solvent and the results of this 
screen are shown below in Table 3.1. It was found that reaction concentration, when using DCM 
as a solvent, had little impact on reaction outcome over the range of 0.1 M to 0.4 M (entries 1-4). 
Despite the negligible impact on yield, nucleophile solubility was a concern (minimally soluble 
at high concentrations), so a concentration of 0.2 M was adopted as the standard. 
Solvent had a noticeable impact on reaction outcome. While using DCE or PhCF3 in 
place of DCM did not influence the reaction greatly (entries 5-7), moving to more polar solvents 
had significant deleterious effects on lactam/imidate selectivity. Acetone (entry 8) eroded 
lactam/imidate selectivity, producing lactam 4a in 34%, along with imidate 5a in 40% (1.2:1 
selectivity for the imidate). Acetonitrile (entry 9) resulted in a reversal of lactam/imidate 
selectivity, producing 4a in 30% and 5a in 55% for a ratio of 1.8:1 in favor 5a. While these 
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results did not advance the transformation, they were nonetheless interesting as they showed that 
non-polar solvents are best for this transformation and that solvent polarity can override the 
nucleophilicity bias imposed by the sulfonyl activating group. We were pleased to see a modest 
increase in yield, and more importantly crude reaction purity, when using the less polar solvent 
chloroform in place of DCM (entry 10). 
Table 3.1 Concentration optimization, solvent optimization, and control experiments 
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methylstyrene was still observed in the absence of H-atom donor despite low product yield (entry 
13). This result highlights the importance of the H-atom donor and its ability to direct the system 
away from unproductive competitive pathways and towards the desired PRCC pathway.  
 N-Tf amide nucleophile scope  3.7
With reaction parameters optimized we set out to examine the scope of this 
transformation with respect to the unsaturated amide nucleophile. The results of this study are 
shown below in Table 3.2. Model system product 4a was produced in a 64% isolated yield (3.6:1 
d.r.) and 5.2:1 N/O ratio favoring the lactam. Cinnamamide nucleophiles with varied aromatic 
substitution and electronic properties also afforded the expected lactams. Electron deficient 
cinnamamide nucleophile 3e produced lactam 4b in 65% yield, albeit with diminished 
diastereoselectivity (1.4:1), while electron rich ortho-substituted cinnamamide nucleophile 3f 
produced corresponding lactam 4c in 55% (3.1:1 d.r.) and N/O ratio of 4.5:1. We were pleased to 
see that β-aryl substitution was not required for radical cyclization as β,β-dialkyl nucleophiles 3g  
and 3h produced lactams 4d and 4e respectively in superior yields (70% and 74%), 
diastereomeric ratios (4.9:1 and 5.8:1) and N/O selectivity ratios (9.2:1 and >20:1). Isolation of 
lactam 4e from β,β-dimethyl nucleophile 3h suggested to us that production of 4d (from 3g) was 
not simply due to exocyclic eclipsing strain release. Extending this trend, monosubstituted β-
alkyl unsaturated amides were also successful in this transformation as N-Tf β-
isopropylacrylamide 3i produced lactam 4f, although in a lower yield (52%) and no 
diastereocontrol. Crude NMR analysis suggested a higher yield and slight diastereselectivity 
favoring the 3,4-trans/4,5-trans γ-lactam, however insufficient chromatographic separation 
between 4f and 4-(MeO)PhSH prevented this from being confirmed upon isolation. Synthetic 
difficulties and nucleophile insolubility prevented β-unsubstituted nucleophiles (e.g. N-Tf 
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acrylamide) from being examined. Formation of an α-quaternary stereocenter was also possible 
using N-Tf α-methylcinnamamide nucleophile 3j. Lactam 4g was isolated in 59% yield with 
modest diastereoselectivity. N-Tf propiolamide nucleophiles were also successful in this 
transformation, affording lactams 4h and 4i with substituted exocyclic olefins in high yields 
(70% and 73% respectively). Alkene formation was E-selective for phenyl-substituted 
propiolamide nucleophile 3k in the synthesis of α-benzylidene lactam 4h. Interestingly, alkene 
formation was Z-selective for TIPS-substituted propiolamide 3l, presumably due to rapid 
equilibration of the fleeting vinyl radical during which the bulky TIPS group is partitioned away 
from the adjacent phenyl substituent. This interesting selectivity reversal was also observed in 
the synthesis of γ-lactones from propiolic acids via PRCC and supported by anisotropic shielding 
observed in 1H NMR spectra. The N-Tf α-methoxycinnamamide nucleophile 3m was very 
sluggish, producing only trace quantities of the desired lactam after extended irradiation and 
returning unconsumed starting material. This may be the result of drastically altered alkene 
polarization, where captodative stabilization would favor a 6-endo-trig cyclization mode over 5-
exo-trig. Finally, for comparison, the corresponding imidate adducts produced from nucleophiles 
3d, 3f, 3g, and 3j (5a, 5c, 5d, and 5g respectively) were fully characterized and included in the 
experimental details. 
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Table 3.2 Lactam formation – amide scope 
 
 Oxidizable alkene scope 3.8
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N
O
Tf
Me
Ph
N
O
Tf
Me
Ph
N
O
Tf
Ph
Me
Me
Ph
4a 64%, 3.6:1 dr
N/O addition: 5.2:1
4g 59%, 1.7:1 dr
N/O addition: 12:1
4b 65%, 1.35:1 dr
N/O addition: 5.2:1
N
O
Tf
Me
Ph
4c 55%, 3.1:1 dr
N/O addition: 4.5:1
N
O
Tf
Me
Ph
4d 70%, 4.9:1 dr
N/O addition: 9.2:1
N
O
Tf
Me
Ph
4e 74%, 5.8:1 dr
N/O addition: >20:1
Me
Me
N
O
Tf
Me
Ph
4h 70%, 6.4:1 E/Z
N/O addition: 8.1:1
Ph
N
O
Tf
Me
Ph
4i 73%, 8.1:1 Z/E
N/O addition: 8.3:1
TIPS
N
O
Tf
Me
Ph
4f 52%, 1:1 dr
N/O addition: >20:1
Me
Me
4-F-C6H4Ph 2-MeO-C6H4
Ph
HN O
R2
Tf
+
N
O
Tf
CHCl3 [0.2 M], rt
3d-3l (1.5 equiv)
Me
R1
R3 Ph
Me
R1
R3
R2 H
455 nm LEDs 42a
5 mol % 1c
20 mol % 2,6-lutidine
20 mol % 4-(MeO)PhSH
N
Mes
BF4Ph
4-(MeO)PhSH
MeO
SH
N-Ph-Mes-Acr+-BF4 1c
Nucleophile Product
HN O
Tf
Ph
3d
HN O
Tf
4-F-C6H4
3e
HN O
Tf
2-MeO-C6H4
3f
HN O
Tf 3g
HN O
Tf 3h
Me
Me
HN O
Tf 3i
Me Me
HN O
Tf
Ph
3j
Me
HN O
Tf 3k
Ph
HN O
Tf 3l
TIPS
Nucleophile Product Nucleophile Product
N
O
Tf
Ph
Me
OMe
Ph
<5%, N/A dr
HN O
Tf
Ph
3m
MeO
 112 
not impact reaction efficiency greatly. Only a decrease in relative stereocontrol was observed 
with ortho-substitution (4o, 2:1 d.r.). Indene also participated in the cyclization, producing fused 
tricyclic lactam 4p in a 60% yield and 10:1 d.r. α-Methylstyrene was a successful substrate, 
producing lactam 4q containing a C4 quaternary stereocenter, albeit in a lower yield (40%, 7:1 
d.r.) possibly due to competitive reaction pathways or steric encumbrance associated with the 
cation radical derived from α-methylstyrene. A TBS ether was retained under the reaction 
conditions as evidenced by the formation of 4r from 2j in good yield (62%), diastereocontrol 
(3.4:1), and lactam/imidate selectivity (16:1). β-methyl-4-bromostyrene (2k) reacted smoothly to 
produce γ-lactam 4s in 50% yield (NMR, relative to internal standard) and 3.3:1 d.r. Product 4s 
retained the aryl bromide functional handle that could be used in metal-catalyzed cross-
couplings. Concluding this portion of the alkene scope, Cbz protected enamine substrate 2l failed 
to produce any identifiable lactam products. While the previously optimized conditions were 
general for most styrene derivatives, anethole (2d) and α-methylstyrene (2i) required 
optimization to elevate yields. Conditions employing the alkene in excess relative to 3d were 
ideal for both substrates (3 equiv. anethole and 2 equiv. α-methylstyrene) and were used to 
produce the results in Table 3.3. 
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Table 3.3 Lactam formation – alkene scope 
 
The transformation also displayed reasonable functional group tolerance beyond a TBS 
ether as shown in Table 3.4, evidenced by the retention of a free alcohol (4t), ester (4u), and 
phthalimide (4v) in the reaction. Due to low 4t yields at the previously optimized conditions, 
parameters had to be examined again for these substrates bearing functionality at the allylic 
position. In reactions using 4-methoxycinnamyl alcohol (2m) as the substrate, measurable 
quantities of 2m (10-20%) were consumed in the formation of 4-methoxycinnamaldehyde rather 
than in 4t synthesis. For this reason, yields were highest (35%) when the alkene was used in 
excess (2 equiv, as shown in Table 3.4). These conditions were also best for the derivative 
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acetate and phthalimide substrates 2n and 2o, producing the resulting γ-lactams 4u and 4v in 
52% and 42% yields respectively and displaying relatively good diastereoselectivity. 
Table 3.4 Functional group tolerance 
 
Lastly, we hoped to extend this transformation beyond styrenyl substrates to oxidizable 
aliphatic alkenes. We were moderately successful in this regard, with the results of this study 
presented in Table 3.5. Trisubstituted aliphatic alkene 2-methyl-2-butene (2p) produced low 
yields of lactam 4w even after closely examining H-atom donor and alkene equivalency. Yields 
of 4w were highest (35%, 1.7:1 d.r.) when employing 3 equiv. of 2p to amide 3d. We reasoned 
that this could be due to 2-methyl-2-butene volatility (b.p. 39 °C), but were disappointed to see 
that less volatile substrate 2q was equally ineffective, producing lactam 4x in 37% yield with 
modestly elevated diastereoselectivity (2.4:1). Finally, while noticeably less efficient than 
styrenyl substrates, diene 2,4-dimethyl-1,3-pentadiene (2r) produced lactam 4y in 35% yield 
(6.8:1 d.r.) as the exclusive regioisomer. In this adduct a trisubstituted alkene was retained, 
which could serve as a functional handle for further manipulation in target oriented synthesis. 
The cation radical intermediates derived from these aliphatic alkenes were strikingly less reactive 
and it is thought that increased steric hindrance about these cation radicals could be a reason for 
the diminished yields. The N-Tf amide nucleophiles used in this system are markedly bulkier 
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than nucleophiles used in related systems, which could aid in suppression of product formation. 
A similar hypothesis was developed to rationalize the lower yield observed with α-
methylstyrene. 
Table 3.5 Aliphatic alkenes in γ-lactam synthesis 
 
 Mechanism 3.9
We propose a mechanism analogous to the lactone-forming polar radical crossover 
cyclization (Scheme 3.1). Excitation of acridinium the catalyst (1c to 1c*) followed by SET with 
the alkene donor generates the cation radical and the reduced acridine radical. Deprotonation and 
nucleophilic attack by the N-Tf unsaturated amide on the cation radical generates carbon-
centered radical A, which readily undergoes 5-exo-trig cyclization (5-exo-dig when using 
propiolamide nucleophiles) to furnish exocyclic radical B. The final lactam product is produced 
upon H-atom transfer (HAT) with 4-methoxythiophenol (S−H BDE = 77 kcal/mol), and single 
electron transfer between thiyl radical C (E1/2red = +0.33 V vs SCE) and the acridine radical 
(E1/2ox = −0.50 V vs. SCE) regenerates acridinium catalyst 1c.44–46,53 Protonation of the thiolate 
(pKa = 11.2 in DMSO), either by lutidinium or directly via N-Tf amide deprotonation, 
regenerates the H-atom donor. 
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Scheme 3.1 Mechanism for the polar radical crossover cyclization between alkenes and 
unsaturated amides 
 
A second mechanism is also plausible, whereby the N-Tf amide nucleophile is 
deprotonated and oxidized (3d, Ep/2ox = +1.88 V vs SCE in MeCN) by 1c to the amidyl radical, 
analogous to recent work by Moeller and coworkers.54 The amidyl radical would then intercept 
an equivalent of alkene in solution to form carbon-centered radical A (vide supra) and reenter the 
catalytic cycle as shown in Scheme 3.1. In theory this would allow alkenes outside the window 
of the acridinium photooxidant to be used; however 1,1-disubstituted and terminal aliphatic 
alkenes of higher oxidation potentials produced no detectible products (Figure 3.22). 
Figure 3.22 Examining terminal and 1,1-disubstituted aliphatic alkenes 
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 Pyrrolidine synthesis by PRCC from allylic amines 3.10
Concurrently, Jean-Marc Grandjean began developing a method to directly access 
pyrrolidine heterocycles from oxidizable alkenes and allylic amine nucleophiles via a similar 
PRCC strategy. The key reaction parameters were identified as the H-atom donor and the amine 
protecting group. Early success was achieved using N-Tf and N-Boc allyl amine and 2-methyl-2-
propen-1-amine nucleophiles with a catalyst system of photoredox catalyst 1b and H-atom donor 
9-CNFl (aryl thiols were ineffective in promoting this transformation). However, yields could 
not be increased to synthetically useful levels and the desired cycloadducts were difficult to 
isolate from the other reaction components (9-CNFl and the protected allylic amine substrate). 
Moving to N-protected cinnamyl amine as a model nucleophile allowed for the use of thiol H-
atom donors as the 5-exo-trig radical cyclization was more favorable and formation of 
uncyclized products was less competitive (Figure 3.23). 
Figure 3.23 Pyrrolidine PRCC reaction design 
 
 Using cinnamyl amine as the model nucleophile, a protecting group screen quickly 
revealed that the Boc group (8) resulted in superior yields and purity when compared to 
analogous N-Ts and N-Tf cinnamyl amine nucleophiles. Phenyldisulfide (which partitions to 
thiophenol upon homolytic cleavage, reduction, and protonation45) was revealed to be the 
optimum H-atom donor for the system and catalyst 1d the optimum photoredox catalyst. Finally, 
yields were highest when excess alkene (3 equiv.) was employed, which helped to suppress 
competitive N-Boc cinnamyl amine consumption through SET/intramolecular cyclization to the 
oxazoline. The scope of the transformation using N-Boc cinnamyl amine 8 was examined with 
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respect to the alkene partner and the results of this study are shown below in Table 3.6. 2,3,4-
substituted pyrrolidine 9a was isolated after TFA deprotection from reaction of 8 with β-
methylstyrene (2a) in 51% yield (3:1 d.r.). Electron deficient para-chloro styrene derivative 2b 
and electron rich para-methyl styrene derivative 2e produced pyrrolidines 9b and 9c in 38% (3:1 
d.r.) and 65% (3:1 d.r.) yields, respectively, after cyclization and deprotection. Fused tricyclic 
pyrrolidine 9d was produced from indene (2h) in 53% yield and 2.5:1 d.r. Unfortunately, more 
electron rich substrates such as anethole (2d) failed to produce products even after prolonged 
irradiation. Aliphatic alkenes were again markedly less reactive; 2-methyl-2-butene (2p) 
produced only low yields of the desired adduct (9e, 20%, 3.4:1 d.r.) and 1,3-cyclohexadiene (2u) 
did not participate. The stability of the cation radical produced from anethole and steric 
hindrance of the 2-methyl-2-butene cation radical are oft-cited reasons for their diminished 
reactivity in these and related systems.41,42 
Table 3.6 Pyrrolidine formation − alkene scope 
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The diastereoselectivity of this transformation was rationalized using a Beckwith-type 
model for 5-exo radical C−C bond forming cyclization (Figure 3.24A).55 The major diastereomer 
arises from the conformer where all substituents occupy pseudo-equatorial positions, whereas the 
minor diastereomer arises from the conformer where the alkene occupies a pseudo-axial position. 
These assignments were confirmed by subjecting 3,4-trans/4,5-trans lactam 6 to LAH reduction 
(Figure 3.24B). Reduction of 6 afforded 2,3-trans/3,4-trans pyrrolidine 9a’, the minor 
diastereomer in the 9a-forming PRCC between β-methylstyrene (2a) and N-Boc cinnamyl amine 
8. Upon completion of product analysis/characterization, the pyrrolidine PRCC was submitted 
for publication along with the γ-lactam method as a joint venture with Jean-Marc Grandjean. 
Figure 3.24 Model for pyrrolidine diastereoselectivity and confirmation 
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In conclusion, we have developed a method to access novel γ-lactam and pyrrolidine 
heterocycles directly from unsaturated N-nucleophiles and oxidizable alkenes through 
photoredox catalysis. In this system, C−N, C−C, and C−H bonds are formed in a controlled 
manner taking advantage of both the radical and polar reaction vectors on the cation radical 
intermediate. The catalyst system comprised of an acridinium organic photooxidant and a 
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lactams were presented along with five direct pyrrolidine examples. Prior work in the field of γ-
lactam synthesis and PRCC methodology highlights the complimentary nature of the system 
presented in this chapter. 
The future of this transformation lies in its application: use as a new γ-lactam or 
pyrrolidine disconnect to construct biologically active small molecules in target oriented 
synthesis. Closer examination of a biologically active small molecule presented earlier in this 
chapter, the synthetic PKC modulator, reveals that the γ-lactam PRCC disconnect could be a 
more direct way to access this compound or its derivatives than previous routes (Figure 3.25). 
Polar radical crossover cyclization between unsaturated N-Tf amide C and acetate ester B would 
produce 3,4-cis/4,5-trans lactam A, which would be transformed into the target after global 
deprotection. 
Figure 3.25 PKC modulator PRCC retrosynthesis 
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 Experimental details 3.12
General Methods. Proton, carbon, and fluorine nuclear magnetic resonance spectra (1H NMR, 
13C NMR, 19F NMR) were recorded on a Bruker model DRX 400 or AVANCE III 600 
CryoProbe spectrometer (1H NMR at 400 MHz or 600 MHz, 13C NMR at 100 MHz or 150 MHz 
and 19F at 376 MHz or 564 MHz respectively). Chemical shifts for proton NMR are reported in 
parts per million downfield from tetramethylsilane and are referenced to residual protium in 
solvent (1H NMR: CHCl3 at 7.24 ppm). Chemical shifts for carbon NMR are reported in parts 
per million downfield from tetramethylsilane and are referenced to the carbon resonances of the 
solvent (13C NMR: CDCl3 at 77.0 ppm). Chemical shifts for fluorine NMR are reported in parts 
per million from CFCl3 (δ 0 ppm) as the external standard.  NMR data are represented as 
follows: chemical shift, multiplicity (s = singlet, br s = broad singlet, d = doublet, dd = doublet of 
doublet, t = triplet, ddd = doublet of doublet of doublet, q = quartet, m = multiplet, etc.), coupling 
constants (Hz), and integration. Mass spectra were obtained using a Micromass Quattro II (triple 
quad) instrument with nanoelectrospray ionization or GC-MS (Agilent 6850 series GC equipped 
with Agilent 5973 network EI-MSD, method: 115 °C/3 min, 20 °C/min ramp, 275 °C/10 min). 
Analytical thin layer chromatography (TLC) was performed on SiliaPlate 250 µm thick silica gel 
plates purchased from Silicycle. Visualization was accomplished using fluorescence quenching, 
KMnO4 stain, or ceric ammonium molybdate (CAM) stain followed by heating. Organic 
solutions were concentrated under reduced pressure using a Büchi rotary evaporator. Purification 
of the reaction products was carried out by chromatography using Siliaflash-P60 (40-63 µm) or 
Siliaflash-T60 (5-20 µm) silica gel purchased from Silicycle. All reactions were carried out 
under an inert atmosphere of nitrogen in flame-dried glassware with magnetic stirring unless 
otherwise noted.  Irradiation of photochemical reactions was carried out using two 21W 455 nm 
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PAR38 Royal Blue LED Aquarium lamps (five 455 nm Cree LEDs per lamp), purchased from 
Ecoxotic (model# 6851).  Reactions were carried out in standard borosilicate glass vials 
purchased from Fisher Scientific.  Yield refers to isolated yield of analytically pure material 
unless otherwise noted.  NMR yields were determined using hexamethyldisiloxane, (Me3Si)2O, 
or mesitylene as an internal standard. Dichloromethane (DCM) was used as the solvent for FT-
IR spectroscopy. 
Procedure for yield determination using (Me3Si)2O NMR internal standard: upon 
consumption of starting material (as determined by TLC), crude reaction mixture was passed 
through a short silica gel plug with DCM.  The crude mixture was concentrated and then taken 
up in deuterated NMR solvent (chloroform-d1, CDCl3).  A carefully measured amount of 
(Me3Si)2O was then added to the solution via micro syringe and a 1H NMR spectrum acquired. 
 
Materials. Commercially available reagents were purchased from Sigma Aldrich, Acros, Alfa 
Aesar, or TCI, and used as received unless otherwise noted. Diethyl ether (Et2O), 
dichloromethane (DCM), tetrahydrofuran (THF), toluene (PhMe), and dimethylformamide 
(DMF) were dried by passing through activated alumina columns under nitrogen prior to use. 
Other common solvents such as chloroform (CHCl3) and acetonitrile (MeCN), and reagents such 
as oxidation-prone aldehydes were purified by standard published methods when necessary.  
 
Photoreactor Setup and Lamp Information 
2 x 21W 455 nm PAR38 Royal Blue LED Aquarium lamps (five 455 nm Cree LEDs per lamp) 
Ecoxotic model# 6851 
Purchased from Ecoxotic: Vista, CA 92081 (http://www.ecoxotic.com) 
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Lamps off: Lamps on: 
   
NOTE: Foil used to cover photoreactor/lamps during reactions to ensure complete irradiation and 
to minimize user irritation. 
Catalyst Synthesis 
 
The shown mesityl acridinium and pyrylium catalysts were prepared according to published 
literature procedures. Spectral data were in agreement with literature values.41,56 
Preparation of Alkene Substrates 
β-methylstyrene (2a), anethole (2d), indene (2h), α-methylstyrene (2i), 2-methyl-2-butene (2p), 
2,4-dimethyl-1,3-pentadiene (2r) and 1,3-cyclohexadiene (2u) are commercially available and 
were purchased prior to use (Sigma-Aldrich). 
 
Substrates 2b, 2c, 2e, 2f, 2g, 2j, 2k and 2q were prepared according to the following Wittig 
olefination procedure (in all cases but 2q producing an inconsequential mixture of E and Z 
isomers):  
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1.4 equiv. (relative to the necessary aldehyde precursor) ethyltriphenylphosphonium bromide 
(for 2q: 1.4 equiv. isopropyltriphenylphosphonium iodide) and 1.3 equiv. potassium t-butoxide 
were weighed and dispensed into a flame-dried round bottom flask equipped with a magnetic stir 
bar.  The flask was flushed with N2, the contents cooled to 0 °C, and THF carefully added (to 0.4 
M concentration) to the stirring solids (color change observed).  The contents were stirred at 0 °C 
for 0.5 hours after which 1 equiv. of the necessary aldehyde (when possible purified by 
distillation prior to use) was added dropwise at 0 °C to the stirring ylide.  The reaction warmed to 
room temperature and was stirred overnight.  The next day, the reaction was quenched with 
saturated aqueous NH4Cl, diluted with equal amounts DI water and diethyl ether, and the organic 
phase was separated.  The aqueous layer was extracted three times with diethyl ether then the 
combined organics were washed with brine, dried with anhydrous magnesium sulfate (MgSO4), 
filtered, and concentrated.  The styrenyl products were purified either by vacuum distillation or 
column chromatography (10% Et2O/pentane) to afford pure substrates. 
Alkene substrates can be used as a mixture of E and Z isomers with no impact on relative 
stereochemistry/diastereoselectivity of the product. An E/Z isomeric mixture of an alkene gives 
an equivalent result to using the only the E (or Z) isomer of that alkene.  This was observed in 
the development of this method (trans-β-methylstyrene vs. a mixture of E/Z isomers) and was 
consistent with previously published observations.42,43 
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β-methyl-4-chlorostyrene (2b) 
 
Spectral data were in agreement with literature values.57 
β-methyl-3-methoxystyrene (2c) 
 
Spectral data were in agreement with literature values.58 
β-methyl-4-methylstyrene (2e) 
 
Spectral data were in agreement with literature values.59 
β-methyl-3-methylstyrene (2f) 
 
Spectral data were in agreement with literature values.60 
β-methyl-2-methylstyrene (2g) 
 
Spectral data were in agreement with literature values.58 
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tert-butyldimethyl(4-(prop-1-en-1-yl)phenoxy)silane (2j) 
 
Spectral data were in agreement with literature values.61 
β-methyl-4-bromostyrene (2k) 
 
Spectral data were in agreement with literature values.62 
benzyl 3,4-dihydropyridine-1(2H)-carboxylate (2l) 
 
Prepared according to a published procedure.  Spectral data were in agreement with literature 
values.63 
(E)-3-(4-methoxyphenyl)prop-2-en-1-ol (2m) 
 
Prepared according to a published procedure.  Spectral data were in agreement with literature 
values.64 
(E)-3-(4-methoxyphenyl)allyl acetate (2n) 
 
Prepared according to a published procedure.  Spectral data were in agreement with literature 
values.65 
Me
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(E)-2-(3-(4-methoxyphenyl)allyl)isoindoline-1,3-dione (2o) 
 
Prepared according to a published procedure.  Spectral data were in agreement with literature 
values.66 
(4-methylpent-3-en-1-yl)benzene (2q) 
 
Spectral data were in agreement with literature values.67 
2-methylallyl benzoate (2s) 
 
Prepared according to a published procedure.  Spectral data were in agreement with literature 
values.68 
but-3-en-1-ylbenzene (2t) 
 
Prepared according to a published procedure.  Spectral data were in agreement with literature 
values.69 
Preparation of Unsaturated Amide Nucleophiles for Polar Radical Cyclization 
General Procedure A: N-Sulfonyl Amide Synthesis by Peptide/EDC Coupling 
 
MeO
N
O
O
Me
Me
Me
BzO
Ph
R1 OH
O
+
H2N
S R2
O O
1.2 equiv.
1.2 equiv. EDCI•HCl
1.2 equiv. DMAP
0.2 M DCM, 0 °C to rt, 16h R1 NH
O
S R2
O O
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 A flame dried round bottom flask containing the necessary carboxylic acid precursor (1.0 
equiv) and desired sulfonamide (1.2 equiv) was purged with N2.  The flask contents were then 
dissolved in anhydrous DCM (0.2 M) and cooled to 0 °C with stirring.  At 0 °C, 4-
dimethylaminopyridine (DMAP, 1.2 equiv, 1 portion) was added to the flask and the solution 
was stirred for 15 minutes.  Next, At 0 °C, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (EDCI•HCl, 1.2 equiv, 1 portion) was added to the reaction mixture.  The reaction 
was allowed to warm to room temperature and stir overnight.  The reaction was then quenched 
with 3N HCl (added dropwise) and diluted with equal parts DCM and DI water.  The organic 
layer was separated and washed twice with DI water.  The combined organics were then washed 
with brine, dried with anhydrous MgSO4, filtered, and concentrated to afford a crude oil, from 
which the desired product was isolated by column chromatography on silica gel.  Note: residual 
solvent was sometimes difficult to remove after chromatography/concentration/hi-vac.  Despite 
our repeated and best efforts, trace/residual EtOAc or Et2O appear in some of the spectra. 
N-(methylsulfonyl)cinnamamide (3a) 
 
The title N-sulfonyl amide was prepared according to General Procedure A using cinnamic acid 
and methanesulfonamide. The title compound was purified and isolated using column 
chromatography on silica gel (100% EtOAc) to furnish 0.63 g of the desired species (56%) as a 
white solid.  Analytical data for 3a:  
1H NMR (600 MHz, CDCl3): δ 8.51 (br s, 1H), 7.78 (d, J = 15.7 Hz, 1H), 7.52 (m, 2H), 7.40 (m, 
3H), 7.43 (d, J = 15.7 Hz, 1H), 3.39 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 164.1, 146.6, 133.5, 
N
H
O
S Me
O O
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131.2, 129.1, 128.5, 117.1, 41.8; IR (thin film, cm-1) 3055, 2987, 2305, 1702, 1630, 1421, 1265, 
896, 740; MS (EI/GC-MS): m/z calculated for C10H11NO3S [M]+ 225.05, found 225.05 
N-tosylcinnamamide (3b) 
 
The title N-sulfonyl amide was prepared according to General Procedure A using cinnamic acid 
and 4-toluenesunfonamide. The title compound was purified and isolated using column 
chromatography on silica gel (100% EtOAc) to furnish 1.04 g of the desired species (49%) as a 
white solid.  Analytical data for 3b:  
1H NMR (600 MHz, CDCl3): δ 8.55 (br s, 1H), 7.99 (d, J = 8.4 Hz, 2H), 7.66 (d, J = 15.6 Hz, 
1H), 7.45 (m, 2H), 7.33 (m, 5H), 6.40 (d, J = 15.6 Hz, 1H), 2.41 (s, 3H); 13C NMR (150 MHz, 
CDCl3) δ 163.1, 146.1, 145.2, 135.6, 133.6, 131.0, 129.7, 129.0, 128.41, 128.40, 117.2, 21.7; IR 
(thin film, cm-1) 3944, 3055, 2986, 2305, 1699, 1630, 1421, 1266, 896, 739; MS (EI/GC-MS): 
m/z calculated for C16H15NO3S [M]+ 301.08, found 301.25 
N-((4-nitrophenyl)sulfonyl)cinnamamide (3c) 
 
The title N-sulfonyl amide was prepared according to General Procedure A using cinnamic acid 
and 4-nitrobenzenesulfonamide. The title compound was purified and isolated using column 
chromatography on silica gel 100% EtOAc) to furnish 0.30 g of the desired species (50%) as a 
white solid.  Analytical data for 3c:  
N
H
O
S
O O
Me
N
H
O
S
O O
NO2
 130 
1H NMR (600 MHz, CDCl3): δ 8.38 (d, J = 8.9 Hz, 2H), 8.32 (d, J = 8.9 Hz, 2H), 8.30 (br s, 
1H), 7.68 (d, J = 15.6 Hz, 1H), 7.46 (m, 2H), 7.38 (m, 3H), 6.34 (d, J = 15.6 Hz, 1H); 13C NMR 
(150 MHz, CDCl3) δ 162.7, 150.8, 147.2, 144.0, 133.2, 131.4, 130.0, 129.1, 128.5, 124.2, 116.4; 
IR (thin film, cm-1) 3054, 2986, 2305, 1698, 1412, 1265, 896, 739; MS (EI/GC-MS): m/z 
calculated for C15H12N2O5S [M]+ 332.05, found 332.10 
N-((trifluoromethyl)sulfonyl)cinnamamide (3d) 
 
The title N-Sulfonyl amide was prepared according to General Procedure A using cinnamic 
acid and triflamide. The title compound was purified and isolated using column chromatography 
on silica gel 100% EtOAc) to furnish 2.20 g of the desired species (77%) as a white solid. 
Analytical data for 3d:  
1H NMR (600 MHz, CDCl3): d 7.89 (d, J = 15.5 Hz, 1H), 7.55 (m, 2H), 7.42 (m, 3H), 6.74 (d, J 
= 15.5 Hz, 1H); 13C NMR (150 MHz, CDCl3) d 149.5, 144.7, 133.3, 131.8, 129.2, 128.8, 119.2 
(q, JC-F = 322 Hz), 115.3; 19F NMR (564 MHz, CDCl3) δ -76.4 (br s); IR (thin film, cm-1) 3944, 
3054, 2986, 2685, 2305, 1733, 1626, 1421, 1265, 896, 739; MS (EI/GC-MS): m/z calculated for 
C10H8F3NO3S [M]+ 279.02, found 279.10 
(E)-3-(4-fluorophenyl)-N-((trifluoromethyl)sulfonyl)acrylamide (3e) 
 
The title N-sulfonyl amide was prepared according to General Procedure A using 4-
fluorocinnamic acid and triflamide. The title compound was isolated using column 
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chromatography on silica gel (100% EtOAc) to furnish 1.20 g of the desired species (41%) as a 
white solid.  Analytical data for 3e:  
1H NMR (600 MHz, DMSO-d6): δ 7.67 (m, 2H), 7.42 (d, J = 15.6 Hz, 1H), 7.20 (m, 2H), 6.46 
(d, J = 15.6 Hz, 1H); 13C NMR (150 MHz, DMSO-d6) δ 168.8, 162.8 (d, JC-F = 247 Hz), 139.1, 
131.6 (d, JC-F = 3 Hz), 130.0 (d, JC-F = 8 Hz), 125.5, 120.2 (q, JC-F = 325 Hz), 115.8 (d, J = 22 
Hz); 19F NMR (564 MHz, DMSO-d6) δ -76.9 (s, 3F), -111.5 (s, 1F); IR (thin film, cm-1) 3054, 
2986, 2305, 1868, 1540, 1420, 1265, 896, 739; LRMS (EI/GC-MS): m/z calculated for 
C10H7F4NO3S [M]+ 297.01, found 297.05 
(E)-3-(2-methoxyphenyl)-N-((trifluoromethyl)sulfonyl)acrylamide (3f) 
 
The title N-sulfonyl amide was prepared according to General Procedure A using 2-
methoxycinnamic acid and triflamide. The title compound was isolated using column 
chromatography on silica gel (100% EtOAc) to furnish 1.91 g of the desired species (62%) as a 
yellow solid.  Analytical data for 3f:  
1H NMR (600 MHz, CDCl3): δ 8.06 (d, J = 15.7 Hz, 1H), 7.44 (m, 1H), 7.35 (m, 1H), 6.91 (m, 
1H), 6.87 (m, 1H), 6.83 (d, J = 15.7 Hz, 1H), 3.84 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 159.1, 
144.2, 132.7, 130.4, 122.4, 119.4 (q, JC-F = 321 Hz), 111.2, 55.5; 19F NMR (564 MHz, CDCl3) 
δ -76.6 (br s); IR (thin film, cm-1) 3945, 3055, 2987, 2685, 2305, 1731, 1618, 1438, 1265, 1210, 
896, 737; LRMS (EI/GC-MS): m/z calculated for C11H10F3NO4S [M]+ 309.03, found 309.05 
2-cyclohexylidene-N-((trifluoromethyl)sulfonyl)acetamide (3g) 
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The title N-sulfonyl amide was prepared according to General Procedure A using 2-
cyclohexylideneacetic acid (prepared according to a published procedure)70 and triflamide. The 
title compound was isolated using column chromatography on silica gel (100% EtOAc) to 
furnish 1.40 g of the desired species (52%) as a white solid.  Analytical data for 3g:  
1H NMR (600 MHz, CDCl3): δ 5.73 (s, 1H), 2.81 (t, J = 6.1 Hz, 2H), 2.23 (t, J = 6.3 Hz, 2H), 
1.63 (m, 6H); 13C NMR (150 MHz, CDCl3) δ 172.1, 162.0, 119.2 (q, JC-F = 322 Hz), 111.2, 38.6, 
30.7, 28.7, 27.9, 25.9; 19F NMR (564 MHz, CDCl3) δ -76.3 (br s); IR (thin film, cm-1) 3945, 
3333, 3054, 2986, 2685, 2305, 1732, 1629, 1434, 1261, 1211, 1135, 896, 712; LRMS (EI/GC-
MS): m/z calculated for C9H12F3NO3S [M]+ 271.05, found 271.05 
3-methyl-N-((trifluoromethyl)sulfonyl)but-2-enamide (3h) 
 
The title N-sulfonyl amide was prepared according to General Procedure A using 3-methyl-2-
butenoic acid and triflamide. The title compound was isolated using column chromatography on 
silica gel (100% EtOAc) to furnish 0.92 g of the desired species (40%) as a off-white solid. 
Analytical data for 3h:  
1H NMR (600 MHz, DMSO-d6): δ 5.75 (t, J = 1.3 Hz, 1H), 2.09 (d, J = 1.3 Hz, 3H), 1.86 (d, J = 
1.3 Hz, 3H); 13C NMR (150 MHz, DMSO-d6) δ 164.8, 158.5, 119.4 (q, JC-F = 323 Hz), 117.6, 
27.3, 20.2; 19F NMR (564 MHz, DMSO-d6) δ -76.5 (s); IR (thin film, cm-1) 3945, 3338, 3055, 
2987, 2305, 1736, 1632, 1434, 1265, 1214, 1136, 896, 739, 604; LRMS (EI/GC-MS): m/z 
calculated for C6H8F3NO3S [M]+ 231.02, found 231.05 
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(E)-4-methyl-N-((trifluoromethyl)sulfonyl)pent-2-enamide (3i) 
 
The title N-sulfonyl amide was prepared according to General Procedure A using 4-methyl-2-
pentenoic acid and triflamide. The title compound was isolated using column chromatography on 
silica gel (100% EtOAc) to furnish 0.41 g of the desired species (17%) as a white solid.  
Analytical data for 3i:  
1H NMR (600 MHz, CDCl3): δ 7.07 (dd, J = 15.6 Hz, J = 6.6 Hz, 1H), 5.92 (d, J = 15.6 Hz, 1H), 
2.46 (m, 1H), 1.03 (d, J = 6.8 Hz, 6H); 13C NMR (150 MHz, CDCl3) δ 159.2, 120.3, 119.4 (q, 
JC-F = 321 Hz), 118.2, 31.2, 20.9; 19F NMR (564 MHz, CDCl3) δ -78.9 (s); IR (thin film, cm-1) 
3790, 3640, 3054, 2986, 2305, 1726, 1641, 1422, 1265, 896, 730; LRMS (EI/GC-MS): m/z 
calculated for C7H10F3NO3S [M]+ 245.03, found 245.00 
(E)-2-methyl-3-phenyl-N-((trifluoromethyl)sulfonyl)acrylamide (3j) 
 
The title N-sulfonyl amide was prepared according to General Procedure A using α-
methylcinnamic acid and triflamide. The title compound was isolated using column 
chromatography on silica gel (100% EtOAc) to furnish 1.5 g of the desired species (51%) as a 
white solid.  Analytical data for 3j:  
1H NMR (600 MHz, CDCl3): δ 7.61 (br s, 1H), 7.29 (m, 5H), 2.03 (d, J = 1.4 Hz, 3H); 13C 
NMR (150 MHz, CDCl3) δ 202.3, 140.2, 135.1, 129.8, 128.9, 128.4, 121.7 (q, JC-F = 319 Hz), 
121.6, 13.9; 19F NMR (564 MHz, CDCl3) δ -77.0 (br s); IR (thin film, cm-1) 3435, 1699, 1633, 
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1447, 1288, 1203, 607; LRMS (EI/GC-MS): m/z calculated for C11H10F3NO3S [M]+ 293.03, 
found 293.05 
3-phenyl-N-((trifluoromethyl)sulfonyl)propiolamide (3k) 
 
The title N-sulfonyl amide was prepared according to General Procedure A using 3-
phenylpropiolic acid and triflamide. The title compound was isolated using column 
chromatography on silica gel (100% EtOAc) to furnish 1.39 g of the desired species (55%) as a 
off-white solid.  Analytical data for 3k:  
1H NMR (600 MHz, DMSO-d6): δ 7.52 (m, 2H), 7.42 (m, 3H); 13C NMR (150 MHz, DMSO-d6) 
δ 159.9, 132.1, 129.7, 128.8, 120.7, 120.1 (q, JC-F = 323 Hz), 88.0, 80.1; 19F NMR (564 MHz, 
DMSO-d6) δ -77.7 (s); IR (thin film, cm-1) 3447, 2211, 1584, 1491, 1323, 1204, 1131, 838, 757, 
607; LRMS (EI/GC-MS): m/z calculated for C10H6F3NO3S [M]+ 277.00, found 277.00 
N-((trifluoromethyl)sulfonyl)-3-(triisopropylsilyl)propiolamide (3l) 
 
The title N-sulfonyl amide was prepared according to General Procedure A using 3-
(triisopropylsilyl)propiolic acid (prepared according to a published procedure)71 and triflamide. 
The title compound was isolated using column chromatography on silica gel (100% EtOAc) to 
furnish 1.79 g of the desired species (50%) as a white/clear viscous amorphous solid.  Analytical 
data for 3l:  
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1H NMR (600 MHz, CDCl3): δ 1.12 (m, 3H), 1.08 (d, J = 6.4 Hz, 18H); 13C NMR (150 MHz, 
CDCl3) δ signals obscured by baseline 172.6, 119.3 (q, JC-F = 322 Hz), 61.0, 18.3, 10.9; 19F 
NMR (564 MHz, CDCl3) δ -76.4 (s); IR (thin film, cm-1) 3431, 2166, 1640, 1466, 1143, 599; 
LRMS (EI/GC-MS): m/z calculated for C13H22F3NO3SSi [M]+ 357.10, found 357.10 
(Z)-2-methoxy-3-phenyl-N-((trifluoromethyl)sulfonyl)acrylamide (3m) 
 
The title N-sulfonyl amide was prepared according to General Procedure A using α-
methoxycinnamic acid (prepared according to a published procedure)72 and triflamide. The title 
compound was isolated using column chromatography on silica gel (100% EtOAc) to furnish 
2.08 g of the desired species (67%) as a white solid.  Analytical data for 3m:  
1H NMR (600 MHz, CDCl3): δ 9.00 (br s, 1H), 7.63 (br s, 2H), 7.39 (br s, 3H), 7.24 (s, 1H), 
3.70 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 165.4, 144.9, 131.7, 130.5, 130.2, 128.9, 125.7, , 
119.3 (q, JC-F = 323 Hz), 60.2; 19F NMR (564 MHz, CDCl3) δ -75.8 (br s); LRMS (EI/GC-MS): 
m/z calculated for C11H10F3NO4S [M]+ 309.03, found 309.10 
Preparation of tert-Butyl Cinnamylcarbamate (8) for Pyrrolidine Polar Radical Cyclization 
2-cinnamylisoindoline-1,3-dione 
 
A 1 L flask was equipped with a condenser, a stir-bar, potassium phthalate (28.2 g, 152.2 mmol, 
1.2 equiv.), cinnamyl bromide (25.0 g, 126.9 mmol, 1.0 equiv.), and DMF (300 mL). The 
resulting slurry was brought to a reflux and stirred overnight. Upon cooling Et2O (300 mL) was 
HN O
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Ph
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added; the ethereal solution was transferred to a separatory funnel, and washed with 10x 100 mL 
of brine. A white suspension was formed and dissolved into the organic layer upon addition of 
DCM (200 mL). The organic layer was dried over anhydrous sodium sulfate (Na2SO4) and the 
solvents removed under reduced pressure. The resulting white solid was recrystallized from 
boiling toluene. The yield for this reaction was 60% (20.5 g recovered).  
1H NMR (400 MHz, CDCl3) δ 7.90 – 7.87 (m, 2H), 7.76-7.73 (m, 2H), 7.32 – 7.31 (m, 2H), 7.28 
– 7.26 (m, 2H), 7.24 – 7.22 (m, 1H), 6.68 (d, J = 15.6 Hz, 1H), 6.28 (dt, J = 6.4, 15.6 Hz, 1H), 
4.47 (d, J = 6.4 Hz, 2H). 
Cinnamyl Amine HCl Salt 
 
A 250 mL flask was equipped with a stir-bar, 2-cinnmylisoindoline-1,3-dione (4.0 g, 14.7 mmol, 
1.0 equiv.), and methanol (60 mL). Hydrazine monohydrate (792 µL, 16.1 mmol, 1.1 equiv.) was 
added dropwise; the resulting solution was brought to a reflux and stirred for three hours. Upon 
cooling the white precipitate was filtered and the solvent removed under reduced pressure. The 
yellow slurry was taken up in cold ethanol and the white precipitate was once again removed by 
filtration. A yellow oil was recovered that did not require further purification. The yield for this 
reaction was 74% (1.4 g recovered). The amine was acidified with dilute HCl and stored as the 
chloride salt.  
1H NMR (400 MHz, CDCl3) δ 7.40 – 7.38 (m, 2H), 7.32 – 7.28 (m, 2H), 7.22 – 7.19 (m, 1H), 
6.52 (d, J = 16.0 Hz, 1H), 6.34 (dt, J = 6.0, 16.0 Hz, 1H), 3.37 (d, J = 6.0 Hz, 2H). 
tert-Butyl Cinnamylcarbamate (8) 
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A 100 mL flask was equipped with a stir-bar and cinnamyl amine•HCl (2.0g, 7.43 mmol, 1.0 
equiv.). The flask was purged with N2 and the solid was solubilized upon addition of DCM (30 
mL) and triethylamine (2.96 mL, 22.2 mmol, 3.0 equiv.). The solution thus formed was cooled to 
-78 ºC using a dry-ice/acetone bath and Boc-anhydride (1.71 mL, 7.43 mmol, 1.0 equiv.) was 
added at once so as to avoid re-freezing of the anhydride in the needle. The solution was allowed 
to slowly warm up to room temperature and the reaction was stirred for 15 hours. The reaction 
was quenched with a saturated ammonium chloride solution (20 mL), the organic layer was dried 
over Na2SO4, and the solvent was removed under reduced pressure. The solid thus recovered was 
recrystallized from boiling hexanes, and the desired product was recovered as white needles. The 
yield for this reaction was 75% (1.3 g recovered).  
1H NMR (600 MHz, CDCl3) δ 7.39 – 7.38 (m, 2H), 7.35 – 7.32 (m, 2H), 7.29 – 7.25 (m, 1H), 
6.52 (d, J = 15.6 Hz, 1H), 6.25 – 6.20 (m, 1H), 4.69 (s, 1H), 3.94 (s broad, 2H), 1.49 (s, 9 H). 
Synthesis of Pyrrolidinones via Polar Radical Crossover Cyclization 
General Procedure B: Polar-Radical Cyclization to Construct Pyrrolidinone Products 
 
The acridinium photoredox catalyst (1c, 5 mol%) and the desired N-sulfonyl amide nucleophile 
(1.5 equiv.) were weighed and dispensed into a flame dried vial (1-dram or 2-dram) equipped 
with a stir bar and Teflon-coated septum cap.  The vial was moved to an inert atmosphere (glove 
box, N2), where solvent was dispensed by syringe (CHCl3 to 0.2 M), 2,6-Lutidine (20 mol%) was 
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added by microsyringe, and alkene substrate was added by microsyringe (1 equiv.).  The vial was 
then sealed and removed from the inert environment.  In a fume hood, 20 mol% H-atom donor 
(4-methoxythiophenol, 4-MeO-PhSH) was added to the vessel via microsyringe through the 
Teflon-coated septum, after which the vial and cap were quickly sealed with electrical tape and 
PTFE tape.  The reactions were irradiated (2x455 nm blue LED lamps) and stirred until 
completion.  Reaction progress was judged by appearance of brown/black color and 
disappearance of the alkene (determined by 1H NMR or TLC, usually complete 24 hours or less).  
Upon completion, the crude reactions were concentrated and products isolated by column 
chromatography on silica gel. 
Note 1: Solid oxidizable alkenes (1 equiv.) were usually dispensed outside glove box with the 
acridinium catalyst and amide nucleophile. Note 2: for NMR yields/optimization, crude reactions 
were passed through a silica gel plug with DCM and then concentrated. Note 3: some substrates 
required deviations from standard conditions.  Those differences are noted below. 
3-benzyl-5-methyl-4-phenyl-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4a) 
 
The average yield for the title compound was 64% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure B with β-methylstyrene 2a, nucleophile 3d, and an irradiation time of 
24 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 5.2:1.  The title 
compound was produced as a 3.6:1 mixture of inseparable diastereomers, isolated by column 
chromatography on silica gel (10% Et2O/pentane) as a tan/colorless oil. Analytical data for 4a: 
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1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.35 (m, 3H), 7.20 (m, 3H), 7.00 (m, 
2H), 6.86 (m, 2H), 4.36 (q, J = 6.6 Hz, 1H), 3.43 (m, 1H), 3.17 (dd, J = 14.6 Hz, J = 4.2 Hz, 1H), 
3.14 (d, J = 8.1 Hz, 1H), 2.42 (dd, J = 14.6 Hz, J = 10.1 Hz, 1H), 1.58 (d, J = 6.7 Hz, 3H); 13C 
NMR for major diastereomer (150 MHz, CDCl3) δ 173.5, 138.2, 137.9, 129.6, 129.2, 128.7, 
128.5, 128.2, 127.9, 127.4, 126.6, 119.2 (q, J = 323 Hz), 63.6, 48.7, 47.2, 31.1, 20.9; 19F NMR 
for major diastereomer (564 MHz, CDCl3) δ -74.9 (s); 1H NMR for minor diastereomer (600 
MHz, CDCl3): δ 7.35 (m, 3H), 7.20 (m, 3H), 7.13 (m, 2H), 7.04 (m, 2H), 4.14 (m, 1H), 3.20 (m, 
1H), 3.08 (dd, J = 14.3 Hz, J = 5.0 Hz, 1H), 2.88 (dd, J = 14.3 Hz, J = 5.8 Hz, 1H), 2.70 (dd, J = 
11.5 Hz, J = 8.7 Hz, 1H), 1.31 (d, J = 6.1 Hz, 3H); 13C NMR for minor diastereomer (150 MHz, 
CDCl3) obscured by major diastereomer and baseline. Selected peaks δ 173.7, 63.1, 51.2, 50.9, 
33.5, 19.5; 19F NMR for minor diastereomer (564 MHz, CDCl3) δ -75.5 (s); IR (thin film, cm-1) 
3064, 2926, 3031, 1954, 1777, 1604, 1496, 1456, 1406, 1210, 1151, 1069, 986, 764, 737, 701, 
622, 583; LRMS (EI/GC-MS): m/z calculated for C19H18 F3NO3S [M]+ 397.10, found 397.10 
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3-(4-fluorobenzyl)-5-methyl-4-phenyl-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4b) 
 
The average yield for the title compound was 65% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure B with β-methylstyrene 2a, nucleophile 3e, and an irradiation time of 
21 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 5.2:1.  The title 
compound was produced as a 1.4:1 mixture of inseparable diastereomers and isolated by column 
chromatography on silica gel (10% to 20% Et2O/pentane) as a light pink oil. Analytical data for 
4b:  
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1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.35 (m, 5H), 6.99 (m, 2H), 6.80 (m, 
2H), 4.35 (q, J = 6.6 Hz, 1H), 3.37 (ddd, J = 10.0 Hz, J = 8.1 Hz, J = 4.6 Hz, 1H), 3.12 (m, 2H), 
2.40 (dd, J = 14.7 Hz, J = 10.0 Hz, 1H), 1.58 (d, J = 6.6 Hz, 3H); 13C NMR for major 
diastereomer (150 MHz, CDCl3) δ 173.4, 162.4, 160.8, 138.0, 133.5 (d, J = 3.3 Hz), 130.2 (d, J = 
7.8 Hz), 129.3, 128.3, 127.9, 119.2 (q, JC-F = 323 Hz), 115.4, 115.3, 63.5, 51.4, 48.7, 30.5, 20.9; 
19F NMR for major diastereomer (564 MHz, CDCl3) δ -74.9 (s), -116.1 (m); 1H NMR for minor 
diastereomer (600 MHz, CDCl3): δ 7.12 (m, 2H), 6.99 (m, 2H), 6.89 (m, 5H), 4.13 (dq, J = 9.0 
Hz, J = 6.0 Hz, 1H), 3.17 (dt, J = 11.8 Hz, J = 5.4 Hz, 1H), 3.03 (dd, J = 14.4 Hz, J = 5.0 Hz, 
1H), 2.85 (dd, J = 14.4 Hz, J = 5.8 Hz, 1H), 2.66 (dd, J = 11.9 Hz, J = 8.9 Hz, 1H), 1.33 (d, J = 
6.0 Hz, 3H); 13C NMR for minor diastereomer (150 MHz, CDCl3) δ 173.5, 162.6, 161.0, 136.8, 
132.3 (d, J = 3.3 Hz), 131.1 (d, J = 8.0 Hz), 129.3, 127.4, 119.0 (q, JC-F = 321 Hz), 115.4, 115.2, 
63.1, 50.9, 47.2, 32.6, 19.4; 19F NMR for minor diastereomer (564 MHz, CDCl3) δ -75.5 (s), -
115.8 (m); IR (thin film, cm-1) 3444, 2098, 1771, 1645, 1510, 1406, 1211, 1144, 1067, 824, 703, 
620; LRMS (EI/GC-MS): m/z calculated for C19H17F4NO3S [M]+ 415.09, found 415.15 
3-(2-methoxybenzyl)-5-methyl-4-phenyl-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4c) 
 
The average yield for the title compound was 55% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure B with β-methylstyrene 2a, nucleophile 3f, and an irradiation time of 
24 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 4.5:1.  The title 
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compound was produced as a 3.1:1 mixture of inseparable diastereomers and isolated by column 
chromatography on silica gel (10% to 20% Et2O/pentane) as a yellow oil. Analytical data for 4c:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.33 (m, 2H), 7.17 (m, 2H), 7.01 (m, 
2H), 6.80 (d, J = 8.2 Hz, 1H), 6.70 (m, 1H), 6.46 (m, 1H), 4.31 (q, J = 6.6 Hz, 1H), 3.77 (s, 3H), 
3.65 (m, 1H), 3.17 (dd, J = 14.1 Hz, J = 4.7 Hz, 1H), 3.07 (d, J = 8.1 Hz, 1H), 2.41 (dd, J = 14.1 
Hz, J = 9.5 Hz, 1H), 1.56 (d, J = 6.6 Hz, 3H); 13C NMR for major diastereomer (150 MHz, 
CDCl3) δ 174.0, 157.4, 138.5, 131.1, 129.1, 128.6, 128.01, 128.0, 127.5, 125.8, 120.1, 120 (q, JC-
F = 321 Hz), 110.1, 63.6, 55.2, 49.0, 44.5, 26.8, 20.9; 19F NMR for major diastereomer (564 
MHz, CDCl3) δ -75.0 (s); 1H NMR for minor diastereomer (600 MHz, CDCl3): δ 7.33 (m, 2H), 
7.17 (m, 1H), 7.04 (m, 2H), 6.95 (m, 2H), 6.75 (m, 1H), 6.54 (d, J = 8.2 Hz, 1H), 4.11 (m, 1H), 
3.58 (s, 3H), 3.39 (dt, J = 11.0 Hz, J = 6.8 Hz, 1H), 3.17 (1H), 2.79 (dd, J = 13.9 Hz, J = 7.2 Hz, 
1H), 2.70 (dd, J = 11.0 Hz, J = 8.4 Hz, 1H), 1.38 (d, J = 6.1 Hz, 3H); 13C NMR for minor 
diastereomer (150 MHz, CDCl3) obscured by major diastereomer and baseline. Selected peaks 
δ 174.4, 157.2, 138.0, 131.2, 128.2, 127.7, 127.5, 125.1, 120.3, 109.7, 63.2, 54.6, 52.5, 48.6, 
30.6, 19.9; 19F NMR for minor diastereomer (564 MHz, CDCl3) δ -75.4 (s); IR (thin film, cm-1) 
3434, 2098, 1772, 1646, 1496, 1405, 1207, 1142, 1065, 755, 625; LRMS (EI/GC-MS): m/z 
calculated for C20H20F3NO4S [M+H]+ 427.11, found 427.15 
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3-cyclohexyl-5-methyl-4-phenyl-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4d) 
 
The average yield for the title compound was 70% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure B with β-methylstyrene 2a, nucleophile 3g, and an irradiation time of 
24 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 9.2:1.  The title 
compound was produced as a 4.9:1 mixture of separable (difficult) diastereomers and isolated by 
column chromatography on silica gel (5% to 10% Et2O/pentane) as a tan/off-white oil. 
Analytical data for 4d:  
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1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.32 (m, 3H), 7.12 (m, 2H), 4.19 (qd, J = 
6.6 Hz, J = 1.5 Hz, 1H), 3.23 (dd, J = 7.7 Hz, J = 1.5 Hz, 1H), 2.79 (dd, J = 9.3 Hz, J = 7.7 Hz, 
1H), 2.46 (d, J = 12.7 Hz, 1H), 1.65 (m, 2H), 1.59 (d, J = 6.6 Hz, 3H), 1.51 (m, 2H), 1.08 (m, 
4H), 0.88 (m, 2H); 13C NMR for major diastereomer (150 MHz, CDCl3) δ 173.8, 138.5, 129.1, 
127.9, 127.0, 119.2 (q, JC-F = 323 Hz), 63.3, 49.7, 48.9, 35.0, 30.91, 30.88, 26.1, 25.8, 25.5, 20.7; 
19F NMR for major diastereomer (564 MHz, CDCl3) δ -75.1 (s); 1H NMR for minor 
diastereomer (600 MHz, CDCl3): δ 7.33 (m, 3H), 7.22 (m, 2H), 4.09 (dq, J = 8.3 Hz, J = 6.0 Hz, 
1H), 2.91 (dd, J = 11.2 Hz, J = 8.3 Hz, 1H), 2.80 (1H), 1.81 (m, 1H), 1.73 – 0.81 (m, 10H), 1.45 
(d, J = 6.0 Hz, 3H); 13C NMR for minor diastereomer (150 MHz, CDCl3) δ 173.6, 139.0, 129.3, 
128.1, 127.7, 119.2 (q, JC-F = 323 Hz), 63.0, 54.7, 49.6, 37.7, 29.9, 29.4, 26.4, 26.3, 26.0, 19.9; 
19F NMR for minor diastereomer (564 MHz, CDCl3) δ -75.3 (s); IR (thin film, cm-1) 2928, 2854, 
2361, 1768, 1454, 1405, 1207, 1143, 1066, 980, 628, 520; LRMS (EI/GC-MS): m/z calculated 
for C18H22F3NO3S [M]+ 389.13, found 389.10 
3-isopropyl-5-methyl-4-phenyl-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4e) 
 
The average yield for the title compound was 74% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure B with β-methylstyrene 2a, nucleophile 3h, and an irradiation time of 
27 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: >20:1.  The title 
compound was produced as a 5.8:1 mixture of separable (difficult) diastereomers and isolated by 
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column chromatography on silica gel (5% to 10% Et2O/pentane) as a tan/off-white oil. 
Analytical data for 4e:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.32 (m, 3H), 7.13 (m, 2H), 4.20 (m, 
1H), 3.23 (dd, J = 7.7 Hz, J = 1.3 Hz, 1H), 2.73 (dd, J = 9.6 Hz, J = 7.7 Hz, 1H), 1.86 (m, 1H), 
1.60 (d, J = 6.6 Hz, 3H), 1.19 (d, J = 6.5 Hz, 3H), 0.70 (d, J = 6.7 Hz, 3H); 13C NMR for major 
diastereomer (150 MHz, CDCl3) δ 173.7, 138.5, 129.2, 128.0, 127.1, 119.2 (q, JC-F = 323 Hz), 
63.1, 51.0, 49.4, 25.9, 21.3, 20.8, 20.6; 19F NMR for major diastereomer (564 MHz, CDCl3) δ -
75.0 (s); 1H NMR for minor diastereomer (600 MHz, CDCl3): δ 7.31 (m, 5H), 4.12 (m, 1H), 
2.87 (m, 2H), 2.15 (m, 1H), 1.46 (d, J = 6.0 Hz, 3H), 0.99 (d, J = 7.2 Hz, 3H), 0.80 (d, J = 6.6 
Hz, 3H); 13C NMR for minor diastereomer (150 MHz, CDCl3) obscured by major diastereomer 
and baseline. Selected peaks δ 173.7, 138.8, 129.3, 128.1, 127.8, 119.1 (q, JC-F = 321 Hz), 62.9, 
55.0, 49.6, 27.5, 19.8, 19.1, 19.0; 19F NMR for minor diastereomer (564 MHz, CDCl3) δ -75.4 
(s); IR (thin film, cm-1) 2965, 2360, 1771, 1405, 1211, 1142, 1066, 981, 702, 628, 617; LRMS 
(EI/GC-MS): m/z calculated for C15H18F3NO3S [M]+ 349.10, found 349.10 
3-isobutyl-5-methyl-4-phenyl-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4f) 
 
The average yield for the title compound was 52% (2 trials) at 0.4 and 0.33 mmol scales, 
generated using General Procedure B with β-methylstyrene 2a, nucleophile 3i, and an 
irradiation time of 27 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 
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>20:1.  The title compound was produced as a 1:1 mixture of difficult to separate diastereomers 
and isolated by column chromatography on silica gel (5% to 10% Et2O/pentane) as an off-white 
oil. As shown in the figure above, analysis of the crude reaction mixture provided a different 
result than isolation.  The crude reaction suggested diastereoselectivity in favor of the trans/trans 
diastereomer (~1.2:1, confirmed by DBU-catalyzed epimerization/enrichment) and a yield 
approaching 70%.  Product was lost ultimately lost in the chromatography step (and a 1:1 d.r. 
observed in the isolated product) as complete separation between 4f and 4-MeO-PhSH was not 
achieved. Analytical data for 4f:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.38 (m, 2H), 7.32 (m, 1H), 7.23 (m, 
2H), 4.17 (dq, J = 8.7 Hz, J = 6.1 Hz, 1H), 2.86 (dt, J = 11.3 Hz, J = 6.5 Hz, 1H), 2.70 (dd, J = 
11.3 Hz, J = 8.7 Hz, 1H), 1.73 (m, 1H), 1.62 (m, 1H), 1.45 (d, J = 6.0 Hz, 3H), 1.28 (m, 1H), 
0.74 (d, J = 6.5 Hz, 3H), 0.67 (d, J = 6.6 Hz, 1H); 13C NMR for major diastereomer (150 MHz, 
CDCl3) δ 174.7, 137.7, 129.3, 128.3, 127.7, 119.0 (q, JC-F = 323 Hz), 63.0, 54.2, 47.2, 39.0, 25.0, 
22.3, 21.9, 19.8; 19F NMR for major diastereomer (564 MHz, CDCl3) δ -75.5 (s); 1H NMR for 
minor diastereomer (600 MHz, CDCl3): δ 7.32 (m, 3H), 7.07 (m, 2H), 4.37 (qd, J = 6.6 Hz, J = 
1.3 Hz, 1H), 3.22 (dd, J = 8.2 Hz, J = 1.3 Hz, 1H), 3.12 (td, J = 8.5 Hz, J = 4.6 Hz, 1H), 1.62 (d, 
J = 6.6 Hz, 3H), 1.53 (m, 2H), 1.06 (m, 1H), 0.85 (d, J = 6.2 Hz, 3H), 0.71 (d, J = 6.3 Hz, 3H); 
19F NMR for minor diastereomer (564 MHz, CDCl3) δ -75.0 (s); IR (thin film, cm-1) 2959, 2872, 
1773, 1495, 1404, 1209, 1150, 1067, 980, 704, 621, 585; LRMS (EI/GC-MS): m/z calculated for 
C16H20F3NO3S [M]+ 363.11, found 363.10 
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3-benzyl-3,5-dimethyl-4-phenyl-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4g) 
 
The average yield for the title compound was 59% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure B with β-methylstyrene 2a, nucleophile 3j, and an irradiation time of 
24 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 12:1.  The title 
compound was produced as a 1.7:1 mixture of separable diastereomers and isolated by column 
chromatography on silica gel (10% Et2O/pentane) as a yellow/off-white oil. Analytical data for 
4g:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.35 (m, 5H), 7.28 (m, 1H), 7.22 (m, 
2H), 7.16 (m, 2H), 4.43 (dq, J = 9.4 Hz, J = 6.0 Hz, 1H), 3.30 (d, J = 14.3 Hz, 1H), 2.99 (d, J = 
9.4 Hz, 1H), 2.48 (d, J = 14.3 Hz, 1H), 1.18 (d, J = 6.0 Hz, 3H), 1.11 (s, 3H); 13C NMR for 
major diastereomer (150 MHz, CDCl3) δ 177.4, 136.4, 134.3, 130.5, 129.5, 128.8, 128.7, 128.2, 
127.3, 119.1 (q, JC-F = 323 Hz), 59.4, 52.0, 51.0, 41.8, 22.0, 20.0; 19F NMR for major 
diastereomer (564 MHz, CDCl3) δ -75.1 (s); 1H NMR for minor diastereomer (600 MHz, 
CDCl3): δ 7.42 (m, 3H), 7.26 (m, 2H), 7.20 (m, 3H), 6.92 (m, 2H), 4.77 (m, 1H), 3.05 (d, J = 
10.6 Hz, 1H), 2.87 (d, J = 13.7 Hz, 1H), 2.20 (d, J = 13.7 Hz, 1H), 1.47 (d, J = 5.9 Hz, 3H), 1.11 
(s, 3H); 13C NMR for minor diastereomer (150 MHz, CDCl3) δ 175.3, 134.4, 132.6, 130.4, 
129.3, 129.0, 128.5, 128.0, 127.1, 118.8 (q, JC-F = 322 Hz), 58.7, 57.3, 49.5, 39.0, 19.8, 19.4; 19F 
NMR for minor diastereomer (564 MHz, CDCl3) δ -76.1 (s); IR (thin film, cm-1) 3443, 3033, 
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2936, 2359, 1773, 1496, 1455, 1403, 1382, 1207, 1130, 1047, 911, 702, 628, 602; LRMS 
(EI/GC-MS): m/z calculated for C20H20F3NO3S [M]+ 411.11, found 411.20 
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3-((E)-benzylidene)-5-methyl-4-phenyl-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4h) 
 
The average yield for the title compound was 70% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure B with β-methylstyrene 2a, nucleophile 3k, and an irradiation time of 
21 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 8.1:1.  The title 
compound was produced as a 6.4:1 mixture of separable E/Z olefin isomers and isolated by 
column chromatography on silica gel (10% Et2O/pentane) as a yellow/off-white oil. Analytical 
data for 4h:  
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1H NMR for E isomer (600 MHz, CDCl3): δ 7.92 (s, 1H), 7.33 (m, 8H), 7.23 (m, 2H), 4.31 (q, J 
= 6.5 Hz, 1H), 4.13 (s, 1H), 1.58 (d, J = 6.5 Hz, 3H); 13C NMR for E isomer (150 MHz, CDCl3) 
δ 166.4, 141.6, 139.9, 133.2, 130.8, 129.6, 129.0, 128.2, 128.17, 128.0, 126.5, 119.2 (q, JC-F = 
323 Hz), 64.8, 50.4, 23.5; 19F NMR for E isomer (564 MHz, CDCl3) δ -74.9 (s); 1H NMR for Z 
isomer/minor (600 MHz, CDCl3) key resonances: δ 6.89 (s, vinyl proton, 1H), 4.34 (1H), 3.85 (t 
[apparent], J = 2.5 Hz, 1H), 1.63 (d, J = 6.3 Hz, 3H); IR (thin film, cm-1) 3151, 3075, 1746, 
1638, 1407, 1293, 1204, 1165, 1138, 1047, 775, 699, 607; LRMS (EI/GC-MS): m/z calculated 
for C19H16F3NO3S [M]+ 395.08, found 395.10 
Olefin geometry assigned based on observed anisotropy effect of vinylic proton (major isomer: 
7.92 ppm, minor isomer: 6.89 ppm).  Geometry assignments were informed by literature 
examples and similar reasoning used by others in olefin geometry/radical cyclization 
assignments.43 
5-methyl-4-phenyl-1-((trifluoromethyl)sulfonyl)-3-((triisopropylsilyl)methylene)pyrrolidin-
2-one (4i) 
 
The average yield for the title compound was 73% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure B with β-methylstyrene 2a, nucleophile 3l, and an irradiation time of 
22 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 8.3:1.  The title 
compound was produced as an 8.1:1 mixture of separable Z/E olefin isomers and isolated by 
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column chromatography on silica gel (5% Et2O/pentane) as a yellow/off-white oil. Analytical 
data for 4i:  
1H NMR for Z isomer (600 MHz, CDCl3): δ 7.36 (m, 2H), 7.30 (m, 1H), 7.14 (m, 2H), 6.38 (d, J 
= 2.0 Hz, 1H), 4.26 (m, 1H), 3.75 (dd, J = 3.6 Hz, J = 2.1 Hz, 1H), 1.59 (d, J = 6.3 Hz, 3H), 1.38 
(m, 3H), 1.00 (dd, J = 7.7 Hz, J = 1.8 Hz, 18H); 13C NMR for Z isomer (150 MHz, CDCl3) 
δ 164.9, 147.5, 146.9, 140.8, 129.3, 128.0, 127.3, 119.2 (q, JC-F = 324 Hz), 64.3, 54.9, 22.4, 19.0, 
18.9, 12.0; 19F NMR (564 MHz, CDCl3) δ -74.7 (s, major isomer), -75.0 (s, minor isomer); 1H 
NMR for E isomer (600 MHz, CDCl3) key resonances: δ 4.19 (q, J = 6.6 Hz, 1H), 3.88 (d, J = 
1.4 Hz, 1H), 1.56 (d, J = 6.6 Hz, 3H), 0.82 (d, J = 6.9 Hz, 18H); IR (thin film, cm-1) 3445, 2944, 
2867, 1756, 1623, 1463, 1409, 1308, 1208, 1153, 1132, 1050, 982, 700, 624, 582; LRMS 
(EI/GC-MS): m/z calculated for C22H32F3NO3SSi [M]+ 475.18, found 475.10 
Olefin geometry assigned by analogy to 4h above.  The size of TIPS group makes it unlikely to 
be placed in close proximity to phenyl group.  Additionally, only one olefin resonance was 
identified: 6.38 ppm.  This is likely the Z olefin (similar to minor isomer of 4h) 
3-benzyl-4-(4-chlorophenyl)-5-methyl-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4j) 
 
The average yield for the title compound was 60% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure B with β-methyl-4-chlorostyrene 2b, nucleophile 3d, and an 
irradiation time of 23 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 4:1.  
The title compound was produced as a 3.3:1 mixture of separable diastereomers, purified by 
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column chromatography on silica gel (10% Et2O/pentane) as a tan/colorless oil. Analytical data 
for 4j:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.33 (d, J = 8.3 Hz, 2H), 7.20 (m, 3H), 
6.92 (d, J = 8.3 Hz, 2H), 6.84 (d, J = 6.8 Hz, 2H), 4.30 (q, J = 6.6 Hz, 1H), 3.44 (m, 1H), 3.19 
(dd, J = 14.6 Hz, J = 4.3 Hz, 1H), 3.11 (d, J = 8.1 Hz, 1H), 2.37 (dd, J = 14.6 Hz, J = 10.3 Hz, 
1H), 1.57 (d, J = 6.6 Hz, 3H);  13C NMR for major diastereomer (150 MHz, CDCl3) δ 173.1, 
137.5, 136.6, 134.2, 129.4, 128.8, 128.62, 128.58, 126.8, 119.1 (q, JC-F = 323 Hz), 63.4, 48.1, 
47.0, 31.0, 20.8; 19F NMR for major diastereomer (564 MHz, CDCl3) δ -74.9 (s); 1H NMR for 
minor diastereomer (600 MHz, CDCl3): δ 7.29 (d, J = 8.1 Hz, 2H), 7.19 (m, 3H), 7.01 (m, 4H), 
4.08 (m, 1H), 3.13 (m, 1H), 3.05 (dd, J = 14.3 Hz, J = 5.4 Hz, 1H), 2.90 (dd, J = 14.3 Hz, J = 5.7 
Hz, 1H), 2.67 (dd, J = 11.4 Hz, J = 8.7 Hz, 1H), 1.30 (d, J = 6.0 Hz, 3H); 13C NMR for minor 
diastereomer (150 MHz, CDCl3) δ 173.3, 136.4, 135.8, 134.1, 129.5, 129.4, 129.2, 128.6, 127.0, 
119.0 (q, JC-F = 323 Hz), 62.7, 50.9, 50.7, 33.7, 19.5; 19F NMR for minor diastereomer (564 
MHz, CDCl3) δ -75.4 (s); IR (thin film, cm-1) 3506, 1770, 1651, 1495, 1406, 1210, 1152, 1092, 
1135, 986, 824, 700, 623, 598; LRMS (EI/GC-MS): m/z calculated for C19H17ClF3NO3S [M]+ 
431.06, found 431.10 
3-benzyl-4-(3-methoxyphenyl)-5-methyl-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4k) 
 
The average yield for the title compound was 54% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure B with β-methyl-3-methoxystyrene 2c, nucleophile 3d, and an 
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irradiation time of 22 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 4.8:1.  
The title compound was produced as a 3.8:1 mixture of inseparable diastereomers and isolated 
by column chromatography on silica gel (10% to 20% Et2O/pentane) as a tan oil. Analytical data 
for 4k:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.23 (m, 5H), 6.89 (d, J = 7.4 Hz, 2H), 
6.60 (d, J = 7.6 Hz, 1H), 6.51 (br s, 1H), 4.38 (q, J = 6.6 Hz, 1H), 3.76 (s, 3H), 3.41 (ddd, J = 
10.0 Hz, J = 8.0 Hz, J = 4.2 Hz, 1H), 3.17 (dd, J = 14.4 Hz, J = 4.2 Hz, 1H), 3.10 (d, J = 8.0 Hz, 
1H), 2.43 (dd, J = 14.4 Hz, J = 10.0 Hz, 1H), 1.56 (d, J = 6.6 Hz, 3H); 13C NMR for major 
diastereomer (150 MHz, CDCl3) δ 173.6, 160.1, 139.6, 138.0, 130.3, 128.7, 128.5, 126.6, 119.1 
(q, JC-F = 321 Hz), 119.4, 114.0, 113.8, 113.1, 63.4, 55.2, 48.7, 47.2, 31.2, 20.9; 19F NMR for 
major diastereomer (564 MHz, CDCl3) δ -74.9 (s); 1H NMR for minor diastereomer (600 MHz, 
CDCl3): δ 7.21 (m, 2H), 7.05 (d, J = 6.9 Hz, 2H), 6.86 (m, 2H), 6.82 (dd, J = 8.2 Hz, J = 2.5 Hz, 
1H), 6.71 (d, J = 7.8 Hz, 1H), 6.61 (br s, 1H), 4.14 (m, 1H), 3.78 (s, 3H), 3.17 (1H), 3.08 (1H), 
2.88 (dd, J = 14.3 Hz, J = 5.8 Hz, 1H), 2.66 (dd, J = 11.4 Hz, J = 8.6 Hz, 1H), 1.31 (d, J = 6.0 
Hz, 3H); 13C NMR for minor diastereomer (150 MHz, CDCl3) obscured by major diastereomer 
and baseline. Selected peaks δ 173.6, 160.1, 138.9, 136.7, 63.0, 55.3, 51.1, 50.9, 33.6, 19.6; 19F 
NMR for minor diastereomer (564 MHz, CDCl3) δ -75.4 (s); IR (thin film, cm-1) 2940, 1771, 
1603, 1496, 1456, 1406, 1209, 1142, 1066, 781, 700, 630, 595; LRMS (EI/GC-MS): m/z 
calculated for C20H20F3NO4S [M]+ 427.11, found 427.10 
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3-benzyl-4-(4-methoxyphenyl)-5-methyl-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4l) 
 
The average yield for the title compound was 65% (2 trials) at the 0.5 mmol scale, generated 
using 3 equivalents of anethole 2d, 1 equivalent 3d, and an irradiation time of 24 hours.  Average 
lactam/imidate ratio as observed by crude 1H NMR: 17:1.  The title compound was produced as a 
3.6:1 mixture of separable diastereomers and isolated by column chromatography on silica gel 
(20% Et2O/pentane) as a tan oil. Analytical data for 4l:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.20 (m, 3H), 6.91 (m, 2H), 6.87 (m, 
4H), 4.32 (q, J = 6.6 Hz, 1H), 3.81 (s, 3H), 3.39 (ddd, J = 10.2 Hz, J = 8.1 Hz, J = 4.2 Hz, 1H), 
3.16 (dd, J = 14.5 Hz, J = 4.2 Hz, 1H), 3.08 (d, J = 8.1 Hz, 1H), 2.42 (dd, J = 14.5 Hz, J = 10.2 
Hz, 1H), 1.55 (d, J = 6.6 Hz, 3H); 13C NMR for major diastereomer (150 MHz, CDCl3) δ 173.6, 
159.3, 138.0, 130.2, 128.7, 128.52, 128.51, 126.6, 119.2 (q, JC-F = 323 Hz), 114.5, 63.9, 55.3, 
47.9, 47.3, 31.1, 20.8; 19F NMR for major diastereomer (564 MHz, CDCl3) δ -74.9 (s); 1H NMR 
for minor diastereomer (600 MHz, CDCl3): δ 7.20 (m, 3H), 7.03 (m, 4H), 6.80 (m, 2H), 4.07 (m, 
1H), 3.80 (s, 3H), 3.12 (m, 1H), 3.07 (dd, J = 14.1 Hz, J = 4.7 Hz, 1H), 2.84 (dd, J = 14.1 Hz, J = 
5.8 Hz, 1H), 2.62 (dd, J = 11.6 Hz, J = 8.8 Hz, 1H), 1.29 (d, J = 6.0 Hz, 3H); 13C NMR for 
minor diastereomer (150 MHz, CDCl3) δ 173.7, 159.4, 136.8, 129.6, 129.0, 128.8, 128.5, 126.9, 
119.0 (q, JC-F = 323 Hz), 114.6, 63.2, 55.4, 51.0, 50.5, 33.3, 19.3; 19F NMR for minor 
diastereomer (564 MHz, CDCl3) δ -75.5 (s); IR (thin film, cm-1) 3528, 2938, 2840, 1770, 1613, 
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1515, 1405, 1209, 1143, 1065, 829, 699, 620, 524; LRMS (EI/GC-MS): m/z calculated for 
C20H20F3NO4S [M]+ 427.11, found 427.15 
3-benzyl-5-methyl-4-(p-tolyl)-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4m) 
 
The average yield for the title compound was 66% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure B with β-methyl-4-methylstyrene 2e, nucleophile 3d, and an 
irradiation time of 24 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 5.8:1.  
The title compound was produced as a 4:1 mixture of inseparable diastereomers, purified by 
column chromatography on silica gel (10% Et2O/pentane) as a tan/colorless oil.  Analytical data 
for 4m:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.18 (m, 5H), 6.88 (m, 4H), 4.32 (q, J = 
6.6 Hz, 1H), 3.39 (m, 1H), 3.15 (dd, J = 14.4 Hz, J = 4.2 Hz, 1H), 3.10 (d, J = 8.2 Hz, 1H), 2.43 
(dd, J = 14.5 Hz, J = 10.0 Hz, 1H), 2.36 (s, 3H), 1.56 (d, J = 6.6 Hz, 3H); 13C NMR for major 
diastereomer (150 MHz, CDCl3) δ 173.6, 138.1, 138.0, 135.1, 129.9, 128.7, 128.5, 127.3, 126.6, 
119.2 (q, JC-F = 323 Hz), 63.8, 48.4, 47.3, 31.1, 21.1, 20.8; 19F NMR for major diastereomer 
(564 MHz, CDCl3) δ -74.9 (s); 1H NMR for minor diastereomer (600 MHz, CDCl3): δ 7.18 (m, 
5H), 7.04 (m, 4H), 4.10 (m, 1H), 3.15 (m, 1H), 3.09 (m, 1H), 2.83 (dd, J = 14.2 Hz, J = 5.2 Hz, 
1H), 2.65 (dd, J = 11.6 Hz, J = 8.7 Hz, 1H), 2.34 (s, 3H), 1.29 (d, J = 6.0 Hz, 3H); 13C NMR for 
minor diastereomer (150 MHz, CDCl3) obscured by major diastereomer and baseline. Selected 
peaks δ 173.8, 63.2, 50.9, 50.7, 33.3, 21.0, 19.4; 19F NMR for minor diastereomer (564 MHz, 
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CDCl3) δ -75.5 (s); IR (thin film, cm-1) 3030, 2926, 1771, 1604, 1517, 1496, 1455, 1407, 1209, 
1144, 1066, 1003, 911, 699, 620, 595; LRMS (EI/GC-MS): m/z calculated for C20H20F3NO3S 
[M]+ 411.11, found 411.15 
3-benzyl-5-methyl-4-(m-tolyl)-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4n) 
 
The average yield for the title compound was 65% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure B with β-methyl-3-methylstyrene 2f, nucleophile 3d, and an 
irradiation time of 23 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 5:1.  
The title compound was produced as a 3.5:1 mixture of inseparable diastereomers and isolated 
by column chromatography on silica gel (10% Et2O/pentane) as a tan oil. Analytical data for 4n:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.25 – 6.75 (m, 9H), 4.34 (q, J = 6.6 Hz, 
1H), 3.40 (ddd, J = 10.1 Hz, J = 8.2 Hz, J = 4.4 Hz, 1H), 3.16 (dd, J = 14.5 Hz, J = 4.4 Hz, 1H), 
3.09 (d, J = 8.2 Hz, 1H), 2.41 (dd, J = 14.5 Hz, J = 10.1 Hz, 1H), 2.32 (s, 3H), 1.57 (d, J = 6.6 
Hz, 3H); 13C NMR for major diastereomer (150 MHz, CDCl3) δ 173.6, 138.9, 138.1, 138.0, 
129.6, 129.1, 128.9, 128.7, 128.5, 126.6, 119.2 (q, JC-F = 323 Hz), 63.6, 48.6, 47.1, 31.2, 21.4, 
21.0; 19F NMR for major diastereomer (564 MHz, CDCl3) δ -74.9 (s); 1H NMR for minor 
diastereomer (600 MHz, CDCl3): δ 7.25 – 6.75 (m, 9H), 4.13 (m, 1H), 3.17 (1H), 3.08 (1H), 2.87 
(dd, J = 14.3 Hz, J = 5.9 Hz, 1H), 2.65 (dd, J = 11.4 Hz, J = 8.6 Hz, 1H), 2.32 (s, 3H), 1.30 (d, J 
= 6.0 Hz, 3H); 13C NMR for minor diastereomer (150 MHz, CDCl3) obscured by major 
diastereomer and baseline. Selected peaks δ 173.8, 119.0 (q, JC-F = 321 Hz), 63.1, 51.1, 51.0, 
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33.6, 19.6; 19F NMR for minor diastereomer (564 MHz, CDCl3) δ -75.4 (s); IR (thin film, cm-1) 
3031, 2926, 1770, 1607, 1496, 1406, 1207, 1143, 1066, 911, 787, 700, 625, 594; LRMS (EI/GC-
MS): m/z calculated for C20H20F3NO3S [M]+ 411.11, found 411.15 
3-benzyl-5-methyl-4-(o-tolyl)-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4o) 
 
The average yield for the title compound was 62% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure B with β-methyl-2-methylstyrene 2g, nucleophile 3d, and an 
irradiation time of 25 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 5.2:1.  
The title compound was produced as a 2:1 mixture of inseparable diastereomers and isolated by 
column chromatography on silica gel (10% Et2O/pentane) as a off-white solid. Analytical data 
for 4o:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.18 (m, 5H), 7.02 (m, 2H), 6.73 (m, 
2H), 4.21 (q, J = 6.6 Hz, 1H), 3.46 (ddd, J = 10.6 Hz, J = 8.3 Hz, J = 4.4 Hz, 1H), 3.35 (d, J = 
8.3 Hz, 1H), 3.23 (m, 1H), 2.55 (dd, J = 14.3 Hz, J = 10.6 Hz, 1H), 1.88 (s, 3H), 1.58 (d, J = 6.6 
Hz, 3H); 13C NMR for major diastereomer (150 MHz, CDCl3) δ 173.9, 137.7, 136.5, 136.0, 
131.2, 129.2, 128.5, 127.8, 126.8, 126.7, 125.3, 119.2 (q, JC-F = 323 Hz), 63.7, 46.8, 42.6, 31.0, 
21.5, 19.8; 19F NMR for major diastereomer (564 MHz, CDCl3) δ -74.9 (s); 1H NMR for minor 
diastereomer (600 MHz, CDCl3): δ 7.18 (m, 9H), 4.14 (m, 1H), 3.23 (m, 1H), 3.12 (dd, J = 10.3 
Hz, J = 7.7 Hz, 1H), 2.98 (m, 2H), 2.11 (s, 3H), 1.33 (d, J = 6.1 Hz, 3H); 13C NMR for minor 
diastereomer (150 MHz, CDCl3) obscured by major diastereomer and baseline. Selected peaks 
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δ 174.1, 136.9, 136.4, 132.7, 131.0, 128.5, 127.0, 126.9, 125.8, 120.1, 119.0 (q, JC-F = 321 Hz), 
64.1, 51.6, 45.8, 34.5, 20.0, 19.8; 19F NMR for minor diastereomer (564 MHz, CDCl3) δ -75.4 
(s); IR (thin film, cm-1) 3445, 3065, 2979, 1772, 1645, 1496, 1407, 1208, 1146, 1107, 1068, 733, 
700, 624; LRMS (EI/GC-MS): m/z calculated for C20H20F3NO3S [M]+ 411.11, found 411.15 
3-benzyl-1-((trifluoromethyl)sulfonyl)-3,3a,8,8a-tetrahydroindeno[2,1-b]pyrrol-2(1H)-one 
(4p) 
 
The average yield for the title compound was 60% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure B with indene 2h, nucleophile 3d, and an irradiation time of 17 hours.  
Average lactam/imidate ratio as observed by crude 1H NMR: 10:1.  The title compound was 
produced as a 10:1 mixture of separable diastereomers and isolated by column chromatography 
on silica gel 10% to 20% Et2O/pentane) as a tan oil that solidified upon freezing. Analytical data 
for 4p:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.37 (t, J = 7.4 Hz, 2H), 7.31 (t, J = 7.4 
Hz, 1H), 7.28 (d, J = 7.0 Hz, 2H), 7.18 (m, 2H), 7.09 (m, 1H), 6.56 (d, J = 7.6 Hz, 1H), 4.74 (td, 
J = 7.8 Hz, J = 4.0 Hz, 1H), 3.71 (dd, J = 7.9 Hz, J = 5.4 Hz, 1H), 3.43 (dd, J = 17.5 Hz, J = 7.8 
Hz, 1H), 3.30 (dq, J = 13.1 Hz, J = 4.5 Hz, J = 4.0 Hz, 2H), 3.07 (m, 1H), 3.00 (dd, J = 13.6 Hz, 
J = 8.5 Hz, 1H); 13C NMR for major diastereomer (150 MHz, CDCl3) δ 174.5, 140.9, 139.3, 
136.7, 129.4, 129.1, 128.4, 127.7, 127.4, 125.0, 124.2, 119.2 (q, JC-F = 323 Hz), 63.2, 50.8, 46.9, 
39.6, 36.8; 19F NMR for major diastereomer (564 MHz, CDCl3) δ -74.9 (s); 1H NMR for minor 
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diastereomer (600 MHz, CDCl3): δ 7.21 (m, 7H), 7.06 (d, J = 7.1 Hz, 2H), 4.97 (td, J = 7.2 Hz, J 
= 3.7 Hz, 1H), 4.21 (dd, J = 9.0 Hz, J = 7.2 Hz, 1H), 3.46 (td, J = 9.0 Hz, J = 5.6 Hz, 1H), 3.36 
(dd, J = 17.5 Hz, J = 7.0 Hz, 1H), 3.13 (m, 2H), 3.03 (dd, J = 15.4 Hz, J = 8.7 Hz, 1H); IR (thin 
film, cm-1) 3029, 2925, 1769, 1604, 1408, 1211, 1142, 1108, 975, 755, 702, 614; LRMS (EI/GC-
MS): m/z calculated for C19H16F3NO3S [M]+ 395.08, found 395.10 
 
3-benzyl-4-methyl-4-phenyl-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4q) 
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The average yield for the title compound was 40% (2 trials) at the 0.5 mmol scale, generated 
using 2 equivalents of α-methylstyrene 2i, 1 equivalent N-sulfonylamide 3d, and an irradiation 
time of 18 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 9:1.  The title 
compound was produced as a 7:1 mixture of (barely) separable diastereomers and isolated by 
column chromatography on silica gel (10% Et2O/pentane) as an off-white oil. Analytical data for 
4q:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.35 (m, 2H), 7.29 (m, 3H), 7.18 (m, 
2H), 7.14 (m, 3H), 3.93 (d, J = 10.2 Hz, 1H), 3.84 (d, J = 10.2 Hz, 1H), 3.39 (dd, J = 8.2 Hz, J = 
4.1 Hz, 1H), 3.07 (dd, J = 14.4 Hz, J = 8.2 Hz, 1H), 2.66 (dd, J = 14.4 Hz, J = 4.1 Hz, 1H), 1.56 
(s, 3H); 13C NMR for major diastereomer (150 MHz, CDCl3) δ 173.0, 140.6, 138.2, 129.1, 
128.9, 128.5, 127.8, 126.6, 125.7, 119.5 (q, JC-F = 323 Hz), 59.9, 55.1, 44.4, 30.8, 19.9;  19F 
NMR for major diastereomer (564 MHz, CDCl3) δ -75.2 (s); IR (thin film, cm-1) 3448, 3063, 
2973, 1776, 1603, 1497, 1410, 1213, 1141, 1123, 1105, 699, 616; LRMS (EI/GC-MS): m/z 
calculated for C19H18F3NO3S [M]+ 397.10, found 397.15 
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3-benzyl-4-(4-((tert-butyldimethylsilyl)oxy)phenyl)-5-methyl-1-
((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4r) 
 
The average yield for the title compound was 62% (2 trials) at the 0.5 mmol scale, generated 
using General Procedure B with alkene 2j, nucleophile 3d, and an irradiation time of 24.5 
hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 16:1.  The title compound 
was produced as a 3.4:1 mixture of separable diastereomers and isolated by column 
chromatography on silica gel (10% Et2O/pentane) as a tan oil. Analytical data for 4r:  
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1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.19 (m, 3H), 6.83 (m, 6H), 4.33 (q, J = 
6.6 Hz, 1H), 3.39 (ddd, J = 10.2 Hz, J = 8.1 Hz, J = 4.2 Hz, 1H), 3.15 (dd, J = 15.0 Hz, J = 4.2 
Hz, 1H), 3.06 (d, J = 8.1 Hz, 1H), 2.40 (dd, J = 15.0 Hz, J =10.3 Hz, 1H), 1.55 (d, J = 6.6 Hz, 
3H), 0.93 (s, 9H), 0.20 (s, 6H); 13C NMR for major diastereomer (150 MHz, CDCl3) δ 173.6, 
155.5, 138.0, 130.9, 128.7, 128.5, 128.47, 126.6, 120.7, 119.2 (q, JC-F = 323 Hz), 63.8, 48.0, 
47.2, 31.1, 25.6, 20.8, 18.2, -4.4; 19F NMR for major diastereomer (564 MHz, CDCl3) δ -74.9 
(s); 1H NMR for minor diastereomer (600 MHz, CDCl3): δ 7.18 (m, 3H), 7.02 (m, 2H), 6.96 (m, 
2H), 6.78 (m, 2H), 4.07 (m, 1H), 3.11 (m, 1H), 3.03 (dd, J = 14.2 Hz, J = 5.1 Hz, 1H), 2.89 (dd, 
J = 14.2 Hz, J = 5.7 Hz, 1H), 2.62 (dd, J = 11.7 Hz, J = 8.8 Hz, 1H), 1.30 (d, J = 6.0 Hz, 3H), 
0.97 (s, 9H), 0.19 (s, 6H); 13C NMR for minor diastereomer (150 MHz, CDCl3) δ 173.8, 155.5, 
136.8, 129.6, 129.5, 128.9, 128.5, 126.8, 120.1, 119.0 (q, JC-F = 323 Hz), 63.2, 51.0, 50.8, 33.6, 
25.6, 19.4, 18.2, -4.4; 19F NMR for minor diastereomer (564 MHz, CDCl3) δ 75.5 (s); IR (thin 
film, cm-1) 2956, 2932, 2859, 1773, 1608, 1513, 1408, 1268, 1207, 1144, 1066, 914, 841, 782, 
698, 618; LRMS (+ESI): m/z calculated for C25H32F3NO4SSiNa [M+Na]+ 550.17, found 550.44 
3-benzyl-4-(4-bromophenyl)-5-methyl-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4s) 
 
The yield for the title compound was 50% (one trial, NMR yield relative to (Me3Si)2O internal 
standard) at the 0.2 mmol scale, generated using General Procedure B with β-methyl-4-
bromostyrene 2k, nucleophile 3d, and an irradiation time of 24 hours.  The title compound was 
produced as a 3.3:1 mixture of separable diastereomers, purified by column chromatography on 
silica gel (10% to 20% Et2O/pentane) as a tan/colorless oil. Analytical data for 4s:  
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1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.49 (d, J = 8.4 Hz, 2H), 7.21 (m, 3H), 
6.85 (m, 4H), 4.30 (q, J = 6.6 Hz, 1H), 3.44 (ddd, J = 10.3 Hz, J = 8.1 Hz, J = 4.3 Hz, 1H), 3.19 
(dd, J = 14.6 Hz, J = 4.2 Hz, 1H), 3.10 (d, J = 8.1 Hz, 1H), 2.37 (dd, J = 14.6 Hz, J = 10.3 Hz, 
1H), 1.57 (d, J = 6.6 Hz, 3H); 13C NMR for major diastereomer (150 MHz, CDCl3) δ 173.1, 
137.5, 137.1, 132.4, 129.1, 128.63, 128.58, 126.8, 122.2, 119.1 (q, JC-F = 323 Hz), 63.3, 48.1, 
46.9, 31.0, 20.9; 19F NMR for major diastereomer (564 MHz, CDCl3) δ -74.9 (s); 1H NMR for 
minor diastereomer (600 MHz, CDCl3): δ 7.45 (d, J = 8.4 Hz, 2H), 7.19 (m, 4H), 6.98 (m, 3H), 
4.08 (dq, J = 8.7 Hz, J = 6.0 Hz, 1H), 3.13 (dt, J = 11.3 Hz, J = 5.5 Hz, 1H), 3.05 (dd, J = 14.3 
Hz, J = 5.4 Hz, 1H), 2.90 (dd, J = 14.3 Hz, J = 5.7 Hz, 1H), 2.66 (dd, J = 11.4 Hz, J = 8.7 Hz, 
1H), 1.30 (d, J = 6.0 Hz, 3H); 13C NMR for minor diastereomer (150 MHz, CDCl3) δ 173.3, 
136.4, 136.3, 132.4, 129.5, 129.48, 128.6, 127.0, 122.1, 119.0 (q, JC-F = 323 Hz), 62.8, 50.84, 
50.79, 33.7, 19.5; 19F NMR for minor diastereomer (564 MHz, CDCl3) δ -75.4 (s); LRMS 
(EI/GC-MS): m/z calculated for C19H17ClF3NO3S [M]+ 475.01, found 475.0 
3-benzyl-5-(hydroxymethyl)-4-(4-methoxyphenyl)-1-((trifluoromethyl)sulfonyl)pyrrolidin-
2-one (4t) 
 
The average yield for the title compound was 35% (2 trials) at the 0.5 mmol scale, generated 
using 2 equivalents (E)-3-(4-methoxyphenyl)prop-2-en-1-ol 2m, 1 equivalent N-sulfonylamide 
3d, and an irradiation time of 33 hours.  Average lactam/imidate ratio as observed by crude 1H 
N
O
S
N
O
S
+
Major Minor
F3C F3C
O
O
O
O
MeO MeO
HO HO
 166 
NMR: >20:1.  The title compound was produced as a 6.3:1 mixture of separable diastereomers 
and isolated by column chromatography on silica gel (30% Et2O/pentane) as a tan oil. Analytical 
data for 4t:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.17 (m, 3H), 6.90 (m, 2H), 6.85 (m, 
4H), 4.21 (dd, J = 4.2 Hz, J = 2.4 Hz, 1H), 4.07 (m, 1H), 3.92 (ddd, J = 11.7 Hz, J = 4.4 Hz, J = 
2.4 Hz, 1H), 3.81 (s, 3H), 3.76 (m, 1H), 3.48 (d, J = 8.6 Hz, 1H), 3.13 (dd, J = 14.7 Hz, J = 4.2 
Hz, 1H), 2.37 (dd, J = 14.7 Hz, J = 10.5 Hz, 1H), 1.87 (t, J = 4.6 Hz, 1H); 13C NMR for major 
diastereomer (150 MHz, CDCl3) δ 174.9, 159.2, 138.1, 130.7, 128.7, 128.5, 128.4, 126.4, 119.3 
(q, JC-F = 323 Hz), 114.5, 68.0, 64.0, 55.3, 48.0, 44.3, 31.4; 19F NMR for major diastereomer 
(564 MHz, CDCl3) δ -74.8 (s); IR (thin film, cm-1) 3565, 3031, 2957, 1769, 1612, 1515, 1406, 
1211, 1142, 1035, 829, 734, 700, 621; LRMS (EI/GC-MS): m/z calculated for C20H20F3NO5S 
[M]+ 443.10, found 443.15 
4-benzyl-3-(4-methoxyphenyl)-5-oxo-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-yl)methyl 
acetate (4u) 
 
The average yield for the title compound was 52% (2 trials) at the 0.5 mmol scale, generated 
using 2 equivalents (E)-3-(4-methoxyphenyl)allyl acetate 2n, 1 equivalent N-sulfonylamide 3d, 
and an irradiation time of 25 hours.  Average lactam/imidate ratio as observed by crude 1H 
NMR: 3:1.  The title compound was produced as a 5:1 mixture of separable diastereomers and 
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isolated by column chromatography on silica gel (20% to 35% Et2O/pentane) as a colorless oil. 
Analytical data for 4u:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.19 (m, 3H), 6.88 (m, 4H), 6.82 (m, 
2H), 4.41 (m, 2H), 4.32 (dd, J = 11.2 Hz, J = 2.3 Hz, 1H), 3.81 (s, 3H), 3.54 (ddd, J = 10.4 Hz, J 
= 8.5 Hz, J = 4.1 Hz, 1H), 3.32 (d, J = 8.5 Hz, 1H), 3.16 (dd, J = 14.7 Hz, J = 4.1 Hz, 1H), 2.38 
(dd, J = 14.7 Hz, J = 10.5 Hz, 1H), 2.09 (s, 3H); 13C NMR for major diastereomer (150 MHz, 
CDCl3) δ 174.0, 170.0, 159.5, 137.8, 129.8, 128.53, 128.47, 126.7, 119.2 (q, JC-F = 323 Hz), 
114.6, 65.1, 64.7, 55.3, 48.0, 44.3, 31.3, 20.7; 19F NMR for major diastereomer (564 MHz, 
CDCl3) δ -74.5 (s); IR (thin film, cm-1) 3487, 3031, 2959, 2840, 1774, 1751, 1613, 1516, 1408, 
1218, 1142, 1045, 829, 700, 620; LRMS (EI/GC-MS): m/z calculated for C22H22F3NO6S [M]+ 
485.11, found 485.20 
2-((4-benzyl-3-(4-methoxyphenyl)-5-oxo-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-
yl)methyl)isoindoline-1,3-dione (4v) 
 
The average yield for the title compound was 42% (2 trials) at the 0.5 mmol scale, generated 
using 2 equivalents (E)-2-(3-(4-methoxyphenyl)allyl)isoindoline-1,3-dione 2o, 1 equivalent N-
sulfonylamide 3d, and an irradiation time of 24 hours.  Average lactam/imidate ratio as observed 
by crude 1H NMR: 2.9:1.  The title compound was produced as a 5.7:1 mixture of separable 
diastereomers and isolated by column chromatography on silica gel 20% to 40% Et2O/pentane) 
as a white solid. Analytical data for 4v:  
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1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.85 (m, 2H), 7.75 (m, 2H), 7.17 (m, 
3H), 6.86 (d, J = 6.5 Hz, 2H), 6.77 (s, 4H), 4.49 (dd, J = 8.4 Hz, J = 5.3 Hz, 1H), 4.18 (dd, J = 
14.0 Hz, J = 5.3 Hz, 1H), 4.06 (dd, J = 14.0 Hz, J = 8.4 Hz, 1H), 3.76 (s, 3H), 3.56 (ddd, J = 9.8 
Hz, J = 8.1 Hz, J = 4.9 Hz, 1H), 3.36 (d, J = 8.0 Hz, 1H), 3.14 (dd, J = 14.8 Hz, J = 4.8 Hz, 1H), 
2.44 (dd, J = 14.8 Hz, J = 9.8 Hz, 1H); 13C NMR for major diastereomer (150 MHz, CDCl3) 
δ 173.6, 167.9, 159.3, 137.4, 134.5, 131.4, 128.6, 128.5, 128.43, 128.4, 126.6, 123.8, 119.2 (q, 
JC-F = 323 Hz), 114.4, 64.7, 55.3, 46.3, 43.9, 40.0, 31.1; 19F NMR for major diastereomer (564 
MHz, CDCl3) δ -74.2 (s); 1H NMR for minor diastereomer (600 MHz, CDCl3): δ 7.65 (s, 4H), 
7.23 – 6.89 (m, 7H), 6.56 (d, J = 8.6 Hz, 2H), 4.66 (dd, J = 8.1 Hz, J = 4.2 Hz, 1H), 4.16 (1H), 
3.93 (dd, J = 13.9 Hz, J = 7.9 Hz, 1H), 3.59 (s, 3H), 3.05 (m, 1H), 2.97 (m, 2H), 2.78 (dd, J = 
13.7 Hz, J = 4.0 Hz, 1H); 13C NMR for minor diastereomer (150 MHz, CDCl3) δ 173.4, 167.8, 
158.8, 136.3, 133.9, 131.4, 129.6, 129.4, 129.0, 126.8, 122.4, 119.2 (q, JC-F = 323 Hz), 114.3, 
62.7, 55.1, 52.2, 45.0, 40.7, 33.0; 19F NMR for minor diastereomer (564 MHz, CDCl3) δ -74.0 
(s); IR (thin film, cm-1) 3472, 2936, 1776, 1716, 1613, 1516, 1397, 1217, 1143, 1090, 1033, 911, 
829, 720, 617; LRMS (+ESI): m/z calculated for C28H23F3N2O6SNa [M+Na]+ 595.11, found 
595.45 
3-benzyl-4,4,5-trimethyl-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4w) 
 
The average yield for the title compound was 35% (2 trials) at the 0.5 mmol scale, generated 
using 3 equivalents 2-methyl-2-butene 2p, 1 equivalent N-sulfonylamide 3d, and an irradiation 
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time of 22 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 10:1.  The title 
compound was produced as a 1.7:1 mixture of difficult to separate diastereomers and isolated by 
column chromatography on silica gel (10% Et2O/pentane) as a tan/off-white oil. Analytical data 
for 4w:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.28 (m, 4H), 7.21 (m, 1H), 3.88 (q, J = 
6.7 Hz, 1H), 3.12 (dd, J = 14.5 Hz, J = 6.5 Hz, 1H), 2.79 (t, J = 6.6 Hz, 1H), 2.60 (dd, J = 14.5 
Hz, J = 6.8 Hz, 1H), 1.36 (d, J = 6.7 Hz, 3H), 1.14 (s, 3H), 0.89 (s, 3H); 13C NMR for major 
diastereomer (150 MHz, CDCl3) δ 173.5, 138.9, 128.8, 128.7, 126.7, 119.4 (q, JC-F = 324 Hz), 
66.6, 52.3, 40.7, 30.3, 23.1, 22.3, 16.7; 19F NMR for major diastereomer (564 MHz, CDCl3) δ  -
74.7 (s); 1H NMR for minor diastereomer (600 MHz, CDCl3): δ 7.24 (m, 5H), 3.89 (m, 1H), 
3.10 (m, 1H), 2.65 (m, 2H), 1.41 (d, J = 6.5 Hz, 3H), 0.96 (s, 3H), 0.93 (s, 3H); IR (thin film, 
cm-1) 2921, 1771, 1406, 1315, 1219, 1141, 1093, 993, 699, 611, 583; LRMS (EI/GC-MS): m/z 
calculated for C15H18F3NO3S [M]+ 349.10, found 349.10 
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3-benzyl-4,4-dimethyl-5-phenethyl-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-one (4x) 
 
The average yield for the title compound was 37% (2 trials) at the 0.5 mmol scale, generated 
using 3 equivalents (4-methylpent-3-en-1-yl)benzene 2q, 1 equivalent N-sulfonylamide 3d, and 
an irradiation time of 24 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 
7:1.  The title compound was produced as a 2.4:1 mixture of separable diastereomers and 
isolated by column chromatography on silica gel (5% to 10% Et2O/pentane) as a light pink oil. 
Analytical data for 4x:  
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1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.31 – 7.12 (m, 10H), 3.84 (dd, J = 7.0 
Hz, J = 4.3 Hz, 1H), 3.12 (dd, J = 14.5 Hz, J = 6.4 Hz, 1H), 2.85 (t, J = 6.6 Hz, 1H), 2.71 (m, 
2H), 2.61 (dd, J = 14.5 Hz, J = 6.7 Hz, 1H), 2.16 (m, 1H), 2.00 (m, 1H), 1.17 (s, 3H), 1.01 (s, 
3H); 13C NMR for major diastereomer (150 MHz, CDCl3) δ 173.9, 140.4, 138.8, 128.8, 128.7, 
128.6, 128.2, 126.7, 126.4, 119.5 (q, JC-F = 324 Hz), 70.2, 52.8, 41.9, 34.0, 33.1, 30.5, 23.7, 22.2;  
19F NMR for major diastereomer (564 MHz, CDCl3) δ -73.8 (s); 1H NMR for minor 
diastereomer (600 MHz, CDCl3): δ 7.27 (m, 4H), 7.20 (m, 6H), 3.80 (dd, J = 6.7 Hz, J = 4.2 Hz, 
1H), 3.05 (dd, J = 14.5 Hz, J = 7.3 Hz, 1H), 2.87 (ddd, J = 13.9 Hz, J = 10.2 Hz, J = 5.5 Hz, 1H), 
2.71 (m, 2H), 2.57 (dd, J = 7.2 Hz, J = 5.9 Hz, 1H), 2.34 (m, 1H), 1.99 (m, 1H), 1.02 (s, 3H), 
0.98 (s, 3H); 13C NMR for minor diastereomer (150 MHz, CDCl3) δ 174.6, 140.4, 138.6, 128.8, 
128.7, 128.6, 128.4, 126.7, 126.4, 70.3, 56.3, 41.3, 34.2, 31.6, 31.4, 26.0, 16.8; 19F NMR for 
minor diastereomer (564 MHz, CDCl3) δ -74.8 (s); IR (thin film, cm-1) 2925, 2359, 1774, 1496, 
1456, 1405, 1211, 1138, 1090, 699, 609; LRMS (EI/GC-MS): m/z calculated for C22H24F3NO3S 
[M]+ 439.14, found 439.20 
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3-benzyl-4-methyl-4-(2-methylprop-1-en-1-yl)-1-((trifluoromethyl)sulfonyl)pyrrolidin-2-
one (4y) 
 
The average yield for the title compound was 35% (2 trials) at the 0.5 mmol scale, generated 
using 1 equivalents 2,4-dimethyl-1,3-pentadiene 2r, 1 equivalent N-sulfonylamide 3d, and an 
irradiation time of 21 hours.  Average lactam/imidate ratio as observed by crude 1H NMR: 
11.2:1.  The title compound was produced as a 6.8:1 mixture of separable diastereomers and 
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isolated by column chromatography on silica gel (10% Et2O/pentane) as a colorless oil. 
Analytical data for 4y:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.30 – 7.18 (m, 5H), 5.01 (p, J = 1.4 Hz, 
1H), 3.90 (d, J = 10.0 Hz, 1H), 3.77 (d, J = 10.0 Hz, 1H), 3.08 (dd, J = 14.4 Hz, J = 7.3 Hz, 1H), 
2.90 (dd, J = 7.3 Hz, J = 5.7 Hz, 1H), 2.71 (dd, J = 14.4 Hz, J = 5.7 Hz, 1H), 1.65 (d, J = 1.3 Hz, 
3H), 1.59 (d, J = 1.4 Hz, 3H), 1.30 (s, 3H); 13C NMR for major diastereomer (150 MHz, CDCl3) 
δ 172.7, 138.6, 136.5, 129.0, 128.6, 126.6, 126.0, 119.5 (q, JC-F = 323 Hz), 58.3, 56.0, 41.3, 30.7, 
27.3, 20.2, 19.5; 19F NMR for major diastereomer (564 MHz, CDCl3) δ  -75.3 (s); IR (thin film, 
cm-1) 2919, 1776, 1496, 1456, 1410, 1215, 1139, 1096, 1052, 984, 700, 613, 580; LRMS 
(EI/GC-MS): m/z calculated for C17H20F3NO3S [M]+ 375.11, found 375.30 
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Synthesis of Pyrrolidine Heterocycles by Polar Radical Crossover Cyclization 
General Procedure C: Synthesis of Substituted Pyrrolidines.  
 
In a typical procedure, a 1-dram vial was equipped with a magnetic stir bar, photoredox catalyst 
1d (12.3 mg, 0.025 mmol, 5 mol%), phenyl disulfide (38.5 mg, 0.1 mmol, 20 mol%), and tert-
butyl cinnamylcarbamate 8 (116.7 mg, 0.5 mmol, 1.0 equiv.). The vial was taken under an inert 
atmosphere where CHCl3 (2.0 mL) was added as the solvent to a concentration of approximately 
0.25 M. The alkene substrate (1.5 mmol, 3.0 equiv.) was added via microsyringe. The vial was 
sealed with a Teflon-coated septum cap, and the reaction mixture was irradiated (450 nm) for 24-
48 hours. Upon completion, the crude reaction mixtures were concentrated to a thick oil. The 
Boc-protected products were isolated by silica gel chromatography using a gradient of 2% to 
10% EtOAc/Hexanes as the eluent (Rf = ~0.2 in 10% EtOAc as revealed by CAM stain). The 
collected fractions were concentrated to a thick pale-yellow oil. The oil was diluted in 
dichloromethane, transferred to a pre-tared scintillation vial, and the solvent evaporated. 
Dichloromethane (2.0 mL) was added along with trifluoroacetic acid (300 µL, 3.9 mmol, 8.0 
equiv.), the solution was then stirred at room temperature, and the course of the reaction 
monitored by TLC. The crude reaction mixture was transferred to a separatory funnel containing 
8.0 mL of dichloromethane. The organic phase was washed with 3x 5mL of a saturated sodium 
bicarbonate (NaHCO3) solution and dried over Na2SO4. The pyrrolidine product was recovered 
upon solvent evaporation as a thick oil. 
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4-benzyl-2-methyl-3-phenylpyrrolidine (9a) 
 
The title compound was prepared and isolated according to General Procedure C using β-
methylstyrene (2a). The average isolated yield for the title compound was 51% (two trials) at the 
0.5 mmol scale after 24 hours. The title compound was recovered as an inseparable mixture of 
two diastereomers in a 3:1 d.r. Analytical data for 9a: 
1H NMR (600 MHz, CDCl3) δ 7.40 – 7.32 (m, 3H), 7.31 – 7.20 (m, 9H), 7.19 – 7.13 (m, 3H), 
7.12 – 7.08 (m, 2H), 7.06 – 7.00 (m, 3H), 3.64 – 3.55 (m, 1H), 3.28 – 3.13 (m, 3H), 3.02 – 2.91 
(m, 2H), 2.89 – 2.79 (m, 2H), 2.78 – 2.69 (m, 1H), 2.69 – 2.60 (m, 1H), 2.53 (dd, J = 13.6, 10.1 
Hz, 1H), 2.36 (dd, J = 13.8, 4.7 Hz, 1H), 2.31 (dd, J = 9.6 Hz, 1H), 2.20 (dd, J = 13.8, 11.1 Hz, 
1H), 1.29 (s, 1H), 1.25 (d, J = 6.2 Hz, 3H), 1.14 (d, J = 6.2 Hz, 3H); 13C NMR (151 MHz, 
CDCl3) δ 141.4, 141.1, 140.5, 140.5, 129.1, 128.7, 128.6, 128.6, 128.5, 128.3, 128.2, 128.2, 
128.2, 128.0, 126.6, 126.3, 125.9, 125.7, 62.8, 61.0, 59.4, 56.7, 52.0, 51.1, 49.9, 45.8, 39.5, 36.7, 
30.9, 29.7, 20.6, 19.2; IR (thin film, cm-1) 3375, 3060, 3026, 2959, 2923, 1947, 1806, 1642, 
1601, 1587, 1542, 1494, 1453, 1408, 1375; LRMS (EI/GC-MS): m/z calculated for C18H21N 
[M]+ 251.17, found 251.25 
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4-benzyl-3-(4-chlorophenyl)-2-methylpyrrolidine (9b) 
 
The title compound was prepared and isolated according to General Procedure C using β-
methyl-4-chlorostyrene (2b). The average isolated yield for the title compound was 38% (two 
trials) at the 0.5 mmol scale after 24 hours. The title compound was recovered as an inseparable 
mixture of two diastereomers in a 3:1 d.r. Analytical data for 9b: 
1H NMR (600 MHz, CDCl3) δ 7.36 – 7.26 (m, 5H), 7.26 – 7.20 (m, 4H), 7.20 – 7.12 (m, 5H), 
7.11 – 7.05 (m, 2H), 7.04 – 6.98 (m, 2H), 3.61 – 3.46 (m, 1H), 3.28 – 3.13 (m, 2H), 2.99 – 2.87 
(m, 2H), 2.85 – 2.76 (m, 2H), 2.76 – 2.68 (m, 1H), 2.64 – 2.51 (m, 1H), 2.50 – 2.41 (m, 2H), 
2.33 (dd, J = 13.8, 4.9 Hz, 2H), 2.27 (dd, J = 9.3 Hz, 2H), 2.19 (dd, J = 13.8, 10.8 Hz, 1H), 1.28 
(s, 1H), 1.23 (d, J = 6.2 Hz, 3H), 1.11 (d, J = 6.2 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 140.7, 
140.2, 139.1, 132.2, 132.1, 130.3, 129.2, 128.7, 128.5, 128.5, 128.4, 128.3, 128.2, 126.0, 125.8, 
62.9, 60.3, 59.6, 56.0, 52.1, 51.1, 50.0, 45.5, 39.5, 36.6, 30.9, 29.7, 20.6, 19.1; IR (thin film, cm-
1) 3420, 2923, 1646, 1558, 1540, 1492, 1455, 1411; LRMS (EI/GC-MS): m/z calculated for 
C18H20ClN [M]+ 285.13, found 285.20 
4-benzyl-2-methyl-3-(p-tolyl)pyrrolidine (9c)  
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The title compound was prepared and isolated according to General Procedure C using β-
methyl-4-methylstyrene (2e). The average isolated yield for the title compound was 65% (two 
trials) at the 0.5 mmol scale after 24 hours. The title compound was recovered as an inseparable 
mixture of two diastereomers in a 3:1 d.r. Analytical data for 9c: 
1H NMR (600 MHz, CDCl3) δ 7.27 – 7.21 (m, 4H), 7.20 – 7.13 (m, 10H), 7.12 – 7.09 (m, 2H), 
7.07 – 7.02 (m, 2H), 3.62 – 3.50 (m, 1H), 3.24 – 3.13 (m, 3H), 2.95 – 2.88 (m, 2H), 2.87 – 2.79 
(m, 2H), 2.74 – 2.66 (m, 1H), 2.65 – 2.58 (m, 1H), 2.50 (dd, J = 13.5, 10.1 Hz, 1H), 2.41 – 2.35 
(m, 7H), 2.27 (dd, J = 9.6 Hz, 1H), 2.19 (dd, J = 13.8, 11.2 Hz, 1H), 1.38 (s, 1H), 1.24 (d, J = 6.3 
Hz, 3H), 1.13 (d, J = 6.2 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 141.3, 140.8, 138.5, 137.6, 
136.1, 135.8, 129.3, 129.0, 128.9, 128.8, 128.7, 128.3, 128.2, 127.9, 125.9, 125.7, 62.8, 60.7, 
59.5, 56.4, 52.2, 51.2, 49.9, 45.9, 39.5, 36.8, 30.9, 21.1, 21.1, 20.8, 19.4; IR (thin film, cm-1) 
3648, 3324, 2084, 3024, 2958, 2921, 1899, 1800, 1646, 160, 1582, 1540, 1513, 1496, 1453, 
1418, 1375; LRMS (EI/GC-MS): m/z calculated for C19H23N [M]+ 265.18, found 265.20 
3-benzyl-1,2,3,3a,8,8a-hexahydroindeno[2,1-b]pyrrole (9d) 
 
The title compound was prepared and isolated according to General Procedure C using indene 
(2h). The average isolated yield for the title compound was 53% (two trials) at the 0.5 mmol 
scale after 24 hours. The title compound was recovered as an inseparable mixture of two 
diastereomers in a 2.5:1 d.r. Analytical data for 9d: 
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1H NMR (600 MHz, CDCl3) δ 7.43 – 7.34 (m, 1H), 7.34 – 7.26 (m, 5H), 7.26 – 7.17 (m, 9H), 
7.16 – 7.12 (m, 1H), 7.12 – 7.07 (m, 1H), 6.67 (d, J = 7.5 Hz, 1H), 4.44 – 4.34 (m, 1H), 4.11 (dd, 
J = 7.3 Hz, 1H), 3.87 (dd, J = 8.2 Hz, 1H), 3.46 (dd, J = 7.2, 3.9 Hz, 1H), 3.37 (dd, J = 17.3, 8.7 
Hz, 1H), 3.24 (dd, J = 17.0, 7.3 Hz, 1H), 3.15 – 3.02 (m, 2H), 2.95 – 2.84 (m, 4H), 2.74 – 2.67 
(m, 1H), 2.67 – 2.56 (m, 1H), 2.48 (dd, J = 10.5 Hz, 2H), 2.34 – 2 .22 (m, 2H), 1.30 (s, 1H); 13C 
NMR (151 MHz, CDCl3) δ 145.9, 143.9, 141.7, 141.5, 141.1, 129.0, 128.5, 128.5, 128.4, 128.4, 
126.9, 126.8, 126.7, 126.4, 126.1, 126.0, 125.8, 125.0, 124.6, 63.3, 62.8, 56.0, 53.4, 52.8, 51.2, 
50.3, 46.6, 41.4, 40.8, 39.4, 36.2, 30.9, 29.7;  IR (thin film, cm-1) 3420, 3024, 2921, 1636, 1540, 
1494, 1480, 1455; LRMS (EI/GC-MS): m/z calculated for C18H19N [M]+ 249.15, found 249.15 
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4-benzyl-2,3,3-trimethylpyrrolidine (9e) 
 
The title compound was prepared and isolated according to General Procedure C using 2-
methyl-2-butene (2p). The average isolated yield for the title compound was 20% (two trials) at 
the 0.5 mmol scale after 24 hours. The title compound was recovered as an inseparable mixture 
of two diastereomers in a 3.4:1 d.r. Analytical data for 9e: 
1H NMR (600 MHz, CDCl3) δ 7.25 (m, 5H), 4.94 (br s, 1H), 4.19 (m, 1H), 3.61 (m, 1H), 3.23 
(ddd, J = 13.9 Hz, J = 7.9 Hz, J = 5.3 Hz, 1H), 3.08 (dd, J = 14.3 Hz, J = 5.6 Hz, 1H), 2.96 (dd, J 
= 14.3 Hz, J = 8.2 Hz, 1H), 1.43 (br s, 15H); 13C NMR (151 MHz, CDCl3) δ 155.7, 136.9, 
129.3, 128.5, 127.0, 79.8, 70.5, 63.1, 53.4, 46.6, 42.0, 34.7, 29.7, 28.3, 28.2  
Imidate Characterization 
N-(3-benzyl-5-methyl-4-phenyldihydrofuran-2(3H)-ylidene)-1,1,1-
trifluoromethanesulfonamide (5a) 
 
Byproduct/competing pathway in the pyrrolidinone forming polar radical cyclization reaction 
(representing part of the mass balance). The above pictured imidate was generated using 
General Procedure B, an irradiation time of 24 hours, β-methylstyrene 2a as the substrate, and 
nucleophile 3d.  Appreciable amounts were isolated for characterization, epimerization, and 
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hydrolysis by using MeCN in place of CHCl3. The title compound was produced as a 10:1 
mixture of inseparable diastereomers and isolated by column chromatography on silica gel (10% 
to 20% Et2O/pentane gradient) as a white solid.  Analytical data for 5a:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.32 (m, 3H), 7.18 (m, 3H), 7.11 (m, 
2H), 7.04 (m, 2H), 4.78 (m, 1H), 3.60 (m, 1H), 3.08 (dd, J = 14.4 Hz, J = 5.1 Hz, 1H), 2.96 (dd, 
J = 14.4 Hz, J = 6.0 Hz, 1H), 2.92 (dd, J = 11.7 Hz, J = 9.8 Hz, 1H), 1.38 (d, J = 6.2 Hz, 3H); 
13C NMR for major diastereomer (150 MHz, CDCl3) δ 179.3, 136.0, 134.8, 129.5, 129.3, 128.5, 
128.3, 127.7, 127.0, 119.0 (q, JC-F = 319 Hz), 90.0, 54.2, 52.7, 34.0, 18.2;  19F NMR for major 
diastereomer (564 MHz, CDCl3) δ -79.2 (s);  1H NMR for minor diastereomer (600 MHz, 
CDCl3, some obscured): δ 7.32 (m, 3H), 7.18 (m, 3H), 7.11 (m, 2H), 7.04 (m, 2H), 4.37 (m, 1H), 
3.21 (m, 1H), 3.08 (m, 1H), 2.94 (m, 1H), 2.78 (m, 1H), 1.22 (d, J = 6.1 Hz, 3H); 13C NMR for 
minor diastereomer (150 MHz, CDCl3) obscured by major diastereomer and baseline. Selected 
peaks δ 176.8, 81.1, 54.3, 49.5, 33.6, 18.5; 19F NMR for minor diastereomer (564 MHz, CDCl3) 
δ -79.2 (obscured by major diastereomer signal); IR (thin film, cm-1) 3433, 2110, 1638, 1456, 
1360, 1204, 1131, 1051, 699, 635; LRMS (EI/GC-MS): m/z calculated for C19H18F3NO3S [M]+ 
397.10, found 397.15 
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1,1,1-trifluoro-N-(3-(2-methoxybenzyl)-5-methyl-4-phenyldihydrofuran-2(3H)-
ylidene)methanesulfonamide (5c) 
 
Byproduct/competing pathway in the pyrrolidinone forming polar radical cyclization reaction 
(representing part of the mass balance). The title compound was generated using General 
Procedure B with β-methylstyrene 2a, nucleophile 3f, and an irradiation time of 24 hours (main 
observable byproduct/competing pathway). The title compound was produced as a mixture of 
inseparable diastereomers and isolated by column chromatography on silica gel (10% to 20% 
Et2O/pentane). Analytical data for 5c:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.18 (m, 3H), 7.04 (m, 2H), 6.93 (m, 
2H), 6.75 (m, 1H), 6.49 (m, 1H), 4.74 (m, 1H), 3.83 (dt, J = 11.8 Hz, J = 6.9 Hz, 1H), 3.56 (s, 
3H), 3.16 (dd, J = 13.9 Hz, J = 6.9 Hz, 1H), 2.88 (dd, J = 11.7 Hz, J = 9.9 Hz, 1H), 2.84 (dd, J = 
13.9 Hz, J = 7.1 Hz, 1H), 1.42 (d, J = 6.1 Hz, 3H); 13C NMR for major diastereomer (150 MHz, 
CDCl3) δ 180.5, 157.2, 135.4, 131.3, 128.6, 128.4, 127.7, 127.6, 124.5, 120.2, 118.9 (q, JC-F = 
320 Hz), 109.6, 90.1, 55.6, 54.6, 50.1, 31.3, 18.4; 19F NMR for major diastereomer (564 MHz, 
CDCl3) δ -79.3 (s); IR (thin film, cm-1) 3447, 1634, 1496, 1358, 1247, 1200, 1132, 1050, 838, 
754, 635; LRMS (EI/GC-MS): m/z calculated for C20H20F3NO4S [M]+ 427.11, found 427.20 
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N-(3-cyclohexyl-5-methyl-4-phenyldihydrofuran-2(3H)-ylidene)-1,1,1-
trifluoromethanesulfonamide (5d) 
 
Byproduct/competing pathway in the pyrrolidinone forming polar radical cyclization reaction 
(representing part of the mass balance). The title compound was generated using General 
Procedure B with β-methylstyrene 2a, nucleophile 3g, and an irradiation time of 24 hours (main 
observable byproduct/competing pathway). The title compound was isolated as one diastereomer 
(presumably the major) by column chromatography on silica gel (10% to 20% Et2O/pentane). 
Analytical data for 5d:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.38 (m, 2H), 7.32 (m, 1H), 7.23 (m, 
2H), 4.73 (dq, J = 9.7 Hz, J =6.1 Hz, 1H), 3.26 (dd, J = 11.6 Hz, J =3.6 Hz, 1H), 3.11 (dd, J = 
11.7 Hz, J = 9.7 Hz, 1H), 1.85 (m, 1H), 1.73 (m, 1H), 1.61 (m, 2H), 1.56 (m, 1H), 1.47 (d, J = 
6.2 Hz, 3H), 1.44 (1H), 1.29 (qd, J = 12.4 Hz, J = 3.6 Hz, 1H), 1.17 (m, 2H), 1.03 (m, 1H), 0.88 
(m, 1H); 13C NMR for major diastereomer (150 MHz, CDCl3) δ 179.5, 136.5, 129.4, 128.3, 
127.7, 118.9 (q, JC-F = 319 Hz), 90.0, 56.6, 52.0, 38.2, 30.2, 28.8, 26.4, 26.2, 26.0, 18.3; 19F 
NMR for major diastereomer (564 MHz, CDCl3) δ -79.4 (s); IR (thin film, cm-1) 3434, 1635, 
1361, 1199, 1130, 913, 742; LRMS (EI/GC-MS): m/z calculated for C18H22F3NO3S [M]+ 389.13, 
found 389.20 
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N-(3-benzyl-3,5-dimethyl-4-phenyldihydrofuran-2(3H)-ylidene)-1,1,1-
trifluoromethanesulfonamide (5g) 
 
Byproduct/competing pathway in the pyrrolidinone forming polar radical cyclization reaction 
(representing part of the mass balance).  The title compound was generated using General 
Procedure B with β-methylstyrene 2a, nucleophile 3j, and an irradiation time of 24 hours (main 
observable byproduct/competing pathway). The title compound was isolated as one diastereomer 
(presumably the major) by column chromatography on silica gel (10% Et2O/pentane). Analytical 
data for 5g:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.42 (m, 3H), 7.19 (m, 5H), 6.89 (m, 
2H), 5.35 (m, 1H), 3.25 (d, J = 11.0 Hz, 1H), 2.87 (d, J = 13.8 Hz, 1H), 2.27 (d, J = 13.8 Hz, 
1H), 1.55 (d, J = 6.2 Hz, 3H), 1.24 (s, 3H); 13C NMR for major diastereomer (150 MHz, CDCl3) 
δ 181.0, 133.9, 132.0, 130.7, 129.1, 128.9, 128.6, 128.0, 127.1, 84.1, 60.8, 51.9, 39.9, 21.7, 18.7 
(-SO2CF3 obscured by baseline); 19F NMR for major diastereomer (564 MHz, CDCl3) δ -79.5 
(s); IR (thin film, cm-1) 3445, 1635, 1455, 1358, 1207, 1132, 1051, 912, 701; LRMS (EI/GC-
MS): m/z calculated for C20H20F3NO3S [M]+ 411.11, found 411.15 
Product Confirmation Through Lactam and Imidate Confirmation 
Imidate Epimerization/Hydrolysis to Lactone 7 
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103 mg (0.26 mmol, 1 equiv.) N-Tf imidate product 5a was taken up in 600 µL of a 95/5 
DMF/H2O mixture (0.5 M) and stirred until dissolved/homogeneous. 12 µL DBU (0.08 mmol, 
30 mol%) was then added to the stirring mixture, then the reaction was stirred at room 
temperature for 48h.  After 48 hours, the crude reaction mixture was washed to remove DMF and 
passed through a silica gel plug (with DCM). The product was isolated after concentration and 
chromatography as a clear oil.  Quantitative yield of lactone 7 was achieved in a >20:1 d.r. 
favoring the trans/trans lactone diastereomer (inversion of cis/trans imidate cyclization adduct 
above). Spectral data were in agreement with literature values.13 Analytical data for 7: 
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.30 (m, 2H), 7.25 (m, 1H), 7.18 (m, 
2H), 7.13 (m, 3H), 7.07 (m, 2H), 4.37 (dq, J = 9.6, 6.1 Hz, 1H), 3.20 (m, 1H), 3.09 (dd, J = 14.2, 
5.2 Hz, 1H), 2.92 (dd, J = 14.2, 5.8 Hz, 1H), 2.78 (dd, J = 12.2, 9.6 Hz, 1H), 1.22 (d, J = 6.1 Hz, 
3H); 13C NMR for major diastereomer (150 MHz, CDCl3) δ 176.7, 137.2, 136.9, 129.6, 129.0, 
128.3, 127.8, 127.7, 126.6, 81.1, 54.3, 49.5, 33.6, 18.5; IR (thin film, cm-1) 3443, 2927, 2109, 
1770, 1645, 1496, 1455, 1387, 1333, 1178, 1075, 760, 698; LRMS (EI/GC-MS): m/z calculated 
for C18H18O2 [M]+ 266.13, found 266.10 
Imidate 5a Epimerizaiton. Followed procedure below for lactam epimerization as opposed to 
imidate epimerization/hydrolysis above.  Incomplete epimerization of the α-stereocenter was 
observed (of the cis/trans diastereomer), from 10:1 d.r. to 1.6:1 d.r. 
 
N-Sulfonyl Lactam Epimerization and Deprotection to Lactam 6 
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Epimerization. 1.03 g (2.6 mmol, 1 equiv.) N-Tf lactam 4a was taken up in 8.5 mL dry DCM 
(0.3 M) and stirred until dissolved/homogeneous. 116 µL DBU (0.78 mmol, 30 mol%) was then 
added to the stirring mixture, then the reaction was stirred at room temperature for 48h.  After 48 
hours, the crude reaction mixture was passed through a silica gel plug (with DCM) and the 
product was isolated after concentration.  Yield: 0.931 g (93%), 10:1 d.r. as an off-white/tan oil, 
favoring the trans/trans diastereomer (inversion of cis/trans cyclization adduct above). 
1H NMR for major diastereomer (600 MHz, CDCl3) 4a’: δ 7.35 (m, 3H), 7.20 (m, 3H), 7.13 (m, 
2H), 7.04 (m, 2H), 4.14 (m, 1H), 3.20 (m, 1H), 3.08 (dd, J = 14.3 Hz, J = 5.0 Hz, 1H), 2.88 (dd, 
J = 14.3 Hz, J = 5.8 Hz, 1H), 2.70 (dd, J = 11.5 Hz, J = 8.7 Hz, 1H), 1.31 (d, J = 6.1 Hz, 3H) 
 
Deprotection. The procedure used is a modified protocol reported by Prof. Gregory Fu in 2005. 
193 mg TiCl3 (1.25 mmol, 3 equiv.) and 58 mg Li0 (8.35 mmol, 20 equiv.) were dispensed into a 
flame dried round bottom flask (equipped with a stir bar) in a glove box (N2).  The flask was 
removed from the inert environment and the contents were suspended in 14 mL dry N2-sparged 
THF (0.03 M), stirred, and heated to 50 °C for 45 minutes.  The reaction was then cooled to 
room temperature, the N-Tf lactam (4a’, 166 mg, 0.42 mmol, 1 equiv.) was added dropwise via 
syringe in THF, and then the reaction was stirred at 40 °C for 3.5 hours.  After 3.5 hours, the 
reaction was allowed to stir at room temperature overnight (24 hours total).  The reaction was 
quenched by dropwise addition of saturated aqueous NaHCO3 followed by dilution with equal 
parts DI water and Et2O (similar to the Fu protocol referenced above) and the organic layer was 
separated.  The aqueous layer was then extracted three times with diethyl ether. The combined 
organics were washed with brine, dried with MgSO4, and concentrated to give the crude product.  
Free N-H lactam 6 was isolated by column chromatography on silica gel (50% EtOAc/Hexanes) 
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as a 10:1 mixture of diastereomers. Yield: 74.2 mg (67%) as an off-white oil that appeared to 
solidify upon freezing. Analytical data for 6:  
1H NMR for major diastereomer (600 MHz, CDCl3): δ 7.25 (m, 2H), 7.18 (m, 3H), 7.10 (m, 
5H), 6.61 (br s, 1H), 3.60 (dq, J = 8.4, 6.1 Hz, 1H), 3.04 (m, 2H), 2.90 (m, 1H), 2.61 (m, 1H), 
1.05 (d, J = 6.1 Hz, 3H); 13C NMR for major diastereomer (150 MHz, CDCl3) δ 177.2, 139.8, 
138.2, 129.7, 128.6, 128.1, 128.0, 127.0, 126.1, 55.9, 54.3, 51.0, 34.3, 19.9; IR (thin film, cm-1) 
3253, 3028, 2967, 2925, 2244, 1694, 1603, 1496, 1454, 1378, 1239, 910, 760, 732, 698; LRMS 
(EI/GC-MS): m/z calculated for C18H19NO [M]+ 265.15, found 265.20 
Pyrrolidine Stereochemical Assignment 
Lactam 6 Reduction to Pyrrolidine 9a’ 
 
To a flame dried round bottom flask equipped with a stir bar was added 15 mg (0.40 mmol, 1.9 
equiv.) lithium aluminum hydride.  The flask was purged with N2 and LAH suspended in 1 mL 
dry THF.  The suspension was stirred and 55 mg (0.21 mmol, 1 equiv.) N-H lactam 6 (in 0.5 mL 
dry THF) was added dropwise.  The reaction was refluxed overnight.  The next morning the 
reaction was quenched by the dropwise addition of 1 mL 2N NaOH, 1 mL DI H2O, and 3 mL 
saturated sodium potassium tartrate and diluted with diethyl ether.  The organic layer was 
separated and the aqueous layer was extracted three times with diethyl ether.  The combined 
organics were washed with brine, dried with MgSO4, and concentrated.  The product was not 
purified further however spectral data of the crude product matched those reported above for 
pyrrolidine cyclization product 9a. The shown pyrrolidine was formed as a 8:1 mixture of 
diastereomers (by crude NMR analysis) with the major diastereomer in this reaction matching 
N
HMe
Ph
Bn
O
1.5 equiv. LiAlH4
THF [0.15], reflux, 18h N
HMe
Ph
Bn
6 10:1 d.r. 9a' 8:1 d.r.
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the minor diastereomer in the pyrrolidine polar radical cyclization.  Likewise, the minor 
diastereomer in this LAH reduction matched the major diastereomer in the polar radical 
cyclization.  The stereochemistry of the major diastereomer in pyrrolidine-forming polar radical 
cyclization was thus assigned as the cis/trans diastereomer, in agreement with a Beckwith-type 
model for a 5-exo-trig radical C−C bond forming cyclization. 
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CHAPTER 4: APPLICATION OF A CATION RADICAL MEDIATED POLAR RADICAL CROSSOVER 
CYCLIZATION IN A RUBRIFLORDILACTONE B MODEL SYSTEM 
 Introduction 4.1
In the last chapter, the cation radical mediated polar radical crossover cyclization was 
introduced as a general strategy for O- and N-heterocycle synthesis from oxidizable alkenes and 
unsaturated nucleophiles. The transformation proceeds via visible light photoredox catalysis; 
employing an acridinium photooxidant and an H-atom donor cocatalyst and displays good 
flexibility with regard to oxidizable alkene and unsaturated nucleophile diversity. This chapter 
investigates the application of the polar radical crossover cyclization (PRCC) in target-oriented 
synthesis, specifically towards rubriflordilactone B (Figure 4.1). The development of a 
rubriflordilactone B model system is herein presented, using a PRCC to construct the central 
highly substituted tetrahydrofuran from indene (Figure 4.1). In addition to photoredox polar 
radical cyclizations, this chapter presents extensive work on a key Mukaiyama vinylogous aldol 
reaction (MVAR). This project is a collaborative effort among many in the Nicewicz lab and 
hopefully the work presented in this chapter will provide a solid foundation to enable the 
successful total synthesis of rubriflordilactone B utilizing photoredox catalysis. 
Figure 4.1 Rubriflordilactone B 
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 Rubriflordilactone B 4.2
The isolation and characterization of oxygenated bisnortriterpenoid natural product 
rubriflordilactone B was revealed in 2006 by Sun and coworkers.1 Rubriflordilactone B was 
isolated with related natural product, rubriflordilactone A, both extracted from the stems and 
leaves of deciduous vine Schisandra rubriflora, native to eastern India, western China, and 
southeast Asia  (Figure 4.2A). The biogenesis of rubriflordilactone A and B is proposed to occur 
from cycloartane, as both possess a bisnortriterpenoid backbone (Figure 4.2B).1 Subsequent 
oxygenation, aromatization, and rearrangement steps would generate the natural products. 
Figure 4.2 Rubriflordilactone family of natural products 
 
While Rubriflordilactones A and B share many structural features, one key difference 
sets them apart. Both share the western ABCDE fused ring system, possessing a lactone A ring 
as well as a central aromatic D ring, Rubriflordilactone A is unique in that it lacks the extra 
degree of unsaturation found in the C ring of rubriflordilactone B. Additionally, both share the 
exocyclic butenolide moiety (ring G). They key difference lies in oxygenation (Figure 4.2). 
Rubriflordilactone A possesses oxygenation at C12 of the arene D ring, forming a fused 
hexacyclic ABCDEF dihydrobenzopyran (F) core. Rubriflordilactone B on the other hand lacks 
oxygenation at C12 but possesses oxygenation at C16 of ring E, forming a unique linear fused 
hexacyclic ABCDEF system containing a highly decorated tetrahydrofuran F ring. The 
complexity of these targets alone makes them challenging but attractive targets for synthesis. 
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Additionally, both novel natural products were tested for cytotoxic activity against human 
tumor cells and for anti-HIV activity. While neither rubriflordilactone A or B displayed 
inhibitory activity against K562 cells (IC50 > 200 µg/mL), rubriflordilactone B displayed low 
cytotoxicity in human T cell leukemia cell line C8166 (CC50 = 120.7 µg/mL) and moderate anti-
HIV-1 activity (EC50 = 9.75 µg/mL, SI = 12.39).1 Rubriflordilactone B specifically is an 
appealing target to us because of its biological activity, its complexity, and its tetrahydrofuran-
containing core. This central tetrahydrofuran, bearing four contiguous stereocenters, maps well 
onto a tetrahydrofuran-forming polar radical crossover cyclization. 
 Background  4.3
While no total syntheses have been reported to date for rubriflordilactone B, we can glean 
insight from the successful total syntheses of related triterpenoid natural products 
rubriflordilactone A and schindilactone A, and the ABC ring synthesis of micrandilactone A. 
Also, a closer examination of PRCC tetrahydrofuran synthesis will be discussed. 
 Insight from the total synthesis of related bisnortriterpenoid natural products 4.3.1
The racemic total synthesis of polycyclic natural product schindilactone A was reported 
by Yang and coworkers in 2011,2 while an enantioselective synthesis of rubriflordilactone A was 
achieved by Li and coworkers in 2014.3 While key transformations in the routes leading to 
schindilactone A (Pauson-Khand reaction and a carbonylative annulation) and rubriflordilactone 
A (6π electrocyclization and a diastereoselective vinylogous aldol reaction) differ significantly, 
these routes are united in their approach to construct the ABC 5/5/7 fused ring system (Figure 
4.3).  
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Figure 4.3 Schindilactone A (2011), rubriflordilactone A (2014), micrandilactone A (2006) 
 
Synthesis of the ABC ring system proceeds as shown in Figure 4.4A, beginning with 
Grignard addition into ketone 1 (formed by Diels-Alder [4+2] cycloaddition) to form lactone 2. 
From here, enolate α-oxygenation followed by reduction and TES protection yields silyl ether 3. 
Formation of the key 7-member carbocycle proceeds through cyclopropanation of silyl enol ether 
3 followed by ring expansion to furnish enone 5, possessing the assembled BC ring system. 
From here the two routes diverge, but ultimately converge once again to form lactone A present 
in the final products. The schindilactone A synthesis progresses through a late-stage Sc(OTf)3-
catalyzed deprotection/acylation of 6 to give ester 7. Intramolecular Dieckmann condensation 
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The rubriflordilactone A synthesis relies on the same strategy, but earlier in the route (Figure 
4.4C). Lactone 8 is produced in two steps from 5 and Sc(OTf)3-catalyzed deprotection/acylation 
yields ester 9. Intramolecular Dieckmann condensation followed by Et3SiH/BF3•OEt2 reduction 
provides lactone 10, which is taken on to rubriflordilactone A in 8 steps.3 Micrandilactone A also 
contains a 5/5/7 ABC fused ring system (Figure 4.3), however the approach of Chen and Yang in 
the construction of this segment was notably different (Figure 4.4D).4 Grignard addition into 
Diels-Alder adduct 11 afforded bicyclic lactone 12 (B ring). Enolate oxidation followed by LAH 
reduction of the lactone to the lactol produced diol 13. Treating 13 with triethylphosphonoacetate 
produced tricyclic lactone 16 via a Horner-Wadsworth-Emmons (HWE) cyclization cascade 
O
O
O
MeMe H
HO
O
O
O
O
O
Me Me
O
Me
H
H
H
H
schindilactone A
O
O
O
MeMe H
H
rubriflordilactone A
O
O
O
Me
Me
H
H
H
A
B C
A
B C O
O
O
MeMe H
H
O
O
O
O
O
Me Me
O
Me
H
H
H
OH
micrandilactone A
A
B C
OH
H
OH
 198 
(through intermediates 14 and 15). Both strategies described for the construction of the ABC 
system could also be used in the synthesis of rubriflordilactone B as it shares a similar 5/5/7 
ABC fused ring system with the previously described natural products.  
Figure 4.4 Precedented construction of the western half 
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substituted tetrahydrofurans from oxidizable alkenes and allylic alcohols under photoredox 
conditions in 2013.5 The system utilized the acridinium perchlorate salt 17 as a photooxidant and 
2-phenylmalononitrile (2-PMN) as a redox active H-atom donor cocatalyst. In this reaction three 
bonds were formed: one C−O, one C−C, and one exocyclic C−H. Two examples shown suggest 
the viability of the method as a means to construct rubriflordilactone B: the example using 
indene as the alkene partner to form a tricyclic adduct with modest diastereoselectivity (Figure 
4.5A) and the example using 3-buten-2-ol as the unsaturated alcohol partner to form a fully 
substituted tetrahydrofuran (Figure 4.5B). The major adduct 18 formed from indene and allyl 
alcohol possesses a tricyclic structure with relative stereochemistry matching rubriflordilactone 
B (Figure 4.2). Additionally, the reaction between β-methylstyrene and 3-buten-2-ol, while only 
mildly diastereoselective, produced products with key 4,5-trans stereochemistry, with major 
diastereomer 20 matching the relative stereochemistry of rubriflordilactone B. 
Figure 4.5 Photoredox catalysis: tetrahydrofuran synthesis by polar radical crossover cyclization  
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Figure 4.6 THF PRCC as the key disconnect 
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the requisite formation of a functionalized cyclic precursor, on which butenolide addition occurs. 
Mapping this strategy onto rubriflordilactone B would require preformation of a polycyclic DEF 
lactone or lactol for siloxyfuran addition, and is thus less direct (Figure 4.7E).  
Figure 4.7 Alternative strategies for butenolide incorporation 
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from functionalized indene 28 and allylic alcohol syn-23. Peter Morse and myself are conducting 
work on this aspect of the project. We envision construction of syn-23 from known MVAR 
protocols and construction of 28 from indanone 29, which is readily accessible from 
dihydrocoumarin 30.11 Undergraduate researcher Hunter Ripberger is examining large-scale 
preparation of these precursors. 
Figure 4.8 Rubriflordilactone B reteosynthetic analysis 
 
 Early model system development 4.6
To test the feasibility of the proposed route we needed to examine the key step, 
tetrahydrofuran ring F synthesis, more thoroughly. We envisioned testing DEFG rings synthesis 
in a PRCC model system utilizing indene and syn-23 (Figure 4.9). 
Figure 4.9 DEFG rings PRCC model system 
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To efficiently construct allylic alcohol syn-23 we turned to the work of Brückner, Ohe, 
Evans, and many others in the field of vinylogous aldol chemistry (Figure 4.10), as we 
envisioned facile synthesis of syn-23 from siloxyfuran 1,2-addition into an aldehyde (e.g. 
acrolein). We were inspired by Brückner and Ohe’s work in MVAR methodology (Figure 
4.10A), as they showed 1,2-addition of siloxyfuran nucleophiles into decorated unsaturated 
aldehyde electrophiles and because they showed the ability to select for the syn or anti 
diastereomer of the alkenol product through judicious Lewis acid choice.12,13 For Brückner and 
Ohe, BF3•OEt2 was syn-selective, ZnBr2 was anti-selective, and competitive 1,4-addition was not 
observed (Figure 4.10A). Many other groups have also contributed to MVAR methodology 
(Figadère, Evans, and many others Figure 4.10B-C). Their pioneering work was also 
inspirational.14–22  
Figure 4.10 Established MVAR protocols using siloxyfuran nucleophiles 
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 Initial Lewis acid screen 4.6.1
We proceeded by screening MVAR conditions for reactivity between siloxyfuran TMS-
31 and acrolein to produce syn-23 (Table 4.1). Omitting a Lewis acid from the system (entry 1) 
unfortunately resulted in quantitative conversion to the conjugate addition product, 32 (showing 
the reactivity of both partners in this system). Following precedent set by Brückner and Ohe12 
(Figure 4.10A), we expected BF3•OEt2 to yield the desired syn aldol product (with yields that 
could be optimized). Unfortunately only decomposition was observed (entry 2). Even when 
employing the anti-selective Lewis acid ZnBr2 only trace yields of 23 were observed and 
decomposition was predominant (entry 3). Titanium-based Lewis acids were markedly better in 
this system, producing isolable amounts of 23 together with 32 (entries 4-8). Decomposition was 
still the dominant pathway for TiCl4, however the aldol and Michael adducts were produced in 
isolable amounts, in a 1:3 ratio (entry 4). Moving to alkoxy-substituted titanium Lewis acids, 23 
was produced in a 10% yield and 1:1 23/32 ratio with TiCl3(Oi-Pr) (entry 5) and the vinylogous 
aldol pathway was dominant with TiCl2(Oi-Pr)2 (entry 6). In this reaction, MVAR adduct 23 was 
produced in a 30% yield (5.7:1 d.r.) and selectivity ratio of 6:1 over conjugate addition. 
Continuing this trend to Ti(Oi-Pr)4 (entries 7 and 8) resulted in suppression of the vinylogous 
aldol pathway, TiCl2(Oi-Pr)2 appeared to be the superior Lewis acid for this system. The 1,4-
addition background reaction was further suppressed by replacing siloxyfuran nucleophile TMS-
31 with TBS-31 (entry 9), which also improved MVAR yield (42%), diastereoselectivity (6.5:1), 
and aldol/conjugate addition selectivity (7.2:1, entry 10). 
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Table 4.1 MVAR synthesis of 23 
 
While we succeeded in developing a moderately diastereoselective vinylogous aldol 
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tetrahydrofuran-forming cyclization. Yields of this product were highest with 2-PMN or 9-CNFl 
H-atom donors. Desired adduct 35 was not observed. 
Figure 4.11 PRCC with MVAR adduct 23 
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an initial cyclization of C positioning the exocyclic carbon-centered radical up (diastereomer of 
D), which would prevent the second cyclization event, were not observed.  
Figure 4.12 Divergence in product distribution arising from each nucleophile diastereomer 
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crystals were grown of its 4-chlorobenzoyl ester derivative, 36 (major diastereomer enriched 
through chromatography). The results showed conclusively that Lewis acid TiCl2(Oi-Pr)2 was 
selective for MVAR adduct anti-23 rather than the desired syn product (Figure 4.13). 
Furthermore, the reason the polycyclization PRCC adduct 34 was observed (and desired product 
35 was not observed) was because nucleophile anti-23 was participating in the cyclization 
(Figure 4.12B). If the minor syn aldol diastereomer was participating in the polar radical 
cyclization, these products were not produced in isolable amounts. 
Figure 4.13 Derivitization and structure confirmation by X-ray crystallography 
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Possessing definitive knowledge of the relative stereochemistry of 23, we elected to 
attempt formation of syn-23 from anti-23 (Figure 4.14). Inversion techniques (such as Mitsunobu 
inversion) to produce ester 37 (Figure 4.14A), which could cleave to syn-23 under mild 
conditions, were unsuccessful and only triene 38 was isolated, as a mixture of olefin isomers. 
This result is in line with literature precedent as Brückner used modified Mitsunobu conditions 
(lacking an exogenous nucleophile) to produce γ-alkylidenebutenolides in a stereospecific 
fashion from related MVAR products.12 We were successful, however, in isolating sufficient 
amounts of syn-23 using a less elegant strategy: DBU-catalyzed epimerization (to produce epi-
23) preceding diastereomer separation by chromatography (Figure 4.14B). In this process 
appreciable amounts of 23 were lost to elimination (up to 30%), forming 38, but through 
chromatography adequate quantities of syn-23 (5.3:1 d.r.) were isolated for testing. 
Figure 4.14 Attempts to product syn-23 from anti-23 
 
Subjecting syn-23 to PRCC with indene, catalyst 31, 2-PMN as the H-atom donor, and 4 
days irradiation resulted in isolation of two products: uncyclized product 33 in 15% and 
tetrahydrofuran 35 in 10% (Figure 4.15). We were elated to see that polycyclization product 34 
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was not isolated in this reaction; the only cycloadduct was desired product 35, produced as a 3:1 
mixture of diastereomers. 
Figure 4.15 PRCC with syn-23 
 
While the correct bonds were formed in the reaction shown in Figure 4.15 (matching the 
connectivity of rubriflordilactone B), NOESY experiments revealed stereochemical 
discrepancies between adduct 35 and rubriflordilactone B (Figure 4.16). Observed nOes between 
the C20-methyl group, C17-Ha, and C22-Hc suggest they are on the same face of the 
tetrahydrofuran core. Additional nOes between C17-Ha and C16-Hb (weak) and C16-Hb and 
C22-Hc further suggest ring junction stereochemistry that does not match rubriflordilactone B 
(Figure 4.16). The observed diastereoselectivity may be the result of steric clash between the 
arene and the methyl group in the desired configuration, favoring the diastereomer where they 
are positioned away from each other. Preliminary NOESY analysis of the minor diastereomer of 
35 suggests that this adduct may match the relative stereochemistry of rubriflordilactone B. To 
more closely examine this and explore the feasibility of overriding inherent diastereoselectivity, 
a strategy to reliably produce sufficient amounts of syn-23 is necessary. 
Figure 4.16 NOESY analysis of 35 
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 Attempts to invert MVAR diastereoselectivity 4.7
To develop a direct route to syn-23 we turned to a comprehensive Lewis acid screen in 
the Mukaiyama vinylogous aldol reaction between nucleophile TBS-31 and acrolein (Table 4.2). 
Employing metal/BOX (L1) and metal/PyBOX (L2) Lewis acids, syn diastereoselectivity was 
unfortunately not realized in the shown MVAR manifold. Diastereoselectivity ranged from 2:1 to 
3.1:1 anti/syn, excluding reactions where no vinylogous aldol products were observed (with 
Mg(OTf)2, Table 4.2 entry 5). NMR analysis of selected reactions using bisoxazoline ligand L1 
confirmed the anti/syn diastereoselectivities acquired through GC-MS analysis and furthermore 
showed that the reactions were only marginally selective for producing aldol product 23 over 
conjugate addition product 32 (entries 2, 4-5, 7-8, 10). Finally, as suggested by reports from 
others in the field, TBSOTf was capable of promoting the MVAR pathway (ligands L1 and L2 
excluded).20,22 While syn selective in other systems, TBSOTf was mildly anti selective in this 
system as well (1.7:1-2:1, entry 12). 
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Table 4.2 Initial Lewis acid screen for diastereoselectivity inversion 
 
As TiCl2(Oi-Pr)2 was so successful in this MVAR manifold, we next turned to more 
advanced titanium Lewis acids that displayed syn selectivity in other protocols that employed 
siloxyfuran nucleophiles (Table 4.3). After 4 hours the reactions were discontinued and 
displayed varying degrees of conversion (but yields of the desired product were universally low). 
Employing De Rosa’s Ti(R-BINOL)(Oi-Pr)2 procedure (entry 1), the system was still anti-
selective, but yields were depressed.16 Figadère’s procedures using Ti(R-BINOL)(Oi-Pr)2 or 
Ti(R-BINOL)2 were equally low yielding (entries 2-4).17 The one noteworthy result being the 
system described in Table 4.3 entry 3, which showed moderate syn diastereoselectivity. The 
yield of 23 however was very low at high substrate conversion and syn/anti selectivity was only 
23
O
OTBS
Me
10 mol% Lewis Acid
10 mol% L
DCM, -78 °C, 5 h
RO
O
Me
O
1.2 equiv.
O
Me
O+
O
H
H
O
+
TBS-31 32
Lewis AcidEntry L1 NMR analysis23 anti/synL1 (GC-MS)
23 anti/syn
L2 (GC-MS)
5 N/A 0% 23, 33% 32 N/A
8 2.2:1 9% 23 (2:1 d.r.)14% 32 2:1
9 2.2:1 -- 2:1
6 2.2:1 -- 2.2:1
7 ScOTf)3 2.2:1
16% 23 (2.2:1 d.r.)
10% 32 2.1:1
1 2.3:1 -- 2.1:1
4 2.1:1 20% 23 (1.9:1 d.r.)13% 32 2.5:1
2 2.3:1 21% 23 (2:1 d.r.)10% 32 2.1:1
3 2.1:1 -- 2.1:1
Bi(OTf)3
10 3.1:1 18% 23 (2.6:1 d.r.)10% 32 3.1:1
R = H, TBS
Cu(OTf)2
In(OTf)3
La(OTf)3
Mg(OTf)2
Sm(OTf)3
Sn(OTf)2
Yb(OTf)3
Zn(OTf)2
11 2.2:1 -- 3.1:1ZrCl4
N N
O O
N
N N
O O
t-Bu t-BuL1 L2
12 1.7:1 15% 23 (2:1 d.r.)<5% 32 --TBSOTf
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1.7:1, so this result was not pursued further. Enantioselectivity of the transformations shown in 
Table 4.2 and Table 4.3 was not measured, as the required diastereoselectivity was not achieved. 
Table 4.3 Titanium Lewis acid protocols 
 
We postulated that use of acrolein as the acceptor in this system may be a hindrance; the 
high reactivity of acrolein (and competing conjugate addition pathway) may prohibit the use of 
Lewis acids that would otherwise be syn-MVAR selective with less reactive acceptors (e.g. 
BF3•OEt2, Figure 4.10A and Table 4.1 entry 2). To test this, β-trimethylsilylacrylaldehyde 39 
was constructed and tested under known anti-selective and expected syn-selective conditions 
(Table 4.4). If syn diastereoselectivity was achieved, we envisioned post-MVAR (or post-PRCC) 
desilylation to produce the desired product (syn-23 or 35 respectively). Exploiting anti-selective 
Lewis acid TiCl2(Oi-Pr)2, a 45% yield of 40 (2:1 anti/syn) was realized along with 6% of 41 
(entry 1). BF3•OEt2 (entry 2), TBSOTf (entry 3), SnCl4 (entry 4), and Zn(OTf)2 (entry 5), all syn-
selective under certain MVAR conditions with certain aldehydes, were either unselective or 
selective for anti-40 in this manifold.12,20,22 
 
 
 
23
O
OTBS
Me
conditions
RO
O
Me
OO
H
+
TBS-31
R = H or TBS
Lewis AcidEntry Conditions Yield (NMR)anti/syn d.r.
1 3Å MS, 0.25 M THF, -78 °C 9%, 2.3:1
4 <5%, 1:1
2 3Å MS, 0.25 M DCM, -78 °C <5%, 1.2:1
3 7%, 1:1.7
10 mol % Ti(R-BINOL)(Oi-Pr)2
20 mol % Ti(R-BINOL)(Oi-Pr)2
20 mol % Ti(R-BINOL)2
20 mol % Ti(R-BINOL)2
1.5 equiv. TBS-31
0.25 M DCM, -78 °C
1.5 equiv. acrolein
0.25 M DCM, -78 °C
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Table 4.4 β-TMS acrylaldehyde 39 as an acrolein surrogate 
 
Around this time fellow graduate researcher Peter Morse joined the project and began 
exploring chiral titanium Lewis acids developed by Carreira for vinylogous aldol chemistry (42, 
Figure 4.17).24,25 Complex 42 and related titanium Lewis acids are noteworthy in that they are 
highly selective for 1,2-addition even when using low catalyst loadings and highly reactive 
acceptors such as acrolein or crotonaldehyde.24,26 A recent application of catalyst 42 with 
acrolein, disclosed by Bach, is shown below in Figure 4.17.26 
Figure 4.17 Carreira catalyst in 1,2-addition using acrolein 
 
To summarize work in this area, employing Carreira catalyst 42 in our system led to 
exciting results. While reaction between TMS-31 and acrolein led only formation of 32, reaction 
between TMS-31 and β-TMS acrylaldehyde 39 led to formation of aldol adduct 40 2:1 over 
conjugate addition adduct 41 (Figure 4.18A). Furthermore, syn-40 was the major MVAR 
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Lewis AcidEntry Yield (NMR) 40 anti/syn d.r.
1 45% 40, 6% 41 2:1
5 2.6:1
2 11% 40, 11% 41 1:1
3 1.4:1
1.2 equiv. TiCl2(Oi-Pr)2
1 equiv. BF3•OEt2
20 mol % TBSOTf
20 mol % Zn(OTf)2
17% 40, 0% 41
30% 40, <5% 41
4 1.4:120 mol % SnCl4 17% 40, 0% 41
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BrOTi
O
O
O
t-Bu
t-Bu
Carreira catalyst 42
O
OMe
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OTMS 1 mol% 39
Et2O, -5 °C
10% TFA/THF
1)
2)
O
OMe
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O
OH
85%, 94% ee
H
O
+
Bach, 2012:
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diastereomer, with a diastereomeric ratio of 5:1. Utilizing syn-40 in an exploratory polar radical 
crossover cyclization led to the isolation of cycloadduct 43 as the sole diastereomer (Figure 
4.18B). While ring junction stereochemistry and positioning of the alkylsilane were correct in 43, 
the butenolide moiety was on the incorrect face of the tetrahydrofuran (relative stereochemistry 
assigned by 1H NMR and NOESY analysis). Efforts are underway to explore this strategy further 
and to develop alternative strategies to arrive at the correct tetrahydrofuran adduct via a novel 
polar radical crossover cyclization. 
Figure 4.18 syn-40 selective MVAR with TMS-31 and enal 39; use in PRCC 
 
 Concluding remarks and future directions 4.8
In conclusion, we have presented work towards the total synthesis of nortriterpenoid 
rubriflordilactone B. A photoredox PRCC model system was developed utilizing indene and 
decorated allylic alcohol 23 to forge the DEFG system of rubriflordilactone B, and many efforts 
were spent optimizing Mukaiyama vinylogous aldol chemistry to reliably produce the desired 
allylic alcohol nucleophile for the polar radical cyclization. While this project is far from 
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complete, work presented in this chapter will hopefully be useful in the continued development 
of an improved PRCC model system and eventually the synthesis of rubriflordilactone B. 
Efforts in the near future will continue between Peter Morse and myself to optimize a 
syn-selective Mukaiyama vinylogous aldol reaction in order to rigorously test the 
tetrahydrofuran-forming PRCC for yield and diastereoselectivity. Additionally, alternative 
strategies such as exocyclic alkene hydrogenation will be explored to install correct relative 
stereochemistry (Figure 4.19). In this example, hydrogenation should occur from the convex face 
of the tricyclic species, producing the correct relative stereochemistry. Once a scalable and 
reliable method is found to access the desired substituted tetrahydrofuran F ring of 
rubriflordilactone B, work will focus on assembling rubriflordilactone B and incorporating the 
work of Hudson Roth and Hunter Ripberger. 
Figure 4.19 Alternative approach to DEFG synthesis 
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 Experimental details 4.9
General Methods. Proton and carbon nuclear magnetic resonance spectra (1H NMR, 13C NMR) 
were acquired on a Bruker model DRX 400 or AVANCE III 600 CryoProbe spectrometer (1H 
NMR at 400 MHz or 600 MHz and 13C NMR at 100 MHz or 150 MHz respectively). Chemical 
shifts for proton NMR are reported in parts per million downfield from tetramethylsilane and are 
referenced to residual protium in solvent (1H NMR: CHCl3 at 7.24 ppm). Chemical shifts for 
carbon NMR are reported in parts per million downfield from tetramethylsilane and are 
referenced to the carbon resonances of the solvent (13C NMR: CDCl3 at 77.0 ppm). NMR data 
are represented as follows: chemical shift, multiplicity (s = singlet, br s = broad singlet, d = 
doublet, dd = doublet of doublet, t = triplet, ddd = doublet of doublet of doublet, q = quartet, pent 
= pentet, m = multiplet, etc.), coupling constants (Hz), and integration. Mass spectra were 
obtained using a GC-MS (Agilent 6850 series GC equipped with Agilent 5973 network EI-MSD, 
method: 115 °C/3 min, 20 °C/min ramp, 275 °C/10 min). Analytical thin layer chromatography 
(TLC) was performed on SiliaPlate 250 µm thick silica gel plates purchased from Silicycle. 
Visualization was accomplished using fluorescence quenching, KMnO4 stain, or ceric 
ammonium molybdate (CAM) stain followed by heating. Organic solutions were concentrated 
under reduced pressure using a Büchi rotary evaporator. Purification of the reaction products was 
carried out by chromatography using Siliaflash-P60 (40-63 µm) or Siliaflash-T60 (5-20 µm) 
silica gel purchased from Silicycle. All reactions were carried out under an inert atmosphere of 
nitrogen in flame-dried glassware with magnetic stirring unless otherwise noted.  Irradiation of 
photochemical reactions was carried out using two 21W 455 nm PAR38 Royal Blue LED 
Aquarium lamps (five 455 nm Cree LEDs per lamp), purchased from Ecoxotic (model# 6851).  
Reactions were carried out in standard borosilicate glass vials purchased from Fisher Scientific.  
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Yield refers to isolated yield of analytically pure material unless otherwise noted.  NMR yields 
were determined using hexamethyldisiloxane, (Me3Si)2O, or mesitylene as an internal standard.  
Procedure for yield determination using (Me3Si)2O NMR internal standard: upon 
consumption of starting material (as determined by TLC), crude reaction mixture was passed 
through a short silica gel plug with DCM.  The crude mixture was concentrated and then taken 
up in deuterated NMR solvent (chloroform-d1, CDCl3).  A carefully measured amount of 
(Me3Si)2O was then added to the solution via micro syringe and a 1H NMR spectrum acquired. 
Materials. Commercially available reagents were purchased from Sigma Aldrich, Acros, Alfa 
Aesar, or TCI, and used as received unless otherwise noted. Diethyl ether (Et2O), 
dichloromethane (DCM), tetrahydrofuran (THF), toluene (PhMe), and dimethylformamide 
(DMF) were dried by passing through activated alumina columns under nitrogen prior to use. 
Other common solvents such as chloroform (CHCl3) and acetonitrile (MeCN), and reagents such 
as oxidation-prone aldehydes were purified by standard published methods when necessary.  
 
trimethyl((3-methylfuran-2-yl)oxy)silane (TMS-31) 
 
Prepared according to a published literature procedure. Spectral data were in agreement with 
literature values.27 
tert-butyldimethyl((3-methylfuran-2-yl)oxy)silane (TBS-31) 
 
Prepared according to a published literature procedure. Spectral data were in agreement with 
literature values.28 
O
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5-(1-hydroxyallyl)-3-methylfuran-2(5H)-one (23) 
   
A flame-dried round bottom flask or 2-dram vial was equipped with a stir bar and purged 
with N2. Anhydrous DCM was added (to 0.5 M), followed by the Lewis acid (1.2 equiv. for 
BF3•OEt, TiCl2(Oi-Pr)2, 10 mol % for metal-BOX/metal-PyBOX catalysts) and the flask/vial 
was cooled to -78 °C. At -78 °C, acrolein (1.2 equiv.) was added and the Lewis acid/acrolein 
mixture was allowed to stir for 0.5 h. After 0.5 h, the siloxyfuran nucleophile of choice (TBS-31 
or TMS-31, 1 equiv.) was added in DCM dropwise. The temperature of the reaction was 
maintained at -78 °C and stirred for 4-5 h. Upon completion, the reaction was warmed to room 
temperature, quenched with DI water/sat. aqueous NaHCO3 and diluted with DCM. The organic 
phase was separated and the aqueous phase extracted three times with DCM. The combined 
organics were washed with brine, dried with MgSO4, and concentrated to yield the crude 
product, which was purified by column chromatography on silica gel (50% EtOAc/hexanes) to 
afford the alkenol product as a mixture of diastereomers. Note 1: reactions using in situ 
generated TiCl2(Oi-Pr)2 were prepared as follows: TiCl4 (0.6 equiv.) stirred at room temperature 
in DCM, Ti(Oi-Pr)4 (0.6 equiv.) was then added dropwise. The reaction was stirred for 1.5 h and 
cooled to -78 °C. Acrolein was then added. Note 2: reactions using metal-BOX or metal-PyBOX 
catalysts were prepared as follows: Metal triflate salt (10 mol %) and ligand (10 mol %) were 
suspended in anhydrous DCM and stirred for 1 h. Acrolein was then added and the procedure 
above was followed.  Note 3: referenced MVAR procedures were carried out according to the 
published procedure. Analytical data for 23: 
HO
O
Me
O
HO
O
Me
O
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1H NMR for anti diastereomer (600 MHz, CDCl3): δ 7.04 (pent, 1H), 5.87 (ddd, J = 17.2 Hz, J = 
10.7 Hz, J = 5.3 Hz, 1H), 5.42 (dt, J = 17.2 Hz, J = 1.4 Hz, 1H), 5.31 (dt, J = 10.7 Hz, J = 1.4 
Hz, 1H), 4.87 (m, 1H), 4.43 (m, 1H), 1.91 (s, 3H); 13C NMR for anti diastereomer (150 MHz, 
CDCl3) δ 174.0, 144.0, 134.6, 131.8, 118.1, 83.1, 72.1, 10.8 
1H NMR for syn diastereomer (600 MHz, CDCl3): δ 7.00 (pent, J = 1.7 Hz, 1H), 5.84 (ddd, J = 
17.1 Hz, J = 10.5 Hz, J = 6.4 Hz, 1H), 5.41 (dt, J = 17.2 Hz, J = 1.3 Hz, 1H), 5.32 (dt, J = 10.5 
Hz, J = 1.2 Hz, 1H), 4.83 (m, 1H), 4.17 (m, 1H), 1.92 (t, J = 1.8 Hz, 3H);  
MS (EI/GC-MS): m/z calculated for C8H10O3 [M]+ 154.06, found 154.10. 
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5-(1-((tert-butyldimethylsilyl)oxy)allyl)-3-methylfuran-2(5H)-one (TBS-23) 
  
Produced as the minor product in MVAR procedures using TiCl2(OiPr)2 and as the major 
product using TBSOTf or metal/BOX Lewis acids. Deprotection under acidic conditions (HCl in 
MeOH/1,4-dioxane) converted TBS-23 to 23. Analytical data for 23: 
1H NMR for anti diastereomer (600 MHz, CDCl3): δ 6.96 (p, J = 1.6 Hz, 1H), 5.87 (ddd, J = 
17.1 Hz, J = 10.5 Hz, J = 5.2 Hz, 1H), 5.37 (dt, J = 17.1 Hz, J = 1.6 Hz, 1H), 5.27 (dt, J = 10.5 
Hz, J = 1.5 Hz, 1H), 4.75 (m, 1H), 4.38 (m, 1H), 1.90 (t, J = 1.8 Hz, 3H), 0.89 (s, 9H), 0.08 (s, 
6H); 1H NMR for syn diastereomer (600 MHz, CDCl3): δ 6.99 (p, J = 1.6 Hz, 1H), 5.66 (m, 1H), 
TBSO
O
Me
O
TBSO
O
Me
O
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5.28 (dt, J = 7.2 Hz, J = 1.5 Hz, 1H), 5.18 (dt, J = 10.5 Hz, J = 1.3 Hz, 1H), 4.78 (m, 1H), 4.30 
(m, 1H), 1.90 (t, J = 1.8 Hz, 3H), 0.83 (s, 9H), 0.02 (s, 6H); 
 
3-(4-methyl-5-oxo-2,5-dihydrofuran-2-yl)propanal (32) 
 
Isolated as the minor product in MVAR procedures producing 23 (or as the major product if a 
Lewis acid is omitted). Spectral data were in agreement with literature values.27 Analytical data 
for 32: 
1H NMR (600 MHz, CDCl3): δ 9.78 (s, 1H), 6.99 (pent, J = 1.7 Hz, 1H), 4.93 (m, 1H), 2.63 (m, 
2H), 2.18 (m, 1H), 1.89 (s, 3H), 1.77 (m, 1H). 
O
Me
OH
O
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General procedure for the polar radical crossover cyclization between indene and alkenol 
23: 
The acridinium catalyst (31, 5 mol %), H-atom donor (1 equiv. 2-PMN or 9-CNFl) and the 
alkenol nucleophile 23 (2 equiv.) were weighed and dispensed into a flame dried 1-dram vial 
equipped with a stir bar and Teflon-coated septum cap.  The vial was moved to an inert 
atmosphere (glove box, N2), where solvent was dispensed by syringe (DCM to 0.4 M), followed 
by indene via microsyringe (1 equiv.).  The vial was then sealed and removed from the inert 
environment.  If using thiophenol as an H-atom donor, it was added to the reaction after reagent 
dispensing (20 mol % PhSH added via microsyringe through the Teflon-coated septum in a fume 
hood). The vial and cap were sealed with electrical tape and PTFE tape.  The reaction was 
irradiated (2x450 nm blue LED lamps) and stirred for 4 days. Upon completion, the crude 
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reaction was concentrated and products isolated by column chromatography on silica gel (20% 
EtOAc/hexanes). 
 
5-(1-((2,3-dihydro-1H-inden-2-yl)oxy)allyl)-3-methylfuran-2(5H)-one (33) 
 
Isolated as a mixture of two inseparable diastereomers (1.2:1 according to crude 1H NMR 
analysis), along with 9-CNFl and 2-PMN. Uncyclized product 33 could not be separated from 9-
CNFl or 2-PMN. Isolated as the major product in polar radical crossover cyclizations with syn-
23 or anti-23 with indene and thiol or carbon H-atom donors. Analytical data for 33: 
1H NMR (600 MHz, CDCl3): δ 7.5-7.0 (m, 8H), 7.05 (t, J = 1.7 Hz, 1H), 6.93 (t, J = 1.7 Hz, 
1H), 5.91 (m, 2H), 5.43 (m, 4H), 4.92 (br s, 1H), 4.85 (d, J = 3.2 Hz, 1H), 4.82 (m, 2H), 4.25 (t, 
J = 5.9 Hz, 1H), 4.16 (t, J = 6.1 Hz, 1H), 3.20 (m, 2H), 3.04 (m, 2H), 2.96 (m, 2H), 2,69 (m, 2H), 
1.89 (t, J = 1.8 Hz, 3H), 1.87 (t, J = 1.8 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 174.1, 174.0, 
145.8, 145.6, 134.8, 134.6, 130.4, 130.1, 129.3, 128.8, 128.2, 127.2, 126.5, 126.2, 125.4, 125.2, 
125.1, 124.33, 124.32, 120.6, 120.0, 111.7, 86.4, 85.8, 82.6, 82.2, 79.2, 79.1, 50.7, 50.0, 42.1, 
41.7, 37.9, 37.88, 37.03, 37.00, 36.96, 34.5, 34.2, 28.0, 10.8, 10.75; MS (EI/GC-MS): m/z 
calculated for C17H18O3 [M]+ 270.13, found 270.0. 
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PRCC polycyclization product (34) 
 
Isolated as the minor product in reactions using anti-23. Analytical data for 34: 
1H NMR major diastereomer (600 MHz, CDCl3): δ 7.24 (m, 3H), 7.09 (d, J = 7.3 Hz, 1H), 5.46 
(ddd, J = 6.8 Hz, J = 5.6 Hz, J = 1.1 Hz, 1H), 4.60 (dd, J = 5.3 Hz, J = 3.8 Hz, 1H), 3.77 (t, J = 
6.4 Hz, 1H), 3.43 (dd, J = 12.2 Hz, J = 3.7 Hz, 1H), 3.31 (dd, J = 18.0 Hz, J = 6.9 Hz, 1H), 3.19 
(m, 1H), 3.15 (d, J = 18.1 Hz, 1H), 2.79 (dq, J = 10.1 Hz, J = 7.4 Hz, 1H), 2.49 (m, 1H), 1.83 (m, 
1H), 1.32 (m, 1H), 1.25 (d, J = 7.4 Hz, 3H); 13C NMR major diastereomer (150 MHz, CDCl3) 
δ 179.9, 144.5, 138.8, 127.4, 126.4, 125.5, 124.8, 92.3, 86.7, 74.8, 48.2, 46.9, 46.4, 41.4, 36.5, 
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18.6, 11.0; 1H NMR minor diastereomer (600 MHz, CDCl3): δ 7.19 (m, 3H), 7.07 (m, 1H), 5.48 
(ddd, J = 6.8 Hz, J = 5.6 Hz, J = 1.0 Hz, 1H), 4.62 (dd, J = 5.8 Hz, J = 4.0 Hz, 1H), 3.78 (t, J = 
6.4 Hz, 1H), 3.36 (dd, J = 12.2 Hz, J = 4.0 Hz, 1H), 3.31 (dd, J = 18.0 Hz, J = 6.8 Hz, 1H), 3.15 
(d, J = 18.0 Hz, 1H), 2.76 (t, J = 7.2 Hz, 1H), 2.63 (m, 1H), 2.44 (qd, J = 7.7 Hz, J = 2.1 Hz, 
1H), 1.60 (m, 2H), 1.30 (d, J = 7.7 Hz, 3H); MS (EI/GC-MS): m/z calculated for C17H18O3 [M]+ 
270.13, found 270.2. 
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1-(4-methyl-5-oxo-2,5-dihydrofuran-2-yl)allyl 4-chlorobenzoate (36) 
 
To a flame-dried round bottom flask equipped with a stir bar was added anhydrous DCM (to 0.2 
M). The stirring DCM was cooled to 0 °C and 1.5 equiv. Et3N was added, followed by 1.2 equiv. 
alkenol-23 (6.7:1 diastereomeric mixture). Next, 4-chlorobenzoyl chloride (1 equiv.) was added 
to the stirring solution dropwise. The reaction was warmed to room temperature and stirred 
overnight. The next morning, the reaction was quenched with 2N HCl and partitioned with 
DCM/DI water. The organic phase was extracted and aqueous phase washed with DCM three 
times. The combined organics were washed with brine, dried with MgSO4, and concentrated to 
give the crude product. Ester 36 was purified by column chromatography on silica gel (20% 
EtOAc/hexanes). The major diastereomer was enriched through chromatography (10% to 20% 
EtOAc/hexanes gradient) and recrystallized from EtOAc/hexanes to yield x-ray quality crystals 
(~20:1 d.r. after major diastereomer enrichment). Analytical data for 36: 
1H NMR (600 MHz, CDCl3): δ  7.93 (d, J = 8.3 Hz, 2H), 7.41 (d, J = 8.5 Hz, 2H), 7.05 (br s, 
1H), 5.84 (ddd, J = 17.0 Hz, J = 10.6 Hz, J = 6.3 Hz, 1H), 5.69 (m, 1H), 5.40 (m, 2H), 5.12 (br s, 
1H), 1.96 (s, 3H). 
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5-allylidene-3-methylfuran-2(5H)-one (38) 
 
Triene 38 was formed in DBU-catalyzed epimerization reactions (elimination) in varying 
amounts and as the major product in Mitsunobu inversion reactions. Analytical data for 38: 
1H NMR major geometric isomer (600 MHz, CDCl3): δ  7.37 (br s, 1H), 6.55 (ddd, J = 16.8 Hz, 
J = 11.7 Hz, J = 10.2 Hz, 1H), 6.18 (dt, J = 11.8 Hz, J = 1.0 Hz, 1H), 5.46 (dt, J = 16.8 Hz, J = 
1.1 Hz, 1H), 5.35 (dt, J = 10.2 Hz, J = 1.1 Hz, 1H), 3.02 (s, 3H); 1H NMR minor geometric 
isomer (600 MHz, CDCl3): δ  7.02 (br s, 1H), 6.82 (ddd, J = 17.1 Hz, J = 11.3 Hz, J = 10.3 Hz, 
1H), 5.69 (d, J = 11.2 Hz, 1H), 5.45 (m, 1H), 5.34 (m, 1H), 2.01 (s, 3H); MS (EI/GC-MS): m/z 
calculated for C8H8O2 [M]+ 136.05, found 136.10. 
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3-methyl-5-(3-methyl-3,3a,8,8a-tetrahydro-2H-indeno[2,1-b]furan-2-yl)furan-2(5H)-one  
(35)  
PRCC product produced in 3:1 d.r. (major diastereomer shown above). Produced in PRCC 
reaction between indene and syn-23 as the minor product, along with uncyclized product (33). 
Analytical data for 35: 
1H NMR major diastereomer (600 MHz, CDCl3): δ 7.19 (m, 3H), 7.11 (m, 1H), 6.28 (pent, J = 
1.6 Hz, 1H), 4.87 (td, J = 5.7 Hz, J = 2.0 Hz, 1H), 4.75 (m, 1H), 3.87 (dd, J = 6.2 Hz, J = 4.9 Hz, 
1H), 3.34 (ddd, J = 6.0 Hz, J = 3.9 Hz, J = 1.0 Hz, 1H), 3.09 (d, J = 5.4 Hz, 1H), 3.07 (d, J = 2.0 
Hz, 1H), 2.11 (m, 1H), 1.76 (t, J = 1.8 Hz, 3H), 1.27 (d, J = 7.0 Hz, 3H); 13C NMR major 
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diastereomer (150 MHz, CDCl3): δ 173.8, 145.9, 144.0, 141.1, 131.1, 127.3, 126.9, 125.3, 124.4, 
86.4, 83.7, 80.5, 58.2, 41.0, 39.1, 19.6, 10.8; 1H NMR minor diastereomer (600 MHz, CDCl3): 
δ 7.18 (m, 4H). 6.95 (m, 1H), 4.85 (m, 1H), 4.69 (br s, 1H), 3.81 (m, 1H), 3.48 (m, 1H), 3.20 (dd, 
J = 16.3 Hz, J = 5.9 Hz, 1H), 2.90 (dd, J = 16.3 Hz, J = 3.2 Hz, 1H), 2.76 (m, 1H), 1.93 (t, J = 
1.8 Hz, 3H), 1.23 (d, 3H). MS (EI/GC-MS): m/z calculated for C17H18O3 [M]+ 270.13, found 
270.2. 
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(E)-3-(trimethylsilyl)acrylaldehyde (39) 
 
Prepared according to a published literature procedure. Spectral data were in agreement with 
literature values.29 Analytical data for 39: 
1H NMR (600 MHz, CDCl3): δ 9.48 (d, J = 7.6 Hz, 1H), 7.16 (d, J = 18.6 Hz, 1H), 6.49 (dd, J = 
18.6 Hz, J = 7.6 Hz, 1H), 0.15 (s, 9H). 
 
5-((E-1-hydroxy-3-(trimethylsilyl)allyl)-3-methylfuran-2(5H)-one (40) 
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MVAR product produced (as major product) when using 39 in place of acrolein. Vinylogous 
aldol procedure otherwise unaltered and anti selective under most conditions tested. Analytical 
data for 40: 
1H NMR for anti diastereomer (600 MHz, CDCl3): δ 7.02 (m, 1H), 6.04 (m, 2H), 4.86 (m, 1H), 
4.39 (br s, 1H), 1.92 (t, J = 1.8 Hz, 3H), 0.07 (s, 9H); 
1H NMR for syn diastereomer (600 MHz, CDCl3): δ  6.97 (t, J = 1.7 Hz, 1H), 6.04 (m, 2H), 8.82 
(m, 1H), 4.14 (t, J = 5.6 Hz, 1H), 1.91 (t, 3H), 0.06 (s, 9H); 
MS (EI/GC-MS): m/z calculated for C11H18O3Si [M]+ 226.10, found 226.2. 
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Carreira Schiff base catalyst (42) 
 
Prepared according to published literature procedure from purchased precursors.26 
3-methyl-5-(3-((trimethylsilyl)methyl)-3,3a,8,8a-tetrahydro-2H-indeno[2,1-b]furan-2-
yl)furan-2(5H)-one (43) 
 
Product produced in trace amounts in PRCC reaction between indene and alkenol syn-40. Adduct 
43 was solated as one diastereomer (shown). Relative stereochemistry of the product was 
assigned using 1H NMR and NOESY analysis. 
1H NMR major (600 MHz, CDCl3): δ 7.24 (m, 3H), 7.07 (m, 1H), 5.92 (pent, J = 1.6 Hz, 1H), 
4.85 (t, J = 4.6 Hz, 1H), 4.64 (dt, J = 5.7 Hz, J = 1.9 Hz, 1H), 3.97 (dd, J = 5.7 Hz, J = 4.2 Hz, 
1H), 3.34 (d, J = 5.0 Hz, 1H), 3.10 (d, J = 16.9 Hz, 1H), 3.05 (dd, J = 16.9 Hz, J = 4.4 Hz, 1H), 
2.14 (m, 1H), 1.69 (t, J = 1.8 Hz, 3H), 0.96 (d, J = 10.7 Hz, 1H), 0.94 (d, J = 10.7 Hz, 1H), 0.10 
(s, 9H); 13C NMR major (150 MHz, CDCl3): δ 173.5, 146.0, 144.2, 141.5, 131.1, 127.2, 126.9, 
125.4, 124.7, 88.9, 84.1, 81.0, 58.4, 41.3, 38.9, 29.7, 10.7, -0.9 
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CHAPTER 5: HYDROTRIFLUOROMETHYLATION OF ALIPHATIC ALKENES AND STYRENES* 
 Introduction 5.1
A unifying theme among the previous three chapters was photoinduced single electron 
oxidation of alkenes to generate alkene radical cations, from which the desired products were 
produced due to the unique reactivity of these intermediates. This chapter steps away from the 
alkene substrate oxidation strategy and focuses on reagent oxidation, generating a reactive 
radical species through single electron oxidation-mediated decomposition (a strategy discussed 
in 1.1). In the context of this chapter, this strategy is used to generate the electrophilic 
trifluoromethyl radical (•CF3) from sodium trifluoromethansulfinate (Langlois reagent, Figure 
5.1). A catalyst system comprised of an acridinium organic photoredox catalyst (1) and a redox-
active thiol H-atom donor is used, much like in the work described in the previous chapters, to 
generate products of alkene hydrofunctionalization (hydrotrifluoromethylation). The work 
presented in this chapter was accomplished as collaborative effort between postdoctoral fellow 
Dr. Dale Wilger and myself. 
Figure 5.1 Hydrotrifluoromethylation of alkenes using an organic photoredox system 
 
                                                
* This chapter previously appeared as a communication in Chemical Science. The original citation is as follows: 
Wilger, D. J.; Gesmundo, N. J.; Nicewicz, D. A. “Catalytic Hydrotrifluoromethylation of Styrenes and Unactivated 
Aliphatic Alkenes via an Organic Photoredox System” Chem. Sci. 2013, 4, 3160-3165. – Reproduced by permission 
of The Royal Society of Chemistry. 
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 Motivation: pharmaceutical and medicinal chemistry 5.2
The field of late-stage fluorination and trifluoromethylation has attracted attention lately 
because of fluorine’s unique effects on the properties of physiologically active compounds or 
drug candidates. Fluorine is used in the pharmaceutical and agrochemical industries as an 
isostere for hydrogen (although its van der Waals radius of 1.47 Å is closer to oxygen), and 
strategic incorporation of fluorine or fluorine-containing moieties (e.g. trifluoromethyl group) in 
a molecule can have beneficial effects on biodistribution/availability, lipophilicity, metabolic 
stability, binding, and other properties.1–3 Shown below in Figure 5.2 are six examples from the 
pharmaceutical and agrochemical industries of fluorine-containing molecules with potent 
biological activity. Furthermore, the physiological effects of the six examples shown are diverse, 
ranging from anti-arthritis and diabetes treatment to herbicide activity, showing that the strategy 
of tactical fluorine incorporation is general and not limited to one therapeutic area. In 2012 
Chemical & Engineering News reported that 3 of the 10 best selling drugs in 2011 incorporated 
fluorine, as did 7 of 35 newly approved drugs.4 As such, novel strategies for late-stage 
fluorination or trifluoromethylation are viewed favorably by the synthetic community and 
practitioners of medicinal chemistry as it allows for new fluorinated scaffolds to be tested for 
improved potency. As alkene hydrofunctionalization methodology matured in the Nicewicz 
group, we felt we could contribute to the fluorination field through the development of a catalytic 
alkene hydrotrifluoromethylation manifold.  
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Figure 5.2 Biologically active fluorinated compounds 
 
 Survey of extant methods for trifluoromethyl group incorporation 5.3
 Modern trifluoromethylation strategies 5.3.1
As there is a continuing need for mild and novel ways to incorporate the trifluoromethyl 
moiety, many highly regarded investigators have contributed to this field. Hartwig showed in 
2011 successful trifluoromethylation of readily accessible aryl iodides and aryl bromides using a 
novel copper complex, (phen)CuCF3 (Figure 5.3).5 The method is high yielding, displays 
exceptional functional group tolerance, and was extended to perfluoroalkylation of aryl halides 
through the use of modified copper complexes. This method does however require stoichiometric 
quantities of the preformed copper complex. 
Figure 5.3 Hartwig’s trifluoromethylation of aryl halides 
 
Buchwald also contributed to the area through the disclosure of allylic and vinyl 
trifluoromethylation strategies. Allylic trifluoromethylation was disclosed in 2011 (Figure 5.4A) 
using Togni’s reagent and catalytic CuI, proceeding with allylic transposition to produce the 
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observed products.6 In 2012, Buchwald published a related coupling protocol for vinyl 
trifluoromethylation of potassium vinyltrifluoroborate salts (Figure 5.4B).7 Utilizing Togni’s 
reagent and catalytic FeCl2, products of vinyl trifluoromethylation were produced upon loss of 
the boron-based functional group (BF3) after trifluoromethyl group addition. At the time of 
publication, the mechanisms of both presented transformations were ambiguous to the authors. 
Figure 5.4 Allylic and vinyl trifluoromethylation from Buchwald and coworkers 
 
Baran showed a general strategy for innate trifluoromethylation of N-heterocycles using 
Langlois reagent (CF3SO2Na) and t-butylhydroperoxide (Figure 5.5).8 Trifluoromethylation 
typically occurred at the most nucleophilic site of the heterocycle, in good to high yields. The 
method was operationally simple and general for many unfunctionalized N-heterocycles. This 
strategy was later extended to difluoromethylation and trifluoroethylation of N-heterocycles.9 
Figure 5.5 Baran’s trifluoromethylation of N-heterocycles 
 
Finally, olefin hydrotrifluoromethylation utilizing the Ruppert-Prakash reagent (TMS-
CF3), 1,4-cyclohexadiene, silver nitrate, PhI(OAc)2, and sodium acetate was reported by Qing 
and coworkers in 2013 (Figure 5.6).10 The transformation is believed to proceed through the 
generation of •CF3 from TMS-CF3 and interception of the olefin substrate by •CF3. H-atom 
abstraction from 1,4-cyclohexadiene furnishes the desired hydrotrifluoromethylation products. 
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The transformation is general for alkenes with multiple substitution patterns and is tolerant of 
many functional groups. 
Figure 5.6 Qing’s alkene hydrotrifluoromethylation method 
 
 Photoredox trifluoromethylation strategies 5.3.2
In addition to the medal-mediated (and metal promoted) transformations shown above in 
5.3.1, photoredox catalysis has become a popular tool for mild and selective 
trifluoromethylation, as it allows one to efficiently access the reactive •CF3 species in a 
controlled manner. Four methods will be discussed: MacMillan’s aldehyde α-
trifluoromethylation (2009),11 Sanford’s trifluoromethylation of arylboronic acids (2012),12 
Akita’s oxy- and amino-trifluoromethylation of olefins (2012, 2013),13,14 and Gouverneur’s 
olefin hydrotrifluoromethylation (2013).15  
MacMillan showed that photoredox catalysis could be combined with imidazolidinone 
organocatalysis in a synergistic fashion to furnish fluorinated products (Figure 5.7).11 The 
photoredox cycle produces •CF3 from CF3I (via single electron reduction from reduced Ir2+ 
complex A), which then intercepts the enamine in solution to produce carbon-centered radical B. 
Oxidation of the radical intermediate to the iminium (C) followed by hydrolysis releases the 
aldehyde product. This strategy was general for perfluoroalkylation as well and showed a high 
degree of functional group tolerance. 
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Figure 5.7 MacMillan’s aldehyde α-trifluoromethylation 
 
Sanford showed trifluoromethylation of arylboronic acids through the synergistic 
combination of ruthenium photoredox catalysis and copper catalysis (Figure 5.8).12 
Mechanistically the transformation is proposed to begin with excitation of the Ru(bpy)32+ 
catalyst followed by electron transfer with CuI to generate reduced species A and CuII. Reduction 
of CF3I with A generates •CF3, I−, and regenerates Ru(bpy)32+. Both proposed redox events are 
exergonic according to reported reduction potentials. Addition of •CF3 to CuX2 generates CuIII 
species B and transmetalation with the arylboronic acid affords species C. Finally, reductive 
elimination forms the trifluoromethylarene product and resets the cycle. Notably the scope of this 
transformation was broad, yields high, and conditions mild. Again, photoredox catalysis was 
used to generate the requisite •CF3 species. 
 
 
 
 
−e−
+e−
N
N
t-Bu Me
OMe
R
F
F
F
N
H
N
t-Bu Me
OMe
N
N
t-Bu Me
OMe
R
CF3
N
N
t-Bu Me
OMe
R
CF3
H
Ir(ppy)2(dtb-bpy)
*Ir(ppy)2(dtb-bpy)+
Ir(ppy)2(dtb-bpy)+
I +
−e−+e−
O
R
CF3
H
O
R
H
F
F
F
CF3I
0.5 mol % Ir(ppy)2(dtb-bpy)PF6 
CF3I
2,6-lutidine
26 W lamp
H
R
O
N
H
N
O
t-BuMe
Me
H
CF3
O
R
Mechanism
20 mol %
hν
A
B
C
N
N N
N
Ir3+
Ir(ppy)2(dtb-bpy)PF6
PF6−
t-Bu
t-Bu
 246 
Figure 5.8 Sanford’s trifluoromethylation of arylboronic acids 
 
Akita and coworkers utilized photoredox catalysis to achieve vicinal 
oxytrifluoromethylation and aminotrifluoromethylation of alkenes (Figure 5.9).13,14 Akita utilized 
the electrophilic CF3 source Umemoto’s reagent (Figure 5.9), which upon single electron 
reduction generates •CF3. The transformation is proposed to occur as shown below: excitation of 
the iridium complex [fac-Ir(ppy)3], followed by reduction of Umemoto’s reagent to generate 
•CF3 and fac-Ir(ppy)3+ (A) through an oxidative quenching cycle. The electrophilic •CF3 then 
intercepts the olefin in solution to form carbon-centered radical B, which undergoes SET to 
regenerate the ground state iridium reductant and form carbocation C. Interception of this cation 
by a nucleophile (alcohol solvent, water, MeCN) produces the product. The transformation is 
highly modular and is tolerant of electronically diverse styrenyl alkene substrates as well as 
multiple heteroatom nucleophiles with varying steric demands. This transformation is also 
notable in its installation of two valuable functional groups in one step using photoredox 
catalysis.  
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Figure 5.9 Proposed mechanism for Akita’s vicinal oxytrifluoromethylation of alkenes 
  
Concurrent with our efforts in the field, Gouverneur disclosed a method for alkene 
hydrotrifluoromethylation operating through photoredox catalysis (Figure 5.10).15 The method is 
general for terminal aliphatic alkenes as well as alkynes, producing products in high 
regioselectivity and good yields under mild reaction conditions. Umemoto’s reagent is again 
used as the precursor to •CF3, which is generated via an oxidative quenching cycle with 
Ru(bpy)32+. The transformation proceeds as follows: excitation of Ru(bpy)32+ to *Ru(bpy)32+, 
followed by reduction of Umemoto’s reagent to generate Ru(bpy)33+ (A) and •CF3. The radical 
(•CF3) then intercepts the olefin in solution to produce carbon-centered radical B and H-atom 
abstraction from methanol produces the desired product. SET between ketyl C and complex A 
regenerates the photoredox catalyst and produces formaldehyde. Deuterium labeling studies 
confirmed the α-C−H bond of methanol as the hydrogen atom source and radical clock 
experiments confirmed the intermediacy of radicals in this reaction. After the methods developed 
by Qing, Gouverneur, and Nicewicz (described herein) were disclosed, investigators such as 
Scaiano,16 Cho,17 and Choi18 have since contributed their expertise to this field through the 
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development of alternative photochemical hydrotrifluoromethylation strategies, further 
expanding the scope of this valuable transformation.  
Figure 5.10 Hydrotrifluoromethylation of alkenes under photoredox conditions 
 
 Common theme among presented strategies 5.3.3
A common theme among many of the strategies highlighted in the previous sections 
(including non-photoredox strategies) is the invoked intermediacy of the •CF3 species. One 
factor that differentiates these methods is how •CF3 is generated (Figure 5.11). Umemoto’s 
reagent and CF3I underwent reduction to expel a nucleofuge (e.g. I–) and form •CF3.11–13,15 The 
Langlois reagent and the Ruppert-Prakash reagent generated •CF3 under oxidative conditions 
upon decomposition.8,10 Decomposition of a precursor (vide infra) by either single electron 
oxidation or reduction lends itself to photoredox applications as both strong oxidants and strong 
reductants are accessible, allowing for mild reaction conditions and controlled generation of a 
highly reactive radical species. 
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Figure 5.11 Strategies for •CF3 generation 
 
 Inspiration: Baran, Langlois, and polarity reversal catalysis 5.4
We were inspired by Baran’s use of Langlois reagent in N-heterocycle 
trifluoromethylation (Figure 5.5), the seminal work of Langlois in arene and alkene 
trifluoromethylation, and the principles of polarity reversal catalysis in designing a successful 
trifluoromethylation manifold under oxidative conditions. 
 Baran’s N-heterocycle trifluoromethylation 5.4.1
Baran generated •CF3 under oxidative conditions, utilizing Langlois reagent and t-BuO• 
as the oxidant (Figure 5.12A).8 Upon oxidation, a transient sulfonyl radical is generated which 
readily undergoes fragmentation/homolytic C−S cleavage to generate •CF3 and SO2. The active 
oxidant was generated from t-butylhydroperoxide reduction, either by trace metals found in 
commercial Langlois reagent or by a radical produced during the reaction (in a chain propagation 
step). Baran and coworkers displayed a broad substrate scope, showing high yielding 
trifluoromethylation of naturally occurring compounds caffeine, melatonin, and nicotine in 
addition to synthetic N-heterocyclic species (Figure 5.12B). Trifluoromethylation occurred at the 
most nucleophilic positions. Of additional interest to us was competing alkene capture pathway, 
producing isolable minor products in many examples (Figure 5.12B). The alkene capture 
pathway is believed to occur via isobutene capture by •CF3 to produce a tertiary carbon-centered 
F3C
S
O
OK
F
F
F
S
CF3
I
F
F
F
−e−
+e− +e−
Me3Si CF3
−e−
decomposition under oxidative 
conditions with silver
−SO2
−I−−dibenzothiophene
Umemoto's reagent
Langlois reagentRuppert-Prakash
reagent
 250 
radical, which then intercepts the N-heterocycle (Figure 5.12C). The authors suggested that 
isobutene was produced from t-butylhydroperoxide, but importantly this showed (along with 
Akita’s work, Figure 5.9) that electrophilic •CF3 was inherently reactive towards nucleophilic 
alkenes in solution. 
Figure 5.12 Trifluoromethylation of N-heterocycles 
 
 Langlois prior work in alkene trifluoromethylation 5.4.2
Langlois showed in 2002 the successful trifluoromethylation of alkenes using potassium 
trifluoromethane sulfinate under electrochemical oxidation conditions.19 Figure 5.13 shows the 
results of their studies employing phenylcyclohexene and undecene as substrates. Products of 
oxidative trifluoromethylation (A, C), hydrotrifluoromethylation (B, D), and allylic 
trifluoromethylation (E) were observed. Oxidative trifluoromethylation was the favored pathway 
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due to facile oxidation of the intermediate carbon-centered radicals (produced after •CF3 capture, 
Figure 5.13) under electrochemical oxidation conditions. The hydrotrifluoromethylation product 
was likely produced through a radical disproportionation pathway, affording both the 
hydrotrifluoromethylation product and the oxidative trifluoromethylation product. Langlois 
reported an oxidation potential (E1/2ox) of +1.05 V vs. SCE for sodium trifluoromethane sulfinate, 
the reagent that bears his name, within range of many excited state organic photooxidants.20 
Figure 5.13 Langlois examples of alkene trifluoromethylation under electrochemical oxidation 
 
 Polarity reversal catalysis 5.4.3
Finally, polarity reversal catalysis in the context of H-atom transfer helped us better 
understand and predict the reactivity of electrophilic •CF3. For H-atom transfer, polarity reversal 
states that an electrophilic (electron deficient) radical species (El•) will more readily abstract 
hydrogen from an electron rich R−H bond (to form an electron rich, nucleophilic radical, Nuc•) 
over an electron deficient R−H bond of similar strength (Figure 5.14).21,22 The reverse is also 
true (vide infra), and as the electronegativity difference between El and Nuc (Figure 5.14) 
increases, the kinetic preference for H-atom transfer becomes more significant due to polar 
effects.  
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Figure 5.14 H-atom transfer polarity reversal catalysis 
 
The relative nucleophilicity and electrophilicity of common radical intermediates has 
been tabulated,23 and taking this into account, along with knowledge of polarity reversal catalysis 
and prior work by Baran and Langlois we proposed alkene hydrotrifluoromethylation using 
Langlois reagent, organic photooxidant 1, and an H-atom donor cocatalyst (Figure 5.15). We 
proposed generation of •CF3 photochemically using 1* (exergonic by 1.07 V), obviating the need 
for stoichiometric oxidants or electrochemical oxidation. On the basis of polarity reversal, 
electrophilic •CF3 would intercept a nucleophilic alkene to produce electron rich, nucleophilic 
radical A with regioselectivity controlled by carbon-centered radical stability. Finally, H-atom 
transfer with an electrophilic hydrogen atom source (such as a thiophenol derivative or 2-PMN) 
would generate the hydrotrifluoromethylation product B and the electrophilic thiyl radical (from 
a thiophenol derivative) or carbon−centered radical (from 2-PMN). The favorability of polarity 
reversal would disfavor direct reaction between •CF3 and the electrophilic H-atom donor without 
olefin intervention. 
Figure 5.15 Catalytic hydrotrifluoromethylation of alkenes using an organic photoredox system 
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 Discovery of reactivity and reaction optimization 5.5
Dr. Dale Wilger conducted much of the early system design and reaction optimization. 
The initial goal was to use catalytic loadings of acridinium catalyst 1 and substoichiometric 
loadings of 2-PMN as an H-atom donor, with an acidic additive to serve as the terminal proton 
source for 2-PMN regeneration (Table 5.1).24 Utilizing silyl ether 2a as the model substrate, 
excluding an acidic additive produced only trace quantities of product 3a after 48 hours (entry 1). 
Using additives such as AcOH (entry 2) or TFA (entry 3) improved yields, however significant 
gains in yield were not realized until fluorinated alcohols such as TFE (entry 4) and HFIP (entry 
5) were used. Using TFE and HFIP resulted in 3a yields of 58% and 69% after 48 hours, 
respectively. TFE and HFIP appeared to be unique; methanol, which was successful as an H-
atom donor in Gouverneur’s system, was less effective in this system (entry 6).15 
Table 5.1 Acidic additive screen with 2-PMN 
 
Control experiments ultimately showed that 2-PMN was not necessary for reactivity; a 
solvent system comprised of TFE and CHCl3 (when used with catalyst 1 and Langlois reagent) 
was capable of promoting the transformation (Table 5.2), suggesting that TFE was active as an 
H-atom donor (α-C−H bond similar to Gouverneur’s MeOH observation). Excluding 2-PMN but 
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using a solvent system of 6% TFE/CHCl3 resulted in a 34% yield after 48 hours (entry 1). 
Increasing TFE to 10% increased the yield to 57% (entry 2), however further increasing the TFE 
loading to 24% (entry 3) or 39% (entry 4), had little impact on 3a yield. It was not until 
exogenous H-atom donors were revisited that yields increased: addition of 20 mol % methyl 
thiosalicylate (MTS) to the system as an additional H-atom donor gave a 78% yield of the 
desired adduct after 48 hours (entry 5). To emphasize the importance of TFE in this system 
however, when TFE was excluded but MTS was retained, the yield dropped precipitously (entry 
6). This highlights the synergistic effect of TFE and MTS, suggesting that both play a role in the 
H-atom transfer step of the reaction. 
Table 5.2 Solvent system optimization, H-atom donor optimization 
 
Similar effects were observed when optimizing the reaction for 5-hexenol 2b (Table 5.3). 
Using the 10% TFE/CHCl3 solvent system optimized for silyl ether substrate 2a (lacking added 
H-atom donor), low yields of 3b were observed. Worse, GC-MS analysis of the crude reaction 
showed that a significant amount of the mass balance was consumed in the production of 
dimerization product 4b (entry 1). Using HFIP in place of TFE did little to affect this outcome 
(entry 2), however adding an equivalent of 2-PMN to the reaction did suppress dimerization 
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while providing a modest increase to the yield of 3b (entry 3). Using 20 mol % MTS as the 
exogenous H-atom donor once again proved to be optimum for the transformation as the yield of 
3b was elevated significantly to 67% and dimerization suppressed completely (entry 4). This 
result as well as a control experiment lacking TFE (entry 5) further substantiates the synergistic 
effect of TFE and MTS in providing high trifluoromethylation yields. During the course of 
optimization we realized that the mass balance under optimized conditions was unconsumed 
alkene substrate; longer reaction times provided higher chemical yields. As such, the conditions 
shown in Table 5.2 entry 5 and Table 5.3 entry 4 were adopted as standard. 
Table 5.3 Hydrotrifluoromethylation for 5-hexenol 
 
 Aliphatic alkene reaction scope 5.6
This transformation was tested against aliphatic alkenes of multiple substitution patterns 
containing sensitive functional groups. The results of this study are shown below in Table 5.4. 
Terminal alkenes with a pendant hydroxyl group (2b), tosylate (2c), and benzoyl ester (2d) 
furnished desired products 3b, 3c, and 3d in 50%, 64%, and 42% yields after 24 hours, 
respectively. Additionally, allylic carbamates (2e) and sulfonamides (2f) were retained during 
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the transformation, producing products 3e and 3f in 25% and 32% yields respectively. The 
decreased yields observed with 2e and 2f were attributed to decreased nucleophilicity of these 
particular alkenes (compared to 2b-2d), due to electron-withdrawing groups in close proximity. 
1,1-Disubstituted alkenes were equally competent reaction partners, producing products 
in high yields and complete regioselectivity. Substrates bearing a silyl ether (2a), benzoyl ester 
(2g), and phthalimide (2h) at the allylic position produced corresponding products 3a, 3g, and 3h 
in 54%, 69%, and 68% respectively after 24 hours with the functional groups unaltered. 1,2-
Disubstituted alkene 2i produced the desired product 3i in a 45% yield as a 1.3:1 mixture of 
C3/C2 regioisomers. The diminished regioselectivity of this substrate relative to 1,1-disubstituted 
alkenes was due to minimized differences in accessibility and radical stability at two positions. 
Table 5.4 Aliphatic alkene scope 
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 Finally, trisubstituted aliphatic alkenes were also productive substrates as exemplified by 
substrates 2j-2l. Again substrates bearing a silyl ether (2j), benzoyl ester (2k), and phthalimide 
(2l) were tested and produced the desired products 3j, 3k, and 3l in good to high yields (51%, 
54%, and 69% respectively) after 24 hours. To show scalability of the transformation substrate 2j 
was subjected to hydrotrifluoromethylation at the 10 mmol scale (Figure 5.16). After 48 hours of 
irradiation (all other reaction parameters unchanged), 3j was produced in a 74% yield. Continued 
consumption of unreacted 2j after 24 hours explains the difference in 3j yield between this 
example and the example in Table 5.4. 
Figure 5.16 large-scale hydrotrifluoromethylation of 2j 
 
 Styrenyl alkene optimization 5.7
While the reaction was very efficient for aliphatic alkenes of various substitution 
patterns, we hoped to make the transformation more general by extending this platform to 
styrenyl substrates. Unfortunately, under the previously optimized conditions, 
hydrotrifluoromethylation of β-methylstyrene (2m) and anethole (2n) was very low yielding. An 
additional setback was the realization that substrate conversion was universally high in these 
transformations (in stark contrast to reactions with aliphatic alkenes), with high molecular weight 
oligomeric byproducts comprising the mass balance. Key to achieving success with styrenyl 
substrates was identifying the variable essential for reactivity, the H-atom donor, and optimizing 
it for styrenyl substrates β-methylstyrene (Figure 5.17) and anethole (Figure 5.18). 
As previously mentioned, the yield of 3m, derived from β-methylstyrene 2m, was very 
low when using MTS in a 20 mol % loading (15% yield, 100% conversion, Figure 5.17). 
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Employing a full equivalent of MTS increased the yield significantly (42%) but still not up to 
synthetically useful levels. The reaction efficiency was further improved when less electron 
deficient H-atom donor thiophenol (PhSH) was examined in place of MTS. Scanning PhSH 
loading from 20 mol % to 100 mol %, the yield increased as H-atom donor loading increased, up 
to 73%. In all cases, very little unconsumed 2m was observed, the mass balance was comprised 
of high molecular weight oligomeric byproducts. 
Figure 5.17 Optimization for β-methylstyrene 
 
 
The results of the H-atom donor screen with β-methylstyrene (2m) were mirrored in an 
H-atom donor screen with the more electron rich styrenyl substrate anethole (2n, Figure 5.18). 
Again conditions optimized for aliphatic alkenes produced only low yields of 3n (39%) with 
complete conversion of 2n. Increasing MTS loading to 100 mol % increased 3n yield noticeably, 
to 68%, however thiophenol was again a better match for this system. Catalytic loading of PhSH 
was superior to catalytic loadings of MTS (Figure 5.18), and a 100 mol % loading of PhSH 
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were inefficient in this system (like in the aliphatic alkene system), producing low yields despite 
high conversion. Regarding the superiority of thiophenol compared to MTS (or TFE) for styrenyl 
substrates 2m and 2n, it is possible that the more electron rich aryl thiol (PhSH) is a better H-
atom transfer match for the benzylic radicals produced after •CF3 addition in this 
transformation.25 More favorable H-atom transfer would suppress the oligomerization pathway 
and increase hydrotrifluoromethylation yields. 
Figure 5.18 Optimization for anethole 
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transformation as exemplified by cinnamyl alcohol substrates 2p and 2q producing the desired 
products in good to high yields. A phthalimide was also retained in this transformation, as 3r was 
isolated in 41% yield from styrenyl substrate 2r after 24 hours. Trisubstituted styrenyl substrate 
1-phenylcyclohexene (2s) produced product 3s in 51% as a 12:1 mixture of cis/trans 
diastereomers. Finally, terminal substrate 2-vinylnaphthalene (2t) and aryl enone chalcone (2u) 
produced products 3t and 3u in 29% and 31% (1.1:1 mixture of β/α regioisomers) yields, 
respectively. The example with 1-phenylcyclohexene (2s) is noteworthy as 1-phenylcyclohexene 
was one of Langlois model substrates (Figure 5.13). While Langlois isolated a mixture of 
trifluoromethylation products, we were able select for 3s in moderate yield (oxidative 
trifluoromethylation was not observed). 
Table 5.5 Styrenyl alkene substrate scope 
 
5 mol % 1
1 equiv. PhSH
10% TFE/CHCl3, rt, 24 h
450 nm LEDs
R1
Ar
R1
ArF3C
S
ONa
O
+
1.1−1.5 equiv.
Langlois reagent
R2
R2
CF3
H
N
Mes
BF4Me
PhSH
SH
Mes-Acr+-BF4 1
Styrenyl Substrate Product
2n
3s 51%
12:1 cis/trans
Styrenyl Substrate Product
2 3
3n 64%
2o 3o 56%
3t 29%
MeO
Me
MeO
Me
CF3
Cl
Me
Cl
Me
CF3
MeO
OH
MeO
OH
CF3
OH OH
CF3
MeO
NPhth
MeO
NPhth
CF3
CF3
H
CF3
O OCF3
α
β
2p
2q
3p 67%
3q 51%
2r
2s
2t
2u
3r 41%
3u 31%* (1.1:1 β/α)
* Ran with 20 mol % methyl thiosalicylate
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During investigation of the styrenyl substrate scope, we realized two unique features of 
trifluoromethylation: the products of this transformation tended to be less polar (despite the 
electronegativity of fluorine) and more volatile (despite the added mass), compared to their 
alkene precursors. As such, product isolation was sometimes problematic. Unique substrates 
such as β-methylstyrene (2m, Figure 5.17, a model substrate for optimization), α-methylstyrene, 
styrene, and indene produced the products shown in Figure 5.19 but were abandoned due to 
difficulties associated with isolation. 
Figure 5.19 Successful but problematic styrenyl substrates 
 
 Proposed mechanism 5.9
While some mechanistic aspects of this transformation are clear to us, others such as the 
active H-atom donor are less obvious. The transformation is believed to proceed as shown below 
in Scheme 5.1. Excitation of acridinium catalyst 1 to 1* is followed by SET with Langlois 
reagent. This redox event generates •CF3 after SO2 loss, and interception of an alkene (A) by 
•CF3 produces the shown carbon-centered radical B. H-atom transfer from either the thiol or TFE 
(as we believe both are active H-atom donors in this reaction) produces the product C. From 
here, a redox event involving the active H-atom donor (HAD•) and the acridine radical (1•) 
regenerates acridinium catalyst 1, then protonation restores the H-atom donor.  
 
 
 
Me
CF3
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CF3
CF3
β-methylstyrene α-methylstyrene styrene indene
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Scheme 5.1 Proposed mechanism with generic H-atom donor cycle 
 
Deuterium labeling studies support TFE as an H-atom donor (α-C−H), however the thiol 
effect cannot be ignored and will be discussed. As the reaction proceeds efficiently for many 
aliphatic substrates in the absence of a thiol additive, an H-atom donor cycle involving only TFE 
is plausible, as depicted in Scheme 5.2A.26 The α-C−H bond of TFE would serve as the hydrogen 
atom source to generate the product (supported through the use of d2-TFE), and then the 
(protonated) ketyl radical D shown could play a role in turning over catalyst 1. The reduced 
species produced upon acridine radical oxidation (TFE−, E) would either be lost or protonated by 
another TFE equivalent to reenter the cycle. Thiol intervention is possible in two ways: the thiol 
acting to regenerate TFE and catalyst 1 (Scheme 5.2B) and the thiol assuming the role as H-atom 
donor to produce product (Scheme 5.2C). As shown in Scheme 5.2B, it is possible TFE still 
plays the role of H-atom donor and the thiol regenerates TFE (via HAT) and more efficiently 
turns over the catalyst (the redox event between 1• and F has been studied)27 to form 1. The thiol 
would then be reformed through thiolate G protonation. It is also possible, however, that the thiol 
plays the role of H-atom donor from TFE in a system analogous to other dual catalytic 
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photoredox hydrofunctionalization manifolds (Scheme 5.2C).28–30 Here, H-atom transfer with the 
thiol would produce the product and shown thiyl radical F, which would regenerate 1 in the 
shown redox event. Protonation of thiolate G, possibly by TFE (contrary to what relative pKa 
values suggest) or protonated ketyl D, would regenerate the thiol H-atom donor. Alternatively, it 
could be possible that the thiol is regenerated directly from the thiyl radical by HAT with TFE. 
The cycle depicted in Scheme 5.2C may represent the mechanism of styrene 
hydrotrifluoromethylation as thiols were necessary for high yields. Ultimately, more thorough 
mechanistic studies are required to draw a definitive conclusion on the mechanism of this 
transformation. 
Scheme 5.2 Possible TFE/thiol H-atom donor cycles  
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 Conclusion 5.10
In conclusion, a method for the direct hydrotrifluoromethylation of unactivated aliphatic 
alkenes and styrenes under mild conditions was presented. The manifold used sodium 
trifluoromethanesulfinate (Langlois reagent) as the trifluoromethyl group source, an H-atom 
donor system comprised of an aryl thiol (20 mol % to 100 mol %) and TFE (a component of the 
solvent), and relied on photochemical oxidation of Langlois reagent by an acridinium organic 
photoredox catalyst. 12 examples of aliphatic alkenes were shown along with 8 styrenyl 
examples. While our method was the third published hydrotrifluoromethylation strategy in 2013, 
after Qing (Figure 5.6) and Gouverneur, (Figure 5.10), features of our system such as the 
acridinium photooxidant (which obviates the need for expensive transition metal catalysts), the 
low cost of Langlois reagent, fewer necessary stoichiometric reagents, and minimized waste 
makes it an appealing alternative method to theirs. This project was a great learning experience 
for myself (as a young graduate student) and it was very rewarding to later hear that this method 
has been applied by medicinal chemists in the pharmaceutical industry with success to access 
new fluorinated scaffolds.  
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 Experimental details 5.11
General Methods. Infrared (IR) spectra were obtained using a Jasco 260 Plus Fourier transform 
infrared spectrometer. Proton, carbon, and fluorine magnetic resonance spectra (1H NMR, 13C 
NMR, and 19F NMR) were recorded on a Bruker model DRX 400 or 600 (1H NMR at 400 MHz 
or 600 MHz, 13C NMR at 100 MHz or 150 MHz, and 19F NMR at 376 MHz or 564 MHz) 
spectrometer. Chemical shifts for protons are reported in parts per million downfield from 
tetramethylsilane and are referenced to residual protium in solvent (1H NMR: CHCl3 at 7.27 
ppm). Chemical shifts for carbons are reported in parts per million downfield from 
tetramethylsilane and are referenced to the carbon resonances of the residual solvent peak (13C 
NMR: CDCl3 at 77.0 ppm). Chemical shifts for fluorine are reported in parts per million from 
CFCl3 (δ 0 ppm) as the external standard. NMR data are represented as follows: chemical shift, 
multiplicity (s = singlet, bs = broad singlet, d = doublet, dd = doublet of doublet, t = triplet, q = 
quartet, sept = septuplet, oct = octuplet, m = multiplet), coupling constants (Hz), and integration. 
Mass spectra were obtained using a Micromass Quattro II (triple quad) instrument with 
nanoelectrospray ionization. Analytical thin layer chromatography (TLC) was performed on 
SiliaPlate 250 µm thick silica gel plates provided by Silicycle. Visualization was accomplished 
using fluorescence quenching, KMnO4 stain, or ceric ammonium molybdate (CAM) stain 
followed by heating. Organic solutions were concentrated under reduced pressure using a Büchi 
rotary evaporator with an ice water bath for volatile compounds. Purification of the reaction 
products was carried out by chromatography using Siliaflash-P60 (40-63 µm) or Siliaflash-T60 
(5-20 µm) silica gel purchased from Silicycle. All reactions were carried out under an inert 
atmosphere of nitrogen in flame-dried glassware with magnetic stirring unless otherwise noted. 
Irradiation of photochemical reactions was carried out using a 15W PAR38 blue LED flood lamp 
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purchased from EagleLight (Carlsbad, CA), with standard borosilicate glass vials purchased 
from Fisher Scientific. Gas chromatography (GC) was performed on an Agilent 6850 series 
instrument equipped with a split-mode capillary injection system and Agilent 5973 network mass 
spec detector (MSD). Yield refers to isolated yield of analytically pure material unless otherwise 
noted. GC yields were determined with 1,3-dimethoxybenzene as an internal standard. NMR 
yields were determined using hexamethyldisiloxane as an internal standard. 
Materials. Commercially available reagents were purchased from Sigma Aldrich, Acros, Alfa 
Aesar, or TCI, and used as received unless otherwise noted. Diethyl ether (Et2O), 
dichloromethane (CH2Cl2), tetrahydrofuran (THF), toluene, and dimethylformamide (DMF) 
were dried by passing through activated alumina columns under nitrogen prior to use. 
Chloroform (CHCl3) and 2,2,2-trifluoroethanol (TFE) were both distilled from anhydrous 
sodium sulfate and a small quantity of sodium bicarbonate prior to use. Other common solvents 
and chemical reagents were purified by standard published methods if noted. 5-Hexen-1-ol (2b), 
trans-chalcone (2u), 1-phenyl-1-cyclohexene (2s), cinnamyl alcohol (2q), trans-anethole (2n), 
trans-para-methoxycinnamaldehyde, 2-methyl-2-propen-1-ol, 3-methyl-2-buten-1-ol, 3-chloro-
2-methyl-1-propene, 3,3-dimethallyl bromide, allylamine, benzoyl chloride, tert-
butylchlorodiphenylsilane, di-tert-butyl dicarbonate,  para-toluenesulfonyl chloride, 
bis(((trifluoromethyl)sulfinyl)oxy)zinc, and phthalamide potassium salt were all purchased from 
Sigma Aldrich. Sodium trifluoromethanesulfinate (CF3SO2Na, Langlois reagent) was purchased 
from TCI. 
Preparation of Alkene Substrates 
tert-Butyl((2-methylallyl)oxy)diphenylsilane (2a). Prepared according to a published 
procedure; spectral data were in agreement with literature values.31 
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2-Methylallyl benzoate (2g). Prepared according to a published procedure; spectral data were in 
agreement with literature values.32 
2-(2-Methylallyl)isoindoline-1,3-dione (2h). Prepared according to a published procedure; 
spectral data were in agreement with literature values.33 
Hex-5-en-1-yl 4-methylbenzenesulfonate (2c). Prepared according to a published procedure; 
spectral data were in agreement with literature values.34 
Hex-5-en-1-yl benzoate (2d).  Prepared according to a published procedure; spectral data were 
in agreement with literature values.15 
tert-Butyl allylcarbamate (2e). Prepared according to a published procedure; spectral data were 
in agreement with literature values.35 
N-Allyl-4-methylbenzenesulfonamide (2f). Prepared according to a published procedure; 
spectral data were in agreement with literature values.36 
tert-Butyl-((3-methylbut-2-en-1-yl)oxy)diphenylsilane (2j). Prepared according to a published 
procedure; spectral data were in agreement with literature values.31 
3-Methylbut-2-en-1-yl benzoate (2k). Prepared according to a published procedure; spectral 
data were in agreement with literature values.32 
2-(3-Methylbut-2-en-1-yl)isoindoline-1,3-dione (2l). Prepared according to a published 
procedure; spectral data were in agreement with literature values.33 
(E)-(But-2-en-1-yloxy)-(tert-butyl)diphenylsilane (2i). Prepared according to a published 
procedure; spectral data were in agreement with literature values.37 
1-Chloro-4-(prop-1-en-1-yl)benzene (2o). Prepared as a mixture of diasteriomers (3.5:1 Z:E 
ratio) according to a published procedure using ethyltriphenylphosphonium bromide; spectral 
data were in agreement with literature values.38 
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(E)-3-(4-Methoxyphenyl)-prop-2-en-1-ol (2p). Prepared according to a published procedure; 
spectral data were in agreement with literature values.39 
(E)-2-(3-(4-Methoxyphenyl)allyl)isoindoline-1,3-dione (2r). Prepared according to a published 
procedure; spectral data were in agreement with literature values.40 
2-Vinylnaphthalene (2t). Prepared according to a published procedure; spectral data were in 
agreement with literature values.41 
Preparation of the Acridinium Photocatalyst (Mes-Acr+-BF4) 
The photocatalyst used in this study, 1, was synthesized by the method of Fukuzumi et al.42 
Tetrafluoroboric acid (diethyl ether complex) was substituted for perchloric acid during the 
dehydration. The spectral data matched the values reported in the literature. 1H NMR (600 MHz, 
CDCl3) δ 8.60 (d, J = 9.0 Hz, 2H), 8.37 (t, J = 9.0 Hz, 2H), 7.84 (s, 4H), 7.23 (s, 2H), 4.81 (s, 
3H), 2.46 (s, 3H), 1.68 (s, 6H).  
General Procedure A for the Hydrotrifluoromethylation of Alkyl-Substituted Alkenes.  
 
A flame-dried 2-dram vial was equipped with a magnetic stir-bar, N-Me-9-mesityl acridinium 
tetrafluoroborate (5.0 mol %, 1), sodium trifluoromethanesulfinate (1.5-3.0 equiv), and substrate 
(1 mmol). The solvent, CHCl3/TFE (9:1), was added under a nitrogen atmosphere to a 
concentration of approximately 0.20 M. Liquid substrates were added via microsyringe after the 
solvent. Methyl thiosalicylate (20 mol%) was added via microsyringe. The vial was sealed with a 
Teflon-coated septum cap, and the reaction mixture was irradiated (450 nm) for 24 hours (unless 
some other time is indicated). Upon completion, saturated aqueous sodium bicarbonate was 
added, and the two phases were allowed to separate. The organic phase was collected, and the 
catalyst 1 (5 mol %)
CHCl3 / TFE (9:1), rt
MTS (20 mol%)
450 nm LEDsR2
R2
H
R3
CF3SO2Na
(1.5-3.0 equiv)
R3
CF3
R1
R1
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aqueous phase was extracted with two portions of dichloromethane equal to the reaction volume. 
The combined organic portions were passed through a short plug of SiO2. The solvent was 
removed under reduced pressure. The final products were isolated by silica gel chromatography 
using the conditions listed. 
7,7,7-Trifluoroheptan-1-ol (3b) 
 
The average yield for the title compound was 50% (two trials) at the 1.25 mmol scale, using 2.0 
equivalents Langlois reagent, and an irradiation time of 24 hours. The title compound was 
purified by column chromatography on silica gel (20% EtOAc/Hexanes) to yield a colorless oil. 
Analytical data for 3b were in agreement with literature values15: 1H NMR (600 MHz, CDCl3): δ 
3.64 (t, J = 6.6 Hz, 2H), 2.13-2.00 (m, 2H), 1.66 (bs, 1H), 1.59-1.41 (m, 4H), 1.40-1.38 (m, 4H); 
19F NMR (376 MHz): δ -66.5 (t, J = 10.9 Hz). 
tert-Butyldiphenyl(4,4,4-trifluoro-2-methylbutoxy)silane (3a)  
 
The average yield for the title compound was 54% (two trials) at the 0.64 mmol scale, using 1.5 
equivalents Langlois reagent, and an irradiation time of 24 hours.  The title compound was 
purified by column chromatography on silica gel (5% dichloromethane/hexanes) to yield a 
colorless oil. Analytical data for 3a: 1H NMR (400 MHz, CDCl3): δ 7.67 (d, J = 8.0 Hz, 4H), 
7.46-7.39 (m, 6H), 3.59 (dd, J = 10 Hz, J = 5.2 Hz, 1H), 3.47 (dd, J = 10 Hz, J = 6.4 Hz, 1H), 
2.47 (m, 1H), 2.07 (m, 1H), 1.92 (m, 1H), 1.09 (s, 9H), 1.06 (d, J = 6.4 Hz, 3H); 13C NMR 
(CDCl3, 150 MHz): δ 135.6, 133.5, 133.4, 129.8, 127.7, 127.5 (q, J = 127 Hz), 67.7, 36.7 (q, J = 
27.4 Hz), 30.6 (q, J ~2 Hz), 26.8, 19.3, 16.7; 19F NMR (376 MHz, CDCl3): δ -63.4 (t, J = 11.5 
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Hz); IR (thin film): 3071, 2960, 2932, 2859, 1716, 1698, 1684, 1653, 1590 1558, 1541, 1507, 
1488, 1472, 1428, 1389 cm-1; LRMS (ESI): m/z calculated for C21H28F3OSi ([M+H]+) 381.1862, 
found 381.28. 
4,4,4-Trifluoro-2-methylbutyl benzoate (3g) 
 
The average yield for the title compound was 69% (2 trials) at the 1.2 mmol scale, using 1.5 
equivalents of Langlois reagent, and an irradiation time of 24 hours. The title compound was 
purified by column chromatography on silica gel (10% dichloromethane/hexanes) to yield a 
colorless oil. Analytical data for 3g: 1H NMR (400 MHz, CDCl3): δ 8.06-8.04 (m, 2H), 7.61-
7.56 (m, 1H), 7.49-7.44 (m, 2H), 4.29-4.19 (m, 2H), 2.45-2.31 (m, 2H), 2.15-2.01 (m, 1H) 1.18 
(d, J = 6 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 166.3, 133.1, 129.9, 129.5, 128.4, 126.9 (q, J 
= 275 Hz), 68.3, 37.2 (q, J = 28 Hz), 27.9 (q, J = 2.3 Hz), 17.0; 19F NMR (376 MHz, CDCl3) δ -
63.6 (t, J = 11.1 Hz); IR (thin film) 3066, 3035, 2975, 2948, 2890, 2341, 1967, 1918, 1869, 
1844, 1828, 1792, 1771, 1724, 1684, 1633 cm-1; LRMS (ESI): m/z calculated for C12H14F3O2 
([M+H]+) 247.0946, found 247.08. 
2-(4,4,4-Trifluoro-2-methylbutyl)isoindoline-1,3-dione (3h) 
 
The average yield for the title compound was 68% (2 trials) at the 1.0 mmol scale, using 1.5 
equivalents of Langlois reagent, and an irradiation time of 24 hours. The title compound was 
purified by column chromatography on silica gel (10% EtOAc/hexanes) to yield an off-white 
solid. Analytical data for 3h: 1H NMR (400 MHz, CDCl3): δ 7.88-786 (m, 2H), 7.76-7.74 (m, 
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2H), 3.65 (dd, J = 13.8 Hz, J = 7.2 Hz, 1H),  3.59 (dd, J = 13.8 Hz, J = 6.6 Hz, 1H), 2.43-2.38 
(m, 1H), 2.27-2.18 (m, 1H), 2.05-1.95 (m, 1H) 1.09 (d, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 100 
MHz) δ 168.5, 134.2, 131.8, 123.5, 126.8 (q, J = 275.7 Hz), 43.5, 38.1 (q, J = 27.9 Hz), 27.9 (q, 
J ~ 2.4 Hz), 17.7; 19F NMR (564 MHz, CDCl3) δ -63.4 (t, J = 11.0 Hz); IR (thin film) 3918, 
3901, 3882, 1870, 3853, 3838, 3820, 3801, 3779, 3750, 3734, 3710, 3689, 3674, 3649, 3628, 
3618, 3587, 3567, 3545, 2976, 2940, 2883, 1773, 1750, 1716, 1402, 1362 cm-1; LRMS (ESI): 
m/z calculated for C13H13F3NO2 ([M+H]+) 272.0898, found 272.10. 
7,7,7-Trifluoroheptyl 4-methylbenzenesulfonate (3c) 
 
The average yield for the title compound was 64% (2 trials) at the 1.0 mmol scale, using 2.0 
equivalents of Langlois reagent, and an irradiation time of 24 hours. The title compound was 
purified by column chromatography on silica gel (10% EtOAc/hexanes) to yield a colorless oil. 
Analytical data for 3c were in agreement with the literature values:10 1H NMR (400 MHz, 
CDCl3): δ 7.78 (d, J = 8.4 Hz, 2H), 7.34 (d, J = 8.4 Hz, 2H), 4.02 (t, J = 6.2 Hz, 2H),  2.43 (s, 
3H), 2.04-1.97 (m, 2H), 1.65-1.60 (m, 2H), 1.52-1.45 (m, 2H), 1.40-1.20 (m, 4H); 19F NMR 
(376 MHz, CDCl3) δ -66.4 (t, J = 10.9 Hz). LRMS (ESI): m/z calculated for C14H20F3O3S 
([M+H]+) 325.1085, found 325.19. 
7,7,7-Trifluoroheptyl benzoate (3c) 
 
The average yield for the title compound was 42% (2 trials) at the 1.0 mmol scale, using 2.0 
equivalents of Langlois reagent, and an irradiation time of 24 hours. The title compound was 
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purified by column chromatography on silica gel (5% Et2O/hexanes) to yield a colorless oil. 
Analytical data for 3c were in agreement with the literature values:10,15 1H NMR (400 MHz, 
CDCl3): δ 8.06-8.04 (m, 2H), 7.59-7.55 (m, 1H), 7.47-7.43 (m, 2H), 4.34 (t, J = 6.6 Hz, 2H), 
2.12-2.06 (m, 2H)1.82-1.78 (m, 2H), 1.62-1.58 (m, 2H), 1.50-1.45 (m, 4H); 19F NMR (376 
MHz, CDCl3) δ -66.4 (t, J = 10.9 Hz). LRMS (ESI): m/z calculated for C14H18F3O2 ([M+H]+) 
275.1259, found 275.16. 
tert-Butyl (4,4,4-trifluorobutyl)carbamate (3e) 
 
The average yield for the title compound was 25% (2 trials) at the 1.0-1.3 mmol scale, using 2.0 
equivalents of Langlois reagent, and an irradiation time of 24 hours. The title compound was 
purified by column chromatography on silica gel (10% EtOAc/hexanes) to yield a white solid. 
Analytical data for 3e: 1H NMR (400 MHz, CDCl3): δ 4.60 (bs, 1H), 3.23-3.17 (m, 2H), 2.17-
2.07 (m, 2H), 1.80-1.72 (m, 2H), 1.45 (s, 9H); 13C NMR (CDCl3, 100 MHz) δ 155.9, 127.0 (q, J 
= 274.6 Hz), 79.5, 39.4, 31.1 (q, J = 29.1 Hz), 28.3, 22.9; 19F NMR (564 MHz, CDCl3) δ -66.2 
(t, J = 11.0 Hz); IR (thin film) 3350, 2980, 1691, 1525, 1457, 1392, 1367, 1339, 1254 cm-1; 
LRMS (ESI): m/z calculated for C9H17F3NO2 ([M+H]+) 228.1211, found 228.20. 
4-Methyl-N-(4,4,4-trifluorobutyl)-benzenesulfonamide (3f) 
 
The average yield for the title compound was 32% (2 trials) at the 1.0 mmol scale, using 2.0 
equivalents of Langlois reagent, and an irradiation time of 24 hours. The title compound was 
purified by column chromatography on silica gel (5-20% EtOAc/hexanes) to yield an off-white 
solid. Analytical data for 3f: 1H NMR (400 MHz, CDCl3): δ 7.76-7.74 (d, J = 8.2 Hz, 2H), 7.34-
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7.31 (d, J = 8.2 Hz, 2H), 5.03 (t, J = 6.2 Hz, 1H),  3.02-2.97 (m, 2H), 2.44 (s, 3H), 2.14-2.09 (m, 
2H), 1.77-1.70 (m, 2H); 13C NMR (CDCl3, 100 MHz) δ 143.7, 136.6, 129.8, 127.0, 126.8 (q, J = 
274.7 Hz), 41.9, 30.8 (q, J = 29.1 Hz), 22.4 (q, J = 2.9 Hz), 21.5; 19F NMR (376 MHz, CDCl3) δ 
-66.2 (t, J = 10.7 Hz); IR (thin film) 3261, 2952, 1598, 1494, 1442, 1393, 1320, 1306 cm-1; 
LRMS (ESI): m/z calculated for C11H15F3NO2S ([M+H]+) 282.0776, found 282.09. 
tert-Butyl-(3-methyl-2-(trifluoromethyl)butoxy)diphenylsilane (3j)  
 
The average yield for the title compound was 51% (2 trials) at the 1.0 mmol scale, using 2.0 
equivalents of Langlois reagent, and an irradiation time of 24 hours. The title compound was 
purified by column chromatography on silica gel (5% dichloromethane/hexanes) to yield a 
colorless oil. Analytical data for 3j:  1H NMR (400 MHz, CDCl3): δ 7.69 (d, J = 7.2 Hz, 4H), 
7.45-7.37 (m, 6H), 3.87-3.83 (m, 2H), 2.26-2.23 (m, 1H), 2.19-2.16 (m, 1H), 1.09 (s, 9H), 1.03 
(d, J = 7.2 Hz, 3H), 1.00 (d, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3); δ 135.62, 135.59, 
133.1, 129.8, 127.8 (q, J = 280.6 Hz), 127.7, 59.3 (q, J = 3.7 Hz), 50.9 (q, J = 22.7 Hz), 26.7, 
25.1, 20.39, 19.7, 19.2; 19F NMR (565 MHz, CDCl3) δ -64.8 (d, J = 10.2 Hz); IR (thin film) 
3072, 2962, 2933, 2894, 2859, 1658, 1590, 1550, 1529, 1472, 1428, 1391 cm-1; LRMS (ESI): 
m/z calculated for C22H30F3OSi ([M+H]+) 395.2018, found 395.22. 
3-Methyl-2-(trifluoromethyl)butyl benzoate (3k)  
 
The average yield for the title compound was 54% (2 trials) at the 1.0 mmol scale, using 2.0 
equivalents of Langlois reagent, and an irradiation time of 24 hours. The title compound was 
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purified by column chromatography on silica gel (10% dichloromethane/hexanes) to yield a 
colorless oil. Analytical data for 3k:  1H NMR (600 MHz, CDCl3): δ 8.06-8.04 (m, 2H), 7.60-
7.57 (m, 2H), 7.46 (t, J = 7.8 Hz), 4.57-4.50 (m, 2H), 2.52-2.44 (m, 1H), 2.30-2.24 (m, 1H), 1.16 
(d, J = 7.2 Hz), 1.09 (d, J = 7.2 Hz);  13C NMR (150 MHz, CDCl3); δ 166.2, 133.2, 129.6, 128.4, 
127.3 (q, J = 280.1 Hz), 59.9 (q, J = 3.0 Hz), 47.9 (q, J = 24.1), 25.6, 20.9, 19.0; 19F NMR (565 
MHz, CDCl3) δ -66.0 (d, J = 9.6 Hz); IR (thin film) 1726, 1604, 1585, 1470, 1452, 1384 cm-1; 
LRMS (ESI): m/z calculated for C13H16F3O2 ([M+H]+) 261.1102, found 261.07. 
2-(3-Methyl-2-(trifluoromethyl)butyl)isoindoline-1,3-dione (3l) 
 
The average yield for the title compound was 69% (2 trials) at the 1.0 mmol scale, using 2.0 
equivalents of Langlois reagent, and an irradiation time of 24 hours. The title compound was 
purified by column chromatography on silica gel (30% dichloromethane/hexanes) to yield a 
colorless oil. Analytical data for 3l:  1H NMR (600 MHz, CDCl3): δ 7.86−7.84 (m, 2H), 7.74-
7.72 (m, 2H), 4.04 (dd, J = 14.4 Hz, J = 8.8, 1H), 3.72 (dd, J = 14.4 Hz, J = 5.2, 1H), 2.78-2.67 
(m, 1H), 2.17-2.10 (m, 1H), 1.16 (d, J = 7.2 Hz, 3H), 1.08 (d, J = 6.8 Hz, 3H); 13C NMR (100 
MHz, CDCl3); δ 167.9, 134.1, 131.8, 127.4 (q, J = 280.5 Hz), 123.4, 46.0 (q, J = 23.5 Hz), 33.8 
(q, J = 2.9 Hz), 26.1, 19.7, 18.7; 19F NMR (565 MHz, CDCl3) δ -66.4 (d, J = 9.6 Hz); IR (thin 
film) 3545, 3478, 3222, 3087, 3063, 3033, 2970, 2886, 2783, 2701, 2639, 2476, 1952, 1908, 
1775, 1718, 1615, 1520, 1467, 1371 cm-1; LRMS (ESI): m/z calculated for C14H15F3NO2 
([M+H]+) 286.1055, found 286.22. 
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tert-Butyldiphenyl(4,4,4-trifluoro-3-methylbutoxy)silane (3i, Major Regioisomer) and tert-
Butyldiphenyl(2-(trifluoromethyl)butoxy)silane (3i, Minor Regioisomer).  
 
The average combined yield for the title compound was 45% (major:minor = 1.3:1, 2 trials) at 
the 1.0 mmol scale, using 2.0 equivalents of Langlois reagent, and an irradiation time of 24 
hours. Both title regioisomers were purified by column chromatography on silica gel (3% 
dichloromethane/hexanes) to yield colorless oils. Analytical data for 3i: 1H NMR for the major 
regioisomer (400 MHz, CDCl3):  7.67-7.65 (m, 4H), 7.45-7.38 (m, 6H), 3.79-3.69 (m, 2H), 2.49-
2.45 (m, 1H), 2.03-1.97 (m, 1H), 1.48-1.41 (m, 1H), 1.08-1.06 (m, 12H); 13C NMR for the major 
regioisomer (CDCl3, 100 MHz) δ 135.5, 133.6, 133.5, 129.7, 128.6 (q, J = 276.7 Hz), 127.7, 
60.5, 34.5 (q, J = 26.3 Hz), 32.1 (q, J  = 2 Hz), 26.8, 19.2, 12.3 (q, J  = 3 Hz); 19F NMR for the 
major regioisomer (376 MHz, CDCl3) δ -73.4 (d, J = 9.0 Hz); IR for the major regioisomer (thin 
film) 3072, 2958, 2932, 2858, 1590, 1472, 1428, 1390, 1377, 1346, 1326 cm-1; LRMS for the 
major regioisomer (ESI): m/z calculated for C21H28F3OSi ([M+H]+) 381.1862, found 381.17; 1H 
NMR for the minor regioisomer (400 MHz, CDCl3): δ 7.68-7.66 (m, 4H), 7.46-7.39 (m, 6H), 
3.80 (d, J = 4.8 Hz, 2H), 2.16-2.11 (m, 1H),1.76-1.69 (m, 1H), 1.07 (s, 9H), 0.96 (t, J = 7.4 Hz, 
3H);  13C NMR for the minor regioisomer (CDCl3, 100 MHz) δ 135.59, 135.57, 133.2, 133.1, 
129.8, 127.73, 127.72, 127.7 (q, J = 279.0 Hz), 60.1 (q, J = 3 Hz), 46.9 (q, J  = 24 Hz), 26.7, 
19.2, 18.0 (q, J  ~ 2 Hz), 11.3; 19F NMR for the minor regioisomer (376 MHz, CDCl3) δ -68.6 
(d, J = 9.4 Hz); IR for the minor regioisomer (thin film) 3072, 3051, 2960, 2932, 2894, 2859, 
1590, 1472, 1428, 1390, 1362, 1338, 1314 cm-1; LRMS for the minor regioisomer (ESI): m/z 
calculated for C21H28F3OSi ([M+H]+) 381.1862, found 381.23. 
 276 
4,4,4-Trifluoro-1,3-diphenylbutan-1-one (3u, Major Regioisomer) and 2-Benzyl-3,3,3-
trifluoro-1-phenylpropan-1-one (3u, Minor Regioisomer)  
 
The average combined yield for the title compound was 31% (major:minor = 1.1:1, 2 trials) at 
the 1.0 mmol scale, using 3.0 equivalents of Langlois reagent, and an irradiation time of 24 
hours. Both title regioisomers were purified by column chromatography on silica gel (5% 
Et2O/hexanes).  Analytical data for both regioisomers (3u) were in agreement with the literature 
values: 1H NMR for the major regioisomer43 (400 MHz, CDCl3):  7.93-7.90 (m, 2H), 7.61-7.56 
(m, 1H), 7.49-7.45 (m, 2H), 7.42-7.31 (m, 5H), 4.32-4.21 (m, 1H), 3.71 (dd, J = 17.8 Hz, J = 9.0 
Hz), 3.61 (dd, J = 17.8 Hz, J = 4.2 Hz); 19F NMR for the major regioisomer43 (376 MHz, 
CDCl3) δ -69.6 (d, J = 9.8 Hz); 1H NMR for the minor regioisomer44 (400 MHz, CDCl3): δ 7.76-
7.74 (m, 2H), 7.56-7.52 (m, 1H), 7.42-7.38 (m, 2H), 7.23-7.13 (m, 5H), 4.53-4.44 (m, 1H), 3.44 
(dd, J = 13.8 Hz, J = 10.6 Hz), 3.21 (dd, J = 13.8 Hz, J = 3.8 Hz); 19F NMR for the minor 
regioisomer44 (376 MHz, CDCl3) δ -66.4 (d, J = 7.9 Hz). 
General Procedure B for the Hydrotrifluoromethylation of Aryl-Substituted Alkenes.  
 
A flame-dried 2-dram vial was equipped with a magnetic stir-bar, N-Me-9-mesityl acridinium 
tetrafluoroborate (5.0 mol %, 1), sodium trifluoromethanesulfinate (1.1-1.5 equiv), and substrate 
(1 mmol). The solvent, CHCl3/TFE (9:1), was added under a nitrogen atmosphere to a 
concentration of approximately 0.20 M. Liquid substrates were added via microsyringe after the 
catalyst 1 (5 mol %)
CHCl3 / TFE (9:1), RT
PhSH (1.0 equiv)
450 nm LEDs
Ar
R1
Ar
R1
H
R2
CF3SO2Na
(1.1-1.5 equiv)
R2
CF3
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solvent. The vial was sealed with a Teflon-coated septum cap. Thiophenol (1.0 equiv) was added 
via microsyringe through the septum cap and the reaction mixture was irradiated (450 nm) for 24 
hours (unless some other time is indicated). Upon completion, saturated aqueous sodium 
bicarbonate was added, and the two phases were allowed to separate. The organic phase was 
collected, and the aqueous phase was extracted with two portions of dichloromethane equal to 
the reaction volume. The combined organic portions were passed through a short plug of SiO2. 
The solvent was removed under reduced pressure. The final products were isolated by silica gel 
chromatography using the conditions listed. 
(2-(Trifluoromethyl)cyclohexyl)benzene (3s) 
 
The average yield for the title compound was 51% as a mixture of diastereomers (cis/trans = 
12:1) at the 1.0 mmol scale, using 1.1 equivalents of Langlois reagent, and an irradiation time of 
24 hours. The title compound was purified by column chromatography on silica gel (100% 
pentane). Analytical data for 3s: 1H NMR for cis diastereomer (400 MHz, CDCl3): δ 7.32-7.31 
(m, 4H), 7.26-7.22 (m, 1H), 3.14-3.10 (m, 1H), 2.69-2.60 (m, 1H), 2.18-2.08 (m, 2H), 1.98-1.92 
(m, 1H), 1.87-1.80 (m, 1H), 1.76-1.70 (m, 2H), 1.65-1.51 (m, 2H); 13C NMR for cis 
diastereomer (150 MHz, CDCl3) δ 143.1, 128.2, 128.1, 128.0 (q, J = 280.8 Hz), 126.4, 44.6 (q, J 
= 23.4 Hz), 42.0, 28.9, 24.8, 24.3, 22.2; 19F NMR for cis diastereomer (376 MHz, CDCl3) 
δ −62.5 (s, br); 19F NMR for trans diastereomer (376 MHz, CDCl3) −68.6 (d, J = 7.90 Hz); IR 
(thin film) 3089, 3063, 3030, 2940, 2873, 1604, 1496, 1452, 1400, 1383, 1313 cm-1; LRMS 
(GC-MS): m/z calculated for C13H15F3 228.11, found 228.1. Identification of the major and 
minor diastereomers was accomplished using 1H NMR experiments (1D in CDCl3, 1D in C6D6, 
CF3
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19F decoupled 1H NMR in C6D6, COSY) and 19F NMR.  The cis diastereomer (major) has two 
methine protons which are both coupled to vicinal protons with J values that range from 4.6 to 
5.2 Hz. The trans diastereomer (minor) has two methine protons which are both coupled to 
vicinal protons with J values of 3.6 and 11.6 Hz. The latter is consistent with the expectation for 
a pair of diaxial protons in the trans diastereomer. The Diastereomeric ratio was calculated using 
19F NMR peak areas. 
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(2-(Trifluoromethyl)cyclohexyl)benzene (3s) in (C6D6, 19F-Decoupling) 
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2-Benzyl-3,3,3-trifluoropropan-1-ol (3q) 
 
The average yield for the title compound was 51% (2 trials) at the 1.0 mmol scale, using 1.5 
equivalents of Langlois reagent, and an irradiation time of 24 hours. The title compound was 
purified by column chromatography on silica gel (25% Et2O/pentane) to yield a yellow oil. 
Analytical data for 3q: 1H NMR (600 MHz, CDCl3): δ 7.35-7.33 (m, 2H), 7.28-7.25 (m, 3H), 
3.84-3.80 (m, 1H), 3.71-3.67 (m, 1H), 3.08 (dd, J = 13.8 Hz, J = 4.2 Hz, 1H), 2.85 (dd, J = 13.8 
Hz, J = 10.8 Hz), 2.52 (m, 1H), 1.56 (t, J = 6 Hz, 1H); 13C NMR (150 MHz, CDCl3) 
δ 137.5, 129.1, 128.7, 127.6 (q, J = 279.3), 126.8, 58.7 (q, J = 2.7 Hz), 47.2 (q, J = 23.7 Hz), 
30.5 (q, J = 2.55 Hz); 19F NMR (564 MHz, CDCl3) δ −69.1 (d, J = 9.0 Hz); IR (thin film) 3388, 
3089, 3066, 3032, 2942, 2898, 1890, 1668, 1604, 1586, 1497, 1456, 1392 cm-1; LRMS (GC-
MS): m/z calculated for C10H11F3O 204.08, found 204.1. 
1-Chloro-4-(3,3,3-trifluoro-2-methylpropyl)benzene (3o) 
 
The average yield for the title compound was 56% (2 trials) at the 1.0 mmol scale, using 1.1 
equivalents of Langlois reagent, and an irradiation time of 24 hours. The title compound was 
purified by column chromatography on silica gel (pentane) to yield a colorless oil. Analytical 
data for 3o: 1H NMR (400 MHz, CDCl3): δ 7.30 (d, J = 8.2 Hz, 2H), 7.12 (d, J = 8.2 Hz, 2H), 
3.08 (m, 1H), 2.47 (t, J = 10.8 Hz, 1H), 2.43 (m, 1H), 1.04 (d, J = 6.8 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 136.5, 132.5, 130.4, 128.7, 128.0 (q, J = 278.1 Hz), 39.9 (q, J = 26 Hz), 35.0 (q, 
J = 2.7 Hz), 12.0 (q, J = 2.8 Hz); 19F NMR (376 MHz, CDCl3) δ −73.4 (d, J = 8.3 Hz); IR (thin 
OH
CF3
Me
Cl
CF3
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film) 3031, 2987, 2949, 2892, 1901, 1600, 1494, 1467, 1411, 1378, 1335 cm-1; LRMS (GC-
MS): m/z calculated for C10H10ClF3 222.04, found 222.0. 
1-Methoxy-4-(3,3,3-trifluoro-2-methylpropyl)benzene (3n) 
 
The average yield for the title compound was 64% (2 trials) at the 1.0 mmol scale, using 1.1 
equivalents of Langlois reagent, and an irradiation time of 24 hours. The title compound was 
purified by column chromatography on silica gel (3% Et2O/pentane) to yield a yellow oil. 
Analytical data for 3n: 1H NMR (400 MHz, CDCl3): δ 7.10 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 
Hz, 2H), 3.81 (s, 3H), 3.06 (m, 1H), 2.42 (t, J = 10.4 Hz, 1H), 2.40 (m, 1H), 1.02 (d, J = 6.4 Hz, 
3H); 13C NMR (150 MHz, CDCl3) δ 158.3, 130.1, 130.0, 126.3 (q, J = 278 Hz), 113.9, 55.2, 40.2 
(q, J = 25.6 Hz), 34.7 (q, J = 2.7 Hz), 12.0 (q, 2.7 Hz); 19F NMR (376 MHz, CDCl3) δ −73.4 (d, 
8.3 Hz); IR (thin film) 3033, 2994, 2949, 2838, 2550, 1887, 1613, 1585, 1515, 1466, 1422, 1387 
cm-1; LRMS (GC-MS): m/z calculated for C11H13F3O 218.09, found 218.1. 
3,3,3-Trifluoro-2-(4-methoxybenzyl)propan-1-ol (3p) 
 
The average yield for the title compound was 67% (2 trials) at the 1.0 mmol scale, using 1.5 
equivalents of Langlois reagent, and an irradiation time of 24 hours. The title compound was 
purified by column chromatography on silica gel (20% EtOAc/hexane) to yield a yellow oil. 
Analytical data for 3p: 1H NMR (400 MHz, CDCl3): δ 7.16 (d, J = 8.4 Hz, 2H), 6.87 (d, J = 8.4 
Hz, 2H), 3.81 (s, 3H), 3.80 (m, 1H), 3.68 (dd, J = 12 Hz, J = 5.2 Hz), 2.97 (dd, J = 14.2 Hz, J = 
4.8 Hz, 1H), 2.79 (dd, J = 14.2 Hz, J = 10 Hz, 1H), 2.47 (m, 1H), 1.62 (s, 1H); 13C NMR (100 
MHz, CDCl3) δ 158.4, 130.1, 129.4, 127.6 (q, J = 279.5 Hz), 114.1, 58.7 (q, 2.6 Hz), 55.2, 47.4 
Me
MeO
CF3
OH
CF3MeO
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(q, J = 23.5 Hz), 29.6 (q, J ~ 2.5 Hz); 19F NMR (376 MHz, CDCl3) δ -69.1 (d, J = 9.0 Hz); IR 
(thin film): 3690, 3675, 3649, 3002, 2940, 2835, 2549, 1889, 1885, 1771, 1732, 1613, 1515, 
1457, 1390, 1302; LRMS (GC-MS): m/z calculated for C11H13F3O2 234.09, found 234.1. 
2-(3,3,3-Trifluoro-2-(4-methoxybenzyl)propyl)isoindoline-1,3-dione (3r) 
 
The average yield for the title compound was 41% (2 trials) at the 1.0 mmol scale, using 1.5 
equivalents of Langlois reagent, and an irradiation time of 24 hours. The title compound was 
purified by column chromatography on silica gel (25% EtOAc/hexane) to yield a yellow solid. 
Analytical data for 3r: 1H NMR (400 MHz, CDCl3) δ: 7.74 (m, 2H), 7.67 (m, 2H), 7.06 (d, J = 
8.8 Hz, 2H), 6.66 (d, J = 8.8 Hz, 2H), 3.94 (dd, J = 14.2 Hz, J = 7.2 Hz, 1H), 3.81 (dd, J = 14.2 
Hz, J = 7.6 Hz, 1H), 3.64 (s, 3H), 3.27 (m, 1H), 3.13 (dd, J = 14.6 Hz, J = 4 Hz, 1H), 2.63 (dd, J 
= 14.6 Hz, J = 10 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 167.8, 158.2, 133.9, 131.7, 129.4, 
128.6, 127.0 (q, J = 278.9 Hz), 123.1, 113.9, 55.1, 42.0 (q, J = 24.6 Hz), 36.4 (q, J = ~3 Hz), 
32.0 (q, J = 2.6 Hz); 19F NMR (376 MHz, CDCl3) δ; -70.7 (d, J = 8.6 Hz); IR (thin film): 2978, 
2933, 1966, 1716, 1698, 1683, 1653, 1635, 1615, 1541, 1457, 1417, 1383; LRMS (GC-MS): m/z 
calculated for C19H16F3NO3 363.11, found 363.1. 
2-(3,3,3-Trifluoropropyl)naphthalene (3t) 
 
The average yield for the title compound was 29% (2 trials) at the 1.0 mmol scale, using 1.5 
equivalents of Langlois reagent, and an irradiation time of 24 hours. The title compound was 
purified by column chromatography on silica gel (pentane) to yield a white solid. Analytical data 
N
CF3MeO
O
O
CF3
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for 3t: 1H NMR (400 MHz, CDCl3): δ 7.82 (m, 3H), 7.66 (m, 1H), 7.48 (m, 2H), 7.34 (m, 1H), 
3.06 (m, 2H), 2.50 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 136.4, 133.6, 132.3, 128.4, 127.7, 
127.5, 126.7 (q, J = 275.1 Hz), 126.6, 126.5, 126.3, 125.7, 35.6 (q, J = 27.9 Hz), 28.4 (q, J = 3.2 
Hz); 19F NMR (376 MHz, CDCl3) δ −66.5 (t, J = 10.5 Hz); IR (thin film): 2978, 2867, 1793, 
1716, 1698, 1684, 1653, 1616, 1558, 1507, 1456, 1438, 1382, 1306; LRMS (GC-MS): m/z 
calculated for C13H11F3 224.08, found 224.1. 
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